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Abstract 
Peripheral nerve injury as a result of trauma affects approximately I million people in 
Europe and America annually. The current clinical gold standard treatment for repairing 
long gaps is the nerve autograft, in which only -50% of cases result in satisfactory 
functional recovery. Tissue-engineered cellular bridging devices for surgical 
implantation into peripheral nerve injury sites could provide an attractive alternative to 
the autograft. This project reports the development of a robust, anisotropic biomaterial 
with highly aligned cells that can form the basis of a peripheral nerve repair device. 
Engineered neural tissue (EngNT), which is formed from columns of Schwann cells or 
stem cells within a 3D aligned collagen matrix, can promote directed neurite outgrowth 
in vitro. This study demonstrates that sheets of EngNT can be arranged to form the 
'endoneurium' of a peripheral nerve repair device within a NeuraWrapTM outer tube, 
and can be used for the repair of critical sized defects in rat. 
Schwann cells are the preferred cell type for peripheral nerve repair because of their 
ability to enhance axon migration and secrete factors that further increase regeneration. 
However the use of autologous Schwann cells has a number of disadvantages, including 
the sacrifice of host nerve tissue for their extraction and slow expansion times in vitro. 
Various therapeutic cell types and a bovine collagen source that can potentially be used 
to make EngNT to form the device core were investigated. EngNT devices containing 
Schwann cell-like cells from adipose-derived stem cells (dADSC) or human neural 
progenitor cells differentiated to glial cells (dCX) were tested in a critical sized gap in 
the rat sciatic nerve model. The in vivo experiments demonstrated that there is potential 
7 
for the dADS Cs to be used for peripheral nerve repair. The results from the dCX repairs 
were less clear. 
The technology reported here offers a simple, rapid and effective method for the 
manufacture of an aligned cellular biomaterial, and could be applied to a range of tissue 
engineering applications. This study demonstrates that there is potential for EngNT to 
be used in the construction of nerve repair conduits. 
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1.0 Introduction 
1.1 The nervous system 
The nervous system can be divided into two parts: the central nervous system (CNS) 
and the peripheral nervous system (PNS) (figure 1.1). The CNS consists of the brain , 
spinal cord, optic, olfactory and auditory systems. The PNS consists of all the sensory 
and motor nerves that carry infonnation into and from the spinal cord and the brain. 
This research will focus on the PNS, in particular nerve damage and regeneration. 
Brachial plecus---.." 
MusruloclianeCllS-
nerve 
Radial nerve '---'-, n r 
Medan nerve- -¥.f1 
LlldlvpogcSric-
nerve 
Genitofemcral_ 
nerve 
Obturctor nerve -L.j,LU .'-J.----' 
ConITlO'l permeal nerve 
Deep peroneal nerve -- -
Figure 1.1 The nervous system 
?7'~~---- Brain 
~':l+---Cerebellum 
u----Splnal cad 
Sacral 
plecus 
'\-1:-'11\-1---' Femoral 
nerve 
__ Pudendal 
nerve 
- Sclctlc 
nerve 
t'HH -----Tlblal nerve 
The peripheral nervous system is shown in blue (A.M.A. , 1998). 
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There are three types of peripheral nerve, described below. 
Motor: send impulses from the brain and spinal cord to all of the skeletal 
muscles in the body. 
Sensory: send impulses from muscles, sensors (pain, temperature etc.) in the 
skin and within the body to the spinal cord and brain. 
Autonomic nerves: control involuntary and semi-involuntary functions i.e. heart 
rate, digestion, sweating etc. 
Within these, there are different types of nerve fibres, which are classified according to 
their diameter and whether they are myelinated or not, the type of neurotransmitter they 
release and the rate of conduction of action potentials. The in vivo experiments in this 
project use the rat sciatic nerve model, which is a mixed nerve containing sensory and 
motor neurons. 
Schwann cells are the supporting cells for the PNS fibres and are key regulators of 
peripheral nerve development (lessen and Mirsky, 1997). In a healthy nerve, Schwann 
cells either myelinate individual axons or wrap small groups of unmyelinated axons. 
Each nerve fibre (Schwann cells + axon) is surrounded by a layer of extracellular matrix 
(basal lamina), which is made up of collagen IV mainly and includes laminin 
components, and is secreted by Schwann cells. 
The PNS is made up of neurons which each consist of a cell body (soma) and a long 
thin axon which is surrounded by Schwann cells, some of which are myelinating. In the 
PNS, myelination is the process by which the Schwann cell wraps its membrane around 
an axon, creating a sheath which insulates the axon and propagates impulses along the 
axon, facilitating the transmission of nerve impulses. The axons are packed into the 
endoneurium. These are enclosed by the perineurium to form fascicles, which are 
24 
grouped together by the epineurium to form the nerve itself (figure 1.2). The epineurium 
is the strongest component of the nerve trunk and is a major contributor to nerve tensile 
strength (Topp and Boyd, 2006). 
Fig. 1.2 Anatomical overview of a PNS nerve (Stroncek and Reichert, 2008) 
After a peripheral nerve has been damaged, Schwann cells play a crucial role in the 
repair process, due to their ability to de-differentiate, proliferate, phagocytose debris, 
express growth promoting factors , guide regenerating axons and myelinate new axons 
(Hall, 2005). This is explained in more detail in the next section (1.2). 
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1.2 Peripheral nerve damage 
In this research the focus was peripheral nerve injury as a result of trauma. It has been 
reported that 5% of all open wounds of the limbs are complicated by peripheral nerve 
trauma (Mumenthaler and Mattle, 200 I). Each year approximately 300,000 people of 
working age in Europe are affected by peripheral nerve injury (PNI) (Ruijs et al., 2005); 
of these less than 50% regain full function after treatment (lchihara et al., 2008; Kehoe 
et al., 2012). The most frequent cause of PNI is motor vehicle accidents, while gunshot 
wounds, stabbings, sports and birth trauma are also common causes. PNI incurs high 
healthcare, rehabilitation, social and unemployment costs. Patients with disabilities as a 
result of PNIs can be costly to the healthcare system, with average hospital stays of 28 
days each year in America (Noble, 1998). Forearm PNI patients take an average of 273 
sick days (Rosburg et al., 2005), and the estimated cost to society may exceed 50,000 
euros per person for a median nerve injury in the forearm (Dahlin, 2008). Nerve damage 
can have a major impact on the patient's quality of life and can be the cause of lifelong 
pain, numbness and discomfort; often leading to a permanent disability. PNI is more 
common in young people within the working generation, the average age of patients is 
33 years (statistics from a retrospective study in America that reviewed 96 patients with 
various kinds of PNI) (Wangensteen and Kalliainen, 2010), so a successful therapy 
would have a great impact on lifetime productivity. 
Injury to a peripheral nerve induces a series of cellular and molecular changes in the 
injured neurons and their microenvironment (Fu and Gordon, 1997). After a nerve is 
severed, there are cellular and molecular changes that occur in the neuron body, known 
as retrograde reaction and chromatolysis. In these changes, neurons switch from their 
adult phenotype (the transmission state) to a growth state where there are changes in the 
expression of genes that encode for transcription factors (Leah et al., 1991), which 
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regulate the expression of genes involved In cell survival and neurite outgrowth 
(Raivich and Makwana, 2007). 
In the segment of the axon distal to the injury, which is no longer connected to the cell 
body, Wallerian degeneration begins (Dahlin and Brandt, 2004). Wallerian degeneration 
is an active process controlled by specific genes (Wlcf) and signals (Aldalbert et al., 
2005). During Wallerian degeneration, macrophages penetrate the basal lamina and 
invade the Schwann cell tube, where they degrade the myelin sheaths and phagocytose 
debris (Glass, 2004, Dailey et al., 1998). Schwann cells de-differentiate into their 
"survivor" phenotype, resembling immature Schwann cells, changing the expression of 
genes to promote cell proliferation. This switch in phenotype in the denervated 
Schwann cells is associated with the up-regUlation of several growth associated genes 
including those coding for the proteins GFAP and p7S, and neurotrophic factors such as 
NT-3, NGF, BDNF, NT-4, GDNF and IGF-l (Gillen et al., 1997; Fawcett and Keynes, 
1990). The Schwann cells then proliferate by mitosis and align themselves into columns 
inside the basal lamina and form the "bands of Bungner" - these longitudinal structures 
are crucial in the repair process and they lie within the endoneurial tubes and form 
continuous chains of cells (Hall, 2005). 
In the PNS, nerves can successfully regenerate and spontaneously repair two (class I 
and 11) out of the three types of PNS injuries which are possible: class I (neuropraxia) 
involves temporary disruption of conduction without loss of axonal continuity; class 11 
(axonotmesis) involve loss of continuity of the axons and myelin with preservation of 
connective tissue frame work; and class III is where there is a complete cut through the 
nerve (epineurium and endoneurium) (as classified by Sedden, 1943). Axon sprouts will 
begin to emerge from the proximal end of the nerve and elongate along the Schwann 
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cell columns, which provide a pathway that serves as a guide for sprouts of regenerating 
axons to follow (figure 1.3). The regeneration of an axon that has been cut (class 11 and 
III injuries) involves the transfonnation of a stable axonal segment into a highly motile 
tip, called the growth cone. Each regenerating axon can initially give rise to about 10 
axonal sprouts (Witzel et al., 2005), but the branches that do not make peripheral 
connections (innervate muscle or skin) undergo atrophy and disappear with time. The 
growth cones can sense their environment and are guided by neurotrophic (e.g. NGF, 
GDNF, BDNF, NT-3) and neurotropic (e.g. laminin, collagen) factors produced mainly 
by Schwann cells. Once the regenerating axons make contact with the Schwann cells, 
the Schwann cells differentiate and re-myelinate the re-growing axon, however, the 
newly fonned myelin is thinner than nonnal and the newly fonned intemodes (portion 
of nerve fibre between two Nodes of Ranvier, see figure 1.2) are shorter than nonnal 
(Hall, 2005). However, axons are not necessarily functional immediately; the fibre 
diameter (axon + myelin sheath) and motor conduction velocities are a better indication 
of functional recovery and have been shown to increase with time (Ikeda and Oka, 
2012). Although this spontaneous axonal regeneration occurs naturally in vivo after 
class I and 11 peripheral nerve injuries, complete recovery is rare and so surgical 
intervention is often required. Surgical intervention is also required when there is a 
complete cut in the nerve (class III injury). 
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Figure 1.3 Schematic of the events after a peripheral nerve has been cut, shown at the level 
of a single axon 
euron in red, Schwann cells (Schw) in green, myelin in black, macrophages (m) in pink. After 
a peripheral nerve has been cut, the proximal part seals (A) and Wallerian degeneration begins 
in the axon distal to the injury. The Schwann cells de-differentiate to thei r survivor phenotype; 
macrophages clear away debris (B), and the Schwann cells align to form the Bands of Blingner 
to guide regenerating axons (C). Schwann cells differentiate back to their myelinating 
phenotype and remyelinate the new axon (D). Changes known as chromatolys is, also occur in 
the cell body, where the chromatin and cell nucleus are displaced to the cell periphery (E). 
Adapted from Hall , 2005 . 
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Chronically denervated Schwann cells progressively down-regulate growth promoting 
molecules such as neuregulin (Sulaiman and Gordon, 2000). So where there is a large 
defect, it is likely that the regenerating axons will eventually reach "non-responsive" 
Schwann cells, and this has been related to poor motor recovery (Sulaiman and Gordon, 
2000). With time, Schwann cells that have not been reinnervated apoptose (Hall, 2005). 
In ideal conditions, axons grow at a constant rate of around 1-2 mm per day (Jacobson 
and Guth, 1965). The greater the distance the nerve injury is from the target, the longer 
it will take for the axons to reconnect. Therefore the rate of axonal regeneration in the 
complicated environment after trauma, limits how effective the functional outcome may 
be even when the growth is directed. Delayed reinnervation is associated with poor 
muscle recovery, as the extent of muscle atrophy depends on the time that the muscle 
has been denervated. Damage to extremeties due to lack of sensation is also more likely 
to occur during longer recovery periods. The goal is to accelerate and optimise 
regeneration to reduce the delay and thus maximise function. 
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1.3 Current treatments for peripheral nerve injury 
1.3.1 Primary repair 
If there is a small clean cut (creating a gap of usually no more than a few millimetres) in 
the nerve the surgeon can bring the ends together and perform end-to-end surgical 
reconnection of the damaged nerve ends by suturing (figure lA). In 1973 Hueter 
achieved end-to-end repair by an epineurial suturing technique, which became the 
standard method of short gap repair (Millesi, 1973). This particular therapy carries a 
risk of causing fibrosis; however it can be very effective when the nerve ends are 
directly adjacent and can be brought together without introducing any tension (Schmidt 
and Leach, 2003). Localised tension could cause fibroid adhesions in repaired nerves. 
During normal daily activities, peripheral nerves bend and stretch as limbs move, 
exposing the nerves to various mechanical stresses (Topp and Boyd, 2006; Mason and 
Phillips, 2011). This is also accompanied by 'intraneural' movement, of the internal 
structures to accommodate this stress (Abrams et aI., 1998). Peripheral nerves can 
withstand a certain degree of stress and deformation without adverse effects. However, 
failure to restore the biomechanical integrity of peripheral nerves after injury can 
compromise the repair, as a result of the localised tension causing damage to neural 
elements (Topp and Boyd, 2006). The use of conduits or grafts to bridge longer gaps 
(more than a few millimetres) can alleviate tension and is therefore used to improve 
repair. 
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Epineural Repair 
Figure 1.4 Schematic of epineurial repair 
End-to-end repair of a severed nerve by suturing the epineurium of the two stumps, drawing the 
two ends together. (http://www.vet.purdue.edu/cpr/essaysl .html) 
1.3.2 Clinically available devices for peripheral nerve repair 
1.3.2.1 Conduit repair devices 
For lesions more than a few millimetres in length, where a tension-free repair is not 
possible, empty silicone or bioresorbable tubes can be used to bridge the gap at the 
injury site. In 1997 Lundborg et al. used silicone conduits to repair 3-4 mm defects in 
the ulnar and median nerves in the human forearm (Lundborg et aI., 1997). A five year 
follow-up study showed no significant difference in sensory and motor function 
between repair using the silicone conduits and standard microsurgical repair, except that 
cold intolerance was significantly less severe with the tubular technique (Lundborg et 
aI. , 2004). Silicone is not biodegradable and, in 8 out of 17 cases in the Lundborg study, 
the tubes were removed because they caused discomfort. Ideally a tube used for 
peripheral nerve repair should be biodegradable and not cause any discomfort or an 
inflammatory response during degradation. Only 4 absorbable synthetic conduits, 
involving 3 materials (collagen, polycaprolactone and polyglycolic acid) have obtained 
the US Food and Drug Administration (FDA) and the European approval (CE) for 
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clinical use (these have been summarised in table 1.1) (Kehoe et al., 2012; Bell and 
Haycock, 2012). These devices function by providing a conduit to concentrate factors 
and offer overall tissue guidance/containment, with reduced fibrosis/adhesion 
(Danielsen et al., 1993). However empty tubes are only used to bridge gaps of less than 
3 cm in damaged peripheral nerves, the critical gap length in humans, because beyond 
this length structural and trophic support is required to allow regenerating neurites to 
bridge the gap (Gu et ai., 2011; Bell and Haycock, 2012). A study by Maeda and 
colleagues in 1993 tested empty conduits to bridge an 18 mm gap using a 20 mm 
silicone conduit in rat sciatic nerve, which is beyond the critical gap length in a rat 
(Bellamkonda, 2006). During a 16 week observation period no axons were found in any 
of the conduits (Maeda et ai., 1993). This could be due to the lack of an intraluminal 
guidance structure and the absence of living cells (Daly et al., 2012; Bellamkonda, 
2006). 
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C(ll11pall~ N,1I1h: 1\ Iakria I 
SaluMedica SaJubridge polyvinal alcohol (PV A) 
SaluMedica Salutunnel Nerve Protector PVA 
Integra NeuraGen Nerve Guide Neuragen Nerve Guide Bovine type I collagen 
Integra NeuraWrap Nerve Neurawrap Nerve Protector Bovine type I collagen 
Protector 
Synovis Micro companies Neurotube Polyglycolic acid (PGA) 
Alliance Inc. 
Collagen Matrix Inc. Neuroflex Bovine type I collagen 
Collagen Matrix Inc. Neuro Matrix Bovine type I collagen 
Collagen Matrix Inc. Neuromend Bovine type I collagen 
Cook Biotech Products Axo Guard Nerve Connector Porcine small intestine 
submucosa (SIC) 
Cook Biotech Products Axo Guard Nerve Protector Porcine SIC 
Polyganics Neurolac lactide 
caprolactone co-
polyesters (PCL) 
Table 1.1 Clinically approved conduits for peripheral nerve repair 
Decellularised allografts are also available for peripheral nerve repair. These are 
typically prepared by processing harvested nerves with detergent to selectively remove 
cellular components and debris, and they are then terminally sterilized (Brooks et al., 
2011). Decellularised allografts preserve the correct three-dimensional architecture for 
cell migration and nerve fibre elongation and provide the appropriate biomechanical 
properties to the repair site. However these grafts do not contain any living cells, 
limiting their application to the repair of gaps less than 5cm (Brooks et al., 2012; 
Karabekmez et al., 2009). This is discussed in more detail in the next section (1.3.2.2). 
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1.3.2.2 Decellularised repair devices 
AxoGen are the fIrst company to develop a product, Avance® Nerve Graft, for repair of 
gaps > 3 cm in peripheral nerves. A vance ill Nerve Graft is a processed nerve allograft 
which is a decellularised, sterile extracellular matrix from donor human peripheral nerve 
tissue (Brooks et al., 2012; Karabekmez et ai., 2009). A vance® functions include all 
those mentioned above for conduit repairs, and in addition it provides the inherent and 
relevant structural characteristics of peripheral nerve, the structure can be remodelled by 
the host cells and has similar handling properties to the nerve autograft. Additionally, 
chemically decellularised nerve grafts maintain the laminin component within the 
collagen matrix (Karabekmez et al., 2009), which is known to enhance axon 
regeneration (Hall, 1986). 
1.3.3 Nerve autograft 
The current 'gold standard' to bridge larger gaps (> 3 cm) is to use a live nerve 
autograft (Bhandari et al., 2007). Philipeaux and Vulpian fIrst showed that nerve 
regeneration was possible with autografts in a dog model (Philipeaux and Vulpian, 
1870). Later in 1878, Albert Verhandlungen described the fIrst clinical experience of 
nerve grafting (Verhandlungen, 1878). The nerve autograft is typically harvested from a 
cutaneous sensory nerve from the patient, most commonly the sural nerve, and is 
connected to the proximal and distal stumps with micro-sutures. 
A nerve autograft does not provide neurons, as the axons in the nerve grafts degenerate 
leaving the endoneurial tubes and Schwann cells (autologous, denervated). It provides a 
cell-rich environment with the correct tissue architecture (Schwann cell basal laminae) 
to promote cell adhesion and migration, biomechanical properties and guidance cues, 
which promote axon regeneration from the proximal nerve stump. Disadvantages of the 
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nerve autograft therapy include the requirement for an additional surgery, limited nerve 
availability and donor site morbidity, which can include a loss of sensation within the 
harvest area, neuroma formation, pain and scarring (Rappaport et al., 1993; Staniforth 
and Fisher, 1978). 
The success of the nerve autograft depends on the age of the patient, timing of surgery, 
the size of the defect, altered fascicular architecture causing axons to scatter during 
regeneration, the type of nerve injured, the amount of scarring in the surrounding tissue, 
and the distance to the denervated end-organ (Wolford and Stevao, 2003; Matejcik, 
2002). The extent of vascularisation at the site of injury also has an effect on outcome. 
Free-vascularised nerve grafts (where vasculature in the graft is connected to recipient 
vasculature) have a better outcome than non-vascularised nerve grafts (standard 
autograft repair) (Koshima et ai., 1981, Restrepo et ai., 1985). Free-vascularised grafts 
can be used if the wound bed is heavily scarred or poorly vascularised, and when long 
and large calibre grafts are necessary. Harvesting free-vascularised grafts is time-
consuming and requires great clinical expertise. 
Nerve allografts have been used previously, which give similar regeneration to that 
observed in the autograft; however the requirement for immunosuppression and the risk 
of rejection are a major drawback (Rustemeyer and Dicke, 20 I 0; Mackinnon et al., 
200 I). Other biological materials have also been used as a nerve guidance conduit, such 
as vein (Walton et al., 1989; Risitano et al., 2002), muscle (Battiston et ai., 2000) and 
small intestine submucosa (Badylak et al., 1998). 
After peripheral nerve repair, patients are advised to perform physical and occupational 
therapy to aid the cortical remodelling process. Only 50% of patients treated with an 
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autograft regained the function they had prior to their nerve injury (Kehoe et al., 2012; 
Ichihara et al., 2008). In addition, 20% of autograft repairs do not achieve any 
functional recovery (Chiu, 1995). Without being able to guarantee success, most 
surgeons would prefer to avoid a second operation, and in turn, avoid permanent loss of 
function at the donor site. As a result, extensive research efforts have focussed on 
developing an alternative to the nerve autograft or allograft therapy. 
1.4 Neural tissue engineering 
Tissue engineering is a multi-disciplinary field where biology, material science, 
theoretical modelling and engineering combine towards the development of tissue 
replacements that restore or establish normal function (Langer and Vacanti, \993). 
Conventionally, tissue engineering has relied on the use of scaffolds as temporary 
structures to facilitate cell migration into the repair site and then eventually be replaced 
with native extracellular matrix (ECM). More recently scaffolds have been developed 
that can also confer bio-functionality, and this need is reflected in recent reviews which 
describe how the addition of cells and combination of molecular and mechanical signals 
can enhance the repair and regeneration process (Bell and Haycock, 2012; 
Bellamkonda, 2006). In addition to this, other implant properties that are critical to 
function include the scaffold structure and biomechanical properties (Brown and 
Phillips, 2007). It is not essential for a tissue-engineered implant to exactly reproduce 
every feature of the native tissue; the success of tissue engineering is dependent on the 
restoration of adequate function. For some tissues, function must be restored 
immediately, for example covering a skin wound. For peripheral nerve, function is 
restored in time through regenerative processes including the elongation of neurites, 
reconnection of neurons to target organs and subsequent cortical remodelling. The 
initial design requirement for a peripheral nerve repair device therefore is for it to be 
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able to facilitate the repair process, providing an environment for nerve structure and 
function to be restored. 
Recent academic reviews agree that the optimal solution for peripheral nerve repair 
would be an aligned cellular conduit that can (1) mimic the nerve graft to provide 
guidance and growth-promoting factors (secreted by the cells) to enhance regeneration; 
(2) provide adequate mechanical support for the regenerating axons; and (3) prevent the 
infiltration of fibroblasts that inhibit the repair process. However for cell-containing 
conduits, there are hurdles to be overcome regarding the source and availability of 
suitable cells before this can become a viable clinical option (Bell and Haycock, 2013; 
Nectow et al., 2012; Gu et ai., 2011). 
Recent approaches for making guidance conduits include the use of aligned fibres or 
channels, patterned surfaces, electrical and magnetic fields, mechanical loading and 
gradients of physical and chemical cues to organise engrafted and/or infiltrating cells 
(Yao et ai., 2010; Ceballos et al., 1999; Maeda et al., 1993; Eastwood et ai., 1998). 
Various materials are being explored, with surface modifications to support cell 
attachment and the incorporation of growth factors. Ideally the scaffolds would satisfy 
many properties, for example they would be: 
Biocompatible, to be able to support nonnal cellular behaviours, without 
eliciting any undesirable effects or immune responses. 
Biodegradable, to be able to degrade after the regeneration process and be 
remodelled or resorbed into the host tissue. This would avoid the requirement 
for a second operation to remove the device, which is currently required for non-
biodegradable scaffolds (Lundborg et ai., 2004). Clinical and experimental data 
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suggest that the ideal scaffold should biodegrade m 1-2 years (Bell and 
Haycock, 2012). 
Suitable, in terms of its mechanical properties, to be able to withstand the 
loads that nerves are subjected to during nonnal daily activities, i.e. bending and 
stretching. 
Easy to handle and suture, to be robust enough for easy handling and capable 
of implantation. 
These properties are mainly detennined by the scaffold material, manufacturing process 
and structure. The types of scaffolds used can be divided into two categories: natural 
and synthetic materials, which will now be discussed in more detail. 
1.4.1 Neural scaffolds 
1.4.1.1 Natural biomaterials 
Naturally-derived materials, such as the major components in ECM: collagen, laminin 
and fibronectin, have beneficial properties such as stimulating Schwann cell adhesion, 
migration and proliferation (Babington et ai., 2005; Grimpe and Silver, 2002; Gardiner 
et ai., 2007). 
Collagen 
Collagen is a large complex family of molecules, most commonly found as fibrous 
bundles, that interact with each other and other ECM molecules to provide a range of 
structures and functions throughout tissues of the body, for example, bone, cartilage, 
tendon, cornea, blood vessels, skin and nerve (Cen et ai., 2008). Collagen has a triple a-
helical structure, dependent on a highly characteristic sequence of amino acids, with 
glycine in every third position and also has a high content of proline and hydroxyproline 
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(Gordon and Hahn, 2010). Native type I collagen can aggregate into fibrils 
(fibrillogenesis). In fibrillogenesis, the collagens are cleaved by specific enzymes 
(procollagen metalloproteinases). Fibrillogenesis would not occur without these 
proteinases (Alovskaya et al., 2007). Collagen is a highly conserved protein across 
species and there are various types of collagen currently being used in the clinic for 
peripheral nerve repair (see table 1.1 in section 1.3.2.1; Meek and Coert, 2008). 
Collagen has also been used in the clinic for cosmetic surgery (e.g. Zyplast, Zyderm), 
nerve (e.g. Integra) and skin (e.g. Apligraf). 
Various methods have been used for producing aligned collagen materials. These 
include: high strength magnetic field (Guido and Tranquillo, 1993); micro-fluidic 
channels (Lee et al., 2006); electro spinning (Barnes et al., 2007); hydrodynamic flow 
(Edwina et al., 2011) and cellular self-alignment in tethered gels (Phillips et ai., 2005). 
Additionally, collagen can interact directly with cells to influence cell adhesion, growth 
and differentiation, and play an important role in supporting axon growth and synaptic 
connection and maintenance (Fox, 2008). 
Fibrin 
Fibrinogen molecules are comprised of two sets of disulfide-bridged Aa-, B~-, and y-
chains. Each elongated 46 nm structure contains two outer D domains connected to a 
central E domain by a coiled-coil segment (Laurens et al., 2006). Fibrin is formed after 
thrombin cleavage of fibrinopeptides A and B from fibrinogen Aa- and B~-chains, thus 
initiating fibrin polymerization. Double-stranded fibrils form through end-to-middle 
domain (D:E) associations, and fonn a network of fibrin fibres which create a clot 
network (Laurens et ai., 2006). Fibrin plays an important role in the repair process after 
PNI. Within the first 24 hours after PNI, a fibrin cable forms between the two nerve 
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stumps, serving as a scaffold for cell migration, and also becomes populated with ECM 
proteins (Liu, 1992; Williams et a!., 1983). 
Fibrin is currently being used in the clinic in the fonn of 'fibrin glue', as an alternative 
to micro-surgical sutures in peripheral nerve repair (Anani and El-Sadek, 2009) and as 
an outer tube and as a filler for conduits (Kalbennatten et al., 2009). Improved 
regeneration was observed for the repair of a 15 mm gap in rabbit peroneal nerve using 
a vein graft filled with autologous fibrin glue (Choi et a!., 2005). The commercial kits 
for fibrin glue comprise of fibrinogen and thrombin, which react to fonn fibrin at the 
time it is being used (Currie et a!., 2001). 
Other natural biomaterials 
Other ECM proteins have also been used to engineer nerve repair devices; these include 
laminin (Kuappila et al., 1993; Toba et al., 2002), fibronectin (Whitworth et aI., 1995; 
Ahmed and Brown, 1999), hyaluronic acid (Ozgenel, 2003; Wang et al., 1998; Seckel et 
al., 1995), keratin (Lin et al., 2012; Hill et al., 2011; Apel et al., 2008), chitosan (Wang 
et al., 2012; Wang et al., 2005) and silk fibroin (Huang et al., 2012; Ghaznavi et al., 
2011; Yang et al., 2007). 
Laminin can be found in tissues such as endothelium, smooth muscle and bone marrow 
(Durbeej, 2010; Miner, 2008). It has been shown that the expression of lam inin binding 
integrin subunits is upregulated in DRG neurons after sciatic nerve transection in rats 
(Wallquist et al., 2002), and is considered to play an important role in peripheral nerve 
regeneration (Wallquist et al., 2002; Fried et al., 2005). Laminin, collagen, fibrin and 
hyaluronate matrices were compared within tubes for peripheral nerve repair. It was 
found that longer axons were extended and more axons innervated their targets in the 
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repairs using a laminin matrix (Labrador et al., 1998; Navarro et al., 1996). However 
there have been contrasting results, for example, Valentini and colleagues found that 
collagen and laminin-containing gels impeded regeneration in the rat (Valentini et al., 
1987). 
In the repair process after PNI, hyaluronic acid plays a role in organising the ECM in 
the fibrin matrix phase of regeneration to facilitate migration of regenerating axons 
(Wang et al., 1998). Topical application of hyaluronic acid to transected and 
immediately repaired rat sciatic nerve has been shown to prevent scar formation, 
resulting in faster functional recovery (Ozgenel, 2003). It also permits increased nerve 
conduction velocities after a 12 week recovery period following primary repair of 
sciatic nerve with a topical application of hyaluronic acid, compared to application of 
saline (Ozgenel, 2003). Nerve conduction velocities are also increased when hyaluronic 
acid is injected into conduits bridging the gap in rat sciatic nerve after a 4 week 
recovery period, compared to saline controls (Wang et al., 1998). 
Keratin gel has been used to fill empty conduits and improved functional recovery was 
observed in a mouse model after 6 months, compared to an empty conduit or an 
autograft (Apel et al., 2008). 
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1.4.1.2 Synthetic materials 
The main advantage with using synthetic materials is that their chemical and physical 
properties, such as porosity, degradation rate, and mechanical strength, can be 
controlled. The biocompatibility of some synthetic materials is the main challenge, 
because they require surface modifications to support cell attachment and adhesion if 
they are to be used as core elements ofPNI repair conduits (Bell and Haycock, 2012); 
and so laminin, collagen I and fibronectin have been used as coatings (Bell and 
Haycock, 2012). 
Silicone is a non-biodegradable synthetic material that has been investigated for use as 
an outer tube in peripheral nerve repair since the 1960s (Gu et al., 2011). The inert and 
flexible properties of silicone make it a useful experimental tool (Lundborg et aI., 
1982). However the use of silicone in the clinic may cause a chronic foreign body 
reaction that could ultimately inhibit full functional recovery because silicone is non-
biodegradable and remains in situ as a prosthesis (Merle et aI., 1989). Therefore a 
second operation would be required to remove the tube, which has clear disadvantages 
to the patient. 
Biodegradable synthetic scaffolds have been fabricated for use in peripheral nerve 
repair, including poly(lactic acid) (PLA) (Evans et al., 2002; Evans et aI., 2000), 
poly(caprolactone) (Bertleff et al., 2005), polyesters such as polyglycolic acid (PGA) 
for Neurotube® (Shin et aI., 2009) and poly-3-hydroxybutyrate (PHB) (Young et al., 
2002). These can be fabricated with tailored properties, for example a suitable 
degradation rate and permeability. In PLA-based scaffolds, these properties can be 
controlled by electrospinning the PLA with miscible poly(lactide-co-glycolide) (PLGA) 
random copolymers (Kim et al., 2003). 
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1.4.2 Growth factors 
Neurotrophic factors play an important role in nerve regeneration; they promote 
neuronal growth and survival (Rich et al., 1989; Whitworth et al., 1996; Steme et al., 
1997; Bloch et al., 2001). They are produced and secreted by the cells of the nervous 
system (for example, Schwann cells) and are known to regulate neural cell division, 
survival, and neurite outgrowth of certain neuron populations (Lewin and Barde, 1996; 
Terenghi, 1999). Many neurotrophic factors have been identified, and some of the main 
ones are listed below. 
• Nerve Growth Factor (NGF): This neurotrophin is vital for the development and 
the survival of PNS neurons. NGF is synthesised in peripheral targets. NGF 
binds to specific cell surface receptors on the nerve terminals and is retrogradely 
transported to the cell bodies of the neurons. The decrease in retrograde axonal 
transport of endogenous NGF after PNI informs the neuronal cell body that its 
axon has been disconnected from its target. NGF is secreted from denervated 
peripheral targets for a period of time post-injury, and this facilitates 
reinnervation, for example in laboratory tests involving rats with severed 
sensory nerves (Rich et al., 1989; Rush et al., 1995; Bloch et al., 2001). NGF 
has been shown to act specifically on primary sensory neurons and on 
sympathetic neurons (Levi-Montalcini, 1987). It is needed for collateral 
sprouting of nociceptive and sympathetic axons into denervated skin (Gloster 
and Diamond, 1992). However it has been shown that the addition ofNGF after 
PNI could also delay the regeneration process (Gold, 1997). 
• Neurotrophin-3 (NT-3): NT-3 is produced at the motor end plates of adult 
skeletal muscles and has a trophic role on neurons (motor, sensory and 
autonomic) innervating muscles (Braun et al., 1996). 
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• Fibroblast Growth Factor, basic (FGF-2): FGF-2 has been shown to be the most 
important factor for the initiation of nerve repair after trauma or injury (Grothe 
and Nikkah, 2001; Meisinger et al., 1996). It has been shown to increase axonal 
branching, enhance regeneration and promote Schwann cell proliferation in vitro 
and in vivo (Klimaschewski et al., 2004; Jungnickel et al., 2006; Davis and 
Stroobant, 1990). 
• Glial derived neurotrophic factor (GDNF): GDNF has been shown to have a 
trophic effect on sensory. motor and autonomic neurons in vivo (Hoke et al., 
2000; Trupp et aI., 1995). It has also been shown to have an effect on neuronal 
cell survival after axotomy (Zhao et al., 2004; Henderson et al., 1994). 
• Others: brain-derived neurotrophic factor (BDNF), insulin-like growth factor 
(IGF), ciliary neurotrophic factor (CNTF), which can induce pro-regenerative 
responses in neurons (Kirsch et al., 2003; Funakoshi et al., 1993). 
The use of exogenously applied neurotrophic growth factors can be an effective method 
of enhancing PNS nerve regeneration. The NTFs can be conjugated directly to the 
scaffolds for an enhanced biological effect (Bell and Haycock, 2012). Further research 
and development of devices to deliver these neurotrophic factors to the nerve injury site 
is required. Current challenges that are faced in the delivery process include local 
toxicity and poor stability associated with these factors. 
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1.4.3 Support cells 
It is widely reported that conduits filled with glial cells show much better regeneration 
for longer gaps (> 15 mm in rat, and> 30 mm in human) compared to acellular conduits 
(Bryan et aI., 2000; Bellamkonda, 2006; Gu et aI., 2011; Rodrigues et ai., 2012). 
Naturally occurring peripheral nerve regeneration in the body involves Schwann cells, 
which support axonal regeneration by clearing debris, secreting growth factors and 
ECM proteins and guiding axonal growth (Frostick et aI., 1998; Hall, 2005; Madduri 
and Gander, 2010). Cells could be delivered to the site of injury within a hollow tube, 
within a hydrogel, or on the surface of aligned fibres or channels. Schwann cells are a 
potential cellular source for supplying neurotrophic factors at the injury site (Rodrigues 
et aI., 2012). Other cells that may also have the potential to enhance nerve regeneration 
are stem cells i.e. mesenchymal stem cells (MSCs) and neural stem cells (NSCs), which 
are discussed in more detail in section 1.4.3.2 
1.4.3.1 Schwann cells 
The role of Schwann cells in the natural repair and regeneration processes of damaged 
nerves makes them obvious candidates for use in the development of an implantable 
repair device to provide support and guidance to regenerating axons following PNI. 
Promising results have been reported in the rat sciatic nerve model of PNI that show 
implanted Schwann cells assisting in the regeneration process (Ansselin et al., 1997; 
Bryan et al., 2000; Hadlock et aI., 2000; Phillips et ai., 2005). 
There are several challenges facing Schwann cell therapies, in particular the source and 
availability of the cells. Currently there is no clinically approved Schwann cell line. 
Obtaining autologous Schwann cells would require an invasive nerve biopsy, which 
carries some of the same disadvantages as the nerve autograft therapy. Autologous 
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Schwann cells could alternatively be obtained from a pre-degenerated nerve (at the 
injury site) to avoid sacrificing a healthy nerve. However, for any autologous Schwann 
cell source, the long periods currently required for the expansion of these cells in vitro 
would add a time delay to the surgery to repair the nerve (Gu et al., 2011). An 
allogeneic source of Schwann cells has been explored; however, this would require the 
patient to be immunosuppressed to reduce the risk of the cells being rejected (Gu et al., 
2011). An alternative to these approaches would be to use Schwann cell-like cells that 
have been differentiated from stem cells. 
1.4.3.2 Stem cells 
Stem cells are cells that have the ability to self-renew and differentiate, giving rise to at 
least one other cell type. There are three potential sources of stem cells that can be used 
in tissue engineering: embryonic stem cells (ESCs), adult stem cells (ASCs) and 
induced pluripotent stem cells (iPS). ESCs are pluripotent cells derived from embryos 
that have been fertilised in vitro. They have the ability to self-renew through mitotic cell 
division, and have the capability for unlimited, undifferentiated proliferation. This, 
combined with their ability to give rise to any somatic cell except extra-embryonic 
tissue, gives them great potential for use in medical therapies. ASCs are stem cells 
harvested from adults, e.g. mesenchymal stem cells (MSCs) from bone-marrow or 
adipose tissue. Additionally, normal somatic cells can be taken from an adult and de-
differentiated to form iPS, which are ESC-like cells. This is ethically less controversial 
than using ESCs in an allogeneic therapy, but has not been shown to be safe and 
effective in therapy yet. 
Researchers have investigated the potential of stem cells to be used in nerve 
regeneration. Implanted neural stem cells have been shown to participate in tissue repair 
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and regeneration after injury to promote regeneration of peripheral nerve (Murakami et 
al., 2002; Marchesi et al,. 2007; Rodrigues et al., 2012). Table 1.2 shows some of the 
different types of adult stem cells that have been explored for peripheral nerve repair. 
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BM-MSC Hu et al., Rhesus 40 mm gap in Enhanced regeneration (more 
2007 monkey ulnar nerve, 6 axons) and functional recovery, as 
month recovery assessed by muscle recovery and 
period. electrophysiological studies, 
compared to acellular controls. 
Chen et Sprague- 15 mm gap in Improved walking behaviour as 
al. , 2007 Dawley sciatic nerve, 10 measured by footprint analysis, 
(SD) rat week recovery reduced loss of gastrocnemius 
period. muscle weight and greater number 
of regenerating axons within the 
tube, compared to control 
(acellular 2 % gelatin). 
Dezawa et Wister 15mm gap in Differentiated BM-MS Cs, 
al., 2001 rat sciatic nerve, 3 enhanced regeneration as assessed 
week recovery by axon numbers and myelination, 
period. compared to undifferentiated BM-
MSCs. 
Zhang et SD rat Injected into MSCs had differentiated into 
al. , 2004 mechanically Schwann cell-like cells in vivo. 
injured sciatic 
nerve, 3 week 
recovery period. 
Shimizu et Wistar 10 mm gap in Axons regenerated across the gap. 
al., 2007 rat sciatic nerve, 3 Undifferentiated MSCs and those 
week recovery that differentiated into SI 00-
period. With positive cells were compared. 
immunosuppress More axons regenerated when 
ion (human BM- using the differentiated ce1Js. 
MSCs). 
ADSCs Reid et al. , SDRat 10 mm gap in Differentiated ADSCs were 
2011 sciatic nerve, 2 injected within PCL tubes before 
week recovery implantation. DRG protection 
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period. from apoptosis, compared to 
empty tube controls. 
Di Summa SDRat 10 mm gap in Axons regenerated further into the 
et aI., sciatic nerve, 2 conduit with differentiated 
2010 week recovery ADSCs compared to the empty 
period. tubes, but not as far as in devices 
containing differentiated MSCs 
and Schwann cell repairs. 
Sun et aI., SDRat 8 mm gap in More axonal regeneration and 
2011 facial nerve better reinnervation outcomes 
branch, 8 week with ADSCs compared to the 
recovery period. acellular control. 
Hippoca- Murakami Fischer 15 mm gap in After 10 weeks, more myelinated 
mpal et al., rat sciatic nerve, 6 axons and enhanced 
neuronal 2003 or 10 week electrophysiological recovery, 
progenitor recovery period. compared to acellular controls. 
cells 
Neonatal Marchesi Wistar 16mm gap in More regenerated axons in the 
skin/neur- et ai., rat sciatic nerve. cellular repairs, compared to 
al crest- 2007 acellular controls. 
like 
precursors 
McKenzie Shiverer Sciatic nerve Differentiated skin-derived 
et al., or wild was crushed and precursor cells can myelinate 
2006 type cells were axons in Shiverer mice (genetic-
mouse injected into the ally deficient in myelin basic 
nerve distal to protein). 
the injury, 6 
week recovery 
period. 
Table 1.2 Summary table for cells that have been used in peripheral nerve repair 
(Rodrigues et al., 2012, Walsh and Midha, 2009) BM-MSCs = bone marrow-mesenchymal stem 
cells; ADSCs = adipose-derived stem cells. 
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Stem cells could either be used in their "stem" state or pre-differentiated to the desired 
cell type prior to implantation. Delivery of undifferentiated stem cells to the injury site 
can encourage the stem cells to differentiate into the appropriate cell type in vivo (e.g. a 
Schwann cell-like cell in the case of PNI) as a result of cues from their 
microenvironment. In vitro studies have demonstrated that neural stem/progenitor cells 
in co-culture with cells from the nervous system will adopt a phenotype similar to that 
of their neighbouring cells. For example, dorsal root ganglion cultures (mixed cell 
population of neurons and glia) will induce differentiation of neural stem cells into a 
peripheral neuron, Schwann cell or smooth muscle phenotype (Brannvall et al., 2008). 
1.4.3.3 Considerations for translation of cell therapies to the clinic 
The use of stem cells in regenerative medicine is a relatively new field that is quickly 
expanding. Previous accomplishments using stem cells in the clinic encourage further 
research on stem cells for future cell therapies (Hayani et aI., 2007; Rama et aI., 2010); 
although there are many issues associated with their use at the moment, such as their 
source and availability, the lack of control over cell differentiation and their long term 
safety. 
Recent reviews have predicted that the optimal peripheral nerve repair device would 
include a combination of features including guidance and the presence of living cells 
(Bellamkonda, 2006; Bell and Haycock, 2012; Gu et aI., 2011). Under current 
regulations, the European Medicines Agency (EMA) categorises a cell-based therapy as 
"an advanced therapy medicinal product" (A TMP). The nerve repair device developed 
in this study would be further classed as a tissue engineered product, which is defined 
by the EMA as follows. 
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"A product that contains or consists of engineered cells or tissues and is presented as 
having properties for, or is used in, or administered to human beings with a view to 
regenerating, repairing, or replacing human tissue. A tissue engineered product may 
contain cells or tissues of human or animal origin, or both. The cells or tissues may be 
viable or nonviable. It may also contain additional substances such as cellular 
products, biomolecules, biomaterials, chemical substances, scaffolds, or matrices. " 
The US Food and Drug Administration (FDA) classify such a device as a combination 
product: biological (derived from living sources) and medical device class III (intended 
to affect the structure or function). 
There are many hurdles to be overcome before a cell therapy can reach the patient. 
These include: identifying cells/materials that will not cause adverse effects such as 
formation of tumours/ectopic tissue; fully defining the production process and final 
product; meeting regulations and designing appropriate assays to classify the product; 
confirming safety and efficacy. These hurdles and safety issues in some part explain 
why only one autologous cellular nerve repair device has progressed to clinical trials 
(Sabelman and Hentz, clinical trial, 1999). 
1.4.4 Guidance structures within tissue engineered scaffolds 
Anisotropic guidance structures are considered to be critical within a peripheral nerve 
repair device to efficiently bridge large nerve gaps (Kim et al., 2008; Gupta et al., 2009; 
Wang et al., 2011; Daly et al., 2012). When engineering intraluminal guidance 
structures, it is important to consider the scale of the different structural elements; nano-
(tropocollagen, the molecular component ofa collagen fibre ~300 nm), micro- (collagen 
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fibrils -I Jlm) and macro-scale (collagen fibres -10 Jlm). The scale of the structural 
elements determines the dimensions of the environment on a cellular level. Cells 
binding to channels or fibre-based scaffolds with micro-scale architecture flatten and 
spread over them, similar to how they would in monolayer culture. representing a 
pseudo-third dimension. The scale of the material relative to the cells on/within it, plays 
an important role in cell phenotype, influencing cell shape and gene expression (Dutta 
and Dutta, 2009; Leong et aI., 2003: Behonick and Werb, 2003; Cukierman, 200 I ). 
Cells also respond differently when cultured in 3D, compared to 20 cultures, and can 
adopt more in vivo-like morphologies in 3D culture (East et al., 2010). In 3D culture, 
the cells are able to attach to the substrate through most of their membrane surface 
(Stevens and George, 2005). 
The orientation of the scaffold elements directly affects its mechanical properties and 
also provides topographical cues to cells (Murugan and Ramakrishna, 2007; East et al., 
2010; Nisbet et aI., 2009). Directional organisation is displayed in the cell shape and 
cytoskeleton. Contact-guided cellular alignment is primarily due to the orientation of 
actin filaments or microtubules (Oak1ey and Brunette, 1993; Wojciak-Stothard et al., 
1995). Weiss was first to correlate the orientation of substrate and the directional 
growth of cells as contact guidance (Weiss et al., 1945). Table 1.3 provides a summary 
of some of the materials and techniques that have been reported to create anisotropic 
guidance substrates for peripheral nerve repair. 
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Magnetic Collagen I Aligned fibres guided neurite Guido and 
alignment outgrowth Tranquillo, 
1993; Ceballos 
et al. , 1999; 
Dubey et al., 
1999 
Fibrin Dubey et al., 
2001 
Injection Poly(lactic- Porous conduits Reduced dispersion Hadlock et al .. 
moulding co-glycolic with of regenerating 2000; Sundback 
acid) longitudinal axons, guided et al., 2003 
channels outgrowth 
Collagen Micro-fluidic Guided channels Lee et al., 2006 
channels 
Electrospun Collagen Aligned fibers Improved Tong et al. , 
fibers fibre regeneration in rat 1994 
bundles sciatic nerve model 
Poly- Nanofibres Guided cell Schnell et al., 
[epsilon]- migration and 2007 
caprolactone neurite outgrowth 
(PCL) 
Polyamide Aligned Supported Lundborg et a/. , 
filaments regeneration across 1997 
15mm gap in rat 
sciatic nerve model 
Self- Collagen Columns of improved Phillips et al. , 
alignment type I aligned cells regeneration in vivo 2005 
in tethered within an in rat sciatic nerve 
gels aligned collagen model 
matrix 
Table 1.3 Some of the current techniques and materials used to fabricate anisotropic 
neural scaffolds 
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Hydrogels consist of nano-scale fibres and represent true 3D substrates. They possess 
the desired properties for engineering: capacity for water retention, nano/micro-porosity 
to allow cells to grow and arrange in 3D, biodegradability and porosity to permit 
oxygen and nutrient diffusion (Dutta and Dutta, 2009). Phillips and colleagues used a 
tethered hydrogel with columns of aligned Schwann cells to repair a 5 mm gap in rat 
sciatic nerve (Phillips et aI., 2005). In this study the cellular hydrogel was tethered 
within a silicone tube. The Schwann cells in the collagen formed stable integrin-
mediated attachments with the collagen fibrils. Over time, the cells generated contractile 
forces, which led to gel compaction (Brown and Phillips, 2011). The tethering self-
aligning system avoids the need to manufacture elaborate scaffolds with surface 
modification to support cell attachment, and for a cell-seeding and/or cell alignment 
step. It also uses native collagen rather than synthetic materials. 
The high fluid content of hydrogels means that they have poor mechanical stability 
(Cheema et al., 2007), limiting their use as a scaffold for tissue engineering 
applications. If the gels can be made mechanically stable then a simple and effective 
aligned cellular material could be made, which is the focus of this project. 
Brown and colleagues previously reported that a compressive load can be applied to 
fully hydrated collagen gels to rapidly remove most of the interstitial fluid from the gel 
(Brown et al., 2005). This increases the collagen and cell density by - 50 fold without 
affecting cell viability, producing more robust cellular collagen sheets; this process is 
called plastic compression (Brown et al., 2005). 
This project began with the hypothesis that combining the tethered self-alignment 
technology with the plastic compression process could produce robust, mechanically 
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stable collagen sheets with chains of aligned supporting cells. The key advantage of this 
approach is that it achieves a stable 3D structure without the use of chemical cross-
linking agents, and provides guidance, neurotrophic factors and biological cues in a 
single approach. The purpose of this work was to develop a material that could promote 
guided neuronal growth for use in a peripheral nerve repair device. 
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1.5 Aims and objectives 
The overall aim of this PhD was to develop an implantable tissue-engineered device for 
the surgical repair of the peripheral nervous system. This was divided into three main 
objectives: 
1. To develop and optimise a robust biomaterial with highly aligned cells 
[Engineered Neural Tissue (EngNT)] that could potentially form the basis of a 
peripheral nerve repair device. 
2. To engineer an 'endoneurium' using EngNT that supported the re-growth of 
axons across the gap in injured nerves. 
3. To investigate the feasibility of constructing a repair device from EngNT using 
clinically relevant cells and materials. 
Objective I was addressed by first investigating whether the alignment achieved in 
tethered hydrogels could be stabilized when the gel is removed from the tethering bars 
for implantation, and optimising EngNT. An in vitro co-culture experiment with 
primary adult neurons was used to investigate whether EngNT could support guided 
neurite outgrowth. The next step (objective 2) was to investigate whether EngNT could 
form the basis of a functional peripheral nerve repair device in vivo. This was addressed 
through the exploration of two different EngNT arrangements (rods and sheets) within 
an outer tube in the short gap rat sciatic nerve model, with the best arrangement taken 
forward for testing in a long gap model, which is representative of the clinical situation. 
The fmal part of this study was addressed by testing different types of stem cells 
(undifferentiated and differentiated) within EngNT and assessing their ability to 
promote guided neurite outgrowth in vitro. Promising cell types were taken forward for 
testing in a pilot in vivo study to assess whether they could support neuron regeneration 
across a long gap in the rat sciatic nerve. 
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2.0 Materials and methods 
2.1 Materials 
The following tables list the cell lines purchased (table 2 .1 ), the consumables (table 
2.2), and the antibodies (table 2.3) used for this project. 
Cell line Supplier C~'tul()gue numher 
F7 Schwann cell line, rat Health Protection Agency 93031204 
Culture Collections, UK 
ReNcell CX cells, human MiIlipore, UK SCC007 
Table 2.1 Cell lines used in this project 
This table includes the names of the cell lines, suppliers and catalogue numbers. 
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Dulbecco's modified Eagle's Sigma-Aldrich, UK 06426 
medium (DMEM) 
Fetal bovine serum (FBSIFCS) Sigma-Aldrich, UK F74524 
Penicillin-streptomycin (PIS) Sigma-Aldrich, UK P0781 
DMEM-complete is OMEM supplemented with 10% FCS and 1 % PIS 
ReNcell Neural Stem Cell Millipore, US SCM005 
Maintenance Medium 
Trypsin-EDTA solution (IX) Sigma-Aldrich, UK T3924 
Accutase™ Millipore, US SCR005 
Poly-O-Iysine Sigma-Aldrich, UK P7886 
Poly-L-lysine Sigma-Aldrich, UK P6282 
Lam in in Sigma-Aldrich, UK L-2020 
Phosphate buffered saline (PBS) Sigma-Aldrich, UK P44J7 
Paraformaldehyde (PF A) Fischer-Scientific, UK P/0840153 
Sodium borate BOH, UK 3023 1 
UranyJ acetate Agar Scientific, UK Rl206A 
Osmium tetroxide Agar Scientific, UK R1015 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, UK 05879 
Cytosine Arabinoside (Ara-C) Sigma-Aldrich, UK CI768 
Collagenase type IV Sigma-Aldrich, UK C9407 
£-amino Caproic acid (E-ACA) Sigma-Aldrich, UK A2504 
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2-mercaptoethanol Sigma-Aldrich, UK M3148 
All-trans-retinoic acid Sigma-Aldrich, UK R2625 
Platelet-derived growth factor -
PeproTech, UK 315-17 
AA (PDGF-AA) 
Basic fibroblast growth factor 
Sigma-Aldrich, UK F0291 
(FGF-2) 
Forskolin Sigma-Aldrich, UK F6886 
Glial growth factor-2 (GGF-2) Millipore, US GF030 
Neuregulin-l (NRG-l) Millipore. US 01-201 
Recombinant human fibroblast 
Millipore, US GF003 
growth factor-basic (FGF-2) 
Epithelial growth factor (EGF) 
Millipore, US GF144 
human recombinant protein 
Minimum essential medium 
Sigma-Aldrich, UK M0275 
(MEM) lOX 
Rat tail collagen type I First Link (UK) Ltd. 60-30-810 
Bovine collagen type I 
Invitrogen ™ Life 
A 10644-01 
Technologies, US 
Sodium hydroxide (NaOH) Fischer-Scientific, UK S/4930/17 
Fibrinogen (Fb) Sigma-Aldrich, UK F8630 
Thrombin (Th) Sigma-Aldrich, UK T9549 
CellTracker™ Green CMFDA Invitrogen TM, US C7025 
Hoechst 33258 (Bisbenzimide) Sigma-Aldrich, UK 861405 
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Propidium Iodide (PI) Sigma-Aldrich, UK 81845 
Trypan blue solution (0.4%) Sigma-Aldrich, UK T8154 
Toluidine blue VWR,UK JTW143-3 
Triton® X-lOO Sigma-Aldrich, UK T9284 
Goat serum Dako, Denmark X0907 
FluorSave ™ CalbioChem®, UK 345789 
Isoflurane anaesthetic Minrad Inc, UK From the pharmacist 
Rimadyl analgesic Pfizer, US From the pharmacist 
Lacri-lube Allergan®, UK From the pharmacist 
Opsite skin spray Smith & Nephew, UK From the pharmacist 
10-0 sutures eSutures 2830G 
4-0 sutures Westons W392H 
Neura Wrap ™ Integra LifeSciences, US NW340 
Silicone tubing (medical grade) SF Medical, US SFM3-3050 
aCT Embedding matrix Thermo Scientific 12678646 
Gelatin from porcine skin, type 
Sigma-Aldrich, UK G1890 
A 
Table 2.2 Consumables used in this project 
This table includes the names of the reagents, solutions and other, the supplier and catalogue 
numbers, which were used in this project. 
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Rabbit, polyc1onal anti-S 100 I 1:200 I Dako, Denmark I Z03 11 IOyLight® 488 1:200 Vector I DI-1488 
or 549. Goat Laboraties, 
Rabbit, polyc1onal anti-glial fibrillary 1 :300 Dako, Denmark Z0334 
anti -rabbit IgG US I or 
acidic protein (GFAP) (H+L) I DI-1549 
Rabbit, anti-integrin ~ 1 1:500 Millipore, US AB 1952-20 
Rabbit, anti-nerve growth factor receptor 1:200 Chemicon, UK I ABI554 
p75 
Rabbit, polyclonal anti-sox 10 1:200 Millipore, US MAB5727 
Mouse, monoclonal anti-~-tubulin III 1 :400 Sigma-Aldrich, UK T8660 OyLight® 488 1:200 Vector I DI-2488 or 
or 549. Goat Laboraties, DI-2549 
Mouse, anti -neurofilament 11:1000 1 Covance, UK 1 AMI-35R 1 anti-mouse IgG US 
Mouse, anti-nest in /1:200 / Millipore, US MAB5326 I (H+L) 
Mouse, anti -CD54 /1:100 / Millipore, US MAB2130 
Mouse, anti -CD45 I : lOO Millipore, US 2003607 
Mouse, anti -CDl4 1:000 Millipore, US 2003608 
Table 2.3 Antibodies used in this project 
The table includes the names, suppliers and catalogue numbers of the antibodies used within this project, and the dilutions they were used at. 
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2.2 Cell culture 
2.2.1 Schwann cells (F7 cell line) 
The rat Schwann cell line SCL 4.11F7 (obtained as frozen stocks from the Health 
Protection Agency) was originally derived from neonatal Wistar rat Schwann cells 
(Haynes et aI., 1994). These cells were chosen for the initial experiments to optimise the 
production of EngNT, to ensure a ready supply of cells in the quantities required. 
Cells were cultured on standard tissue culture plastic and the nutrient medium. DMEM-
complete, was replaced every 2-3 days until cells were approximately 80 % confluent, 
as observed under phase-contrast microscopy, at which point they were either sub-
cultured or used for experiments. Cells were removed from the culture dishes by 
trypsinisation with 0.25 % trypsin-EDTA solution for 7-10 minutes at 37 cC, 5 % CO2 
in air; and were recovered by centrifugation at 400 x g for 5 minutes and the pellet was 
resuspended in DMEM-complete for use in the various systems in this study. 
2.2.2 Primary adult rat neurons 
All animal tissue was obtained according to the UK Home Office regulations following 
approval by the Open University Animal Ethics Advisory Group. Adult rats were 
euthanized by carbon dioxide asphyxiation (schedule 1 method) according to the UK 
Animals (Scientific Procedures) Act 1986. 
To obtain the dorsal root ganglia (DRGs), first the spinal column was excised from 
adult Sprague-Dawley rats (250-350 g) that were culled using carbon dioxide (C02) 
asphyxiation. The column was divided in half in the sagittal plane to expose the spinal 
cord, and the cord tissue was removed to expose the DRG and roots in the intervertebral 
foramen. Using the Olympus SZ40 dissecting microscope with Volpi, Intralux® 6000 
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optical fibre light source, the DRGs were removed and placed in a petri dish containing 
DMEM-complete. Twenty DRGs were collected from the thoracic and lumbar regions, 
and cleaned by removal of the roots, capsule and capillaries. Cleaned DRGs were 
placed in a fresh petri dish containing DMEM-complete. The cleaned DRGs were 
dissociated after incubation in 2 ml 0.125 % collagenase type IV (prepared in serum-
free DMEM medium supplemented with 100 f.1g/ml PIS solution) at 37°C, 5 % C02 in 
air for 90 minutes. The collagenase-treated explants were mechanically dissociated 
(triturated) with a 1 ml Gilson pipette. Collagenase was removed by two 20 ml spin 
washes in DMEM-complete at 400 x g for 5 minutes. The pellet was resuspended in 
DMEM-complete supplemented with 0.0 I mM cytosine arabinoside (to deplete the 
dividing satellite glial cells and any fibroblasts, leaving an enriched primary culture of 
adult rat neurons), and plated in a poly-d-Iysine (PDL)-coated (50 mg/ml, RT, 30 
minutes) T75 flask (1-2 rats per flask) and incubated at 37°C, 5 % CO2 for 24 hours 
before use. 
DRG neurons were maintained in PDL-coated flasks and used within 48 hours. They 
were removed by trypsinisation with 0.25 % trypsin-EDTA solution for 7-10 minutes at 
37°C, 5 % CO2• Cells were recovered by centrifugation at 400 x g for 5 minutes and 
then resuspended in DMEM-complete medium for use in the various systems in this 
study. 
2.2.3 Primary rat bone marrow-mesenchymal stem cells 
The femurs of 20 day old Sprague-Dawley rats were harvested from both hind legs 
following C02 asphyxiation. Femurs were trimmed to exclude the proximal and distal 
epiphyses and trimmed of excessive muscular tissue. The bone marrow was flushed out 
with DMEM-complete using a 23G needle. Bone marrow was flushed from both 
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directions, in turn, until all material was recovered. The bone marrow was mechanically 
dissociated using a lml pipette and plated on to PDL-coated T75 flasks (1-2 rats per 
flask; flasks coated as previously described). Daily media changes were required to 
remove the non-adherent haematopoietic cells. Cells were used when 80 % confluent 
without passaging, at which point they were dissociated by trypsinisation (as described 
previously). 
2.2.4 Primary rat Schwann cell-like cells derived from adipose stem cells 
Adipose-derived stem cells (ADSCs) were isolated and differentiated into Schwann 
cell-like cells by Dr Paul Kingham, Umea University, Sweden, using previously 
published protocols (Kingham et al., 2007). 
Isolation of ADSCs 
ADSCs were obtained from adult Sprague-Dawley rats. Visceral fat encasing the 
stomach and intestines was carefully dissected and minced using a sterile razor blade. 
Tissue was then enzymatically dissociated for 60 minutes at 37 cC using 0.15 % (w/v) 
collagenase type I. The suspension was passed through a 70 Jlffi filter to remove 
undissociated tissue, enzymes were neutralized by the addition of Modified Eagle 
Medium (a-MEM) containing 10 % (v/v) foetal bovine serum (FBS) and cells were 
recovered by centrifugation at 800 x g for 5 minutes. The stromal cell pellet was 
resuspended in MEM containing 10 % (v/v) FBS and 1 % (v/v) PIS solution. Cultures 
were maintained at sub-confluent levels in a 37 QC incubator with 5 % CO2 and 
passaged with trypsin-EDT A as required. 
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Differentiation of ADSCs to a Schwann cell phenotype 
Growth medium was removed from sub-confluent ADSC cultures at passage 2 and 
replaced with medium supplemented with I mM ~-mercaptoethanol for 24 h. Cells were 
then washed and fresh medium supplemented with 35 ng/ml all-trans-retinoic acid was 
added. A further 72 h later, cells were washed and medium replaced with differentiation 
medium: cell growth medium supplemented with 5 ng/ml platelet-derived growth 
factor-AA (PDGF-AA), 10 ng/ml basic fibroblast growth factor (bFGF), 14 IlM 
forskolin (FSK) and 252 ng/ml glial growth factor (GGF-2). Cells were incubated for 2 
weeks under these conditions, with fresh medium added approximately every 72 h. 
The resulting Schwann cell-like cells were cultured on standard tissue culture plastic 
and the nutrient medium [DMEM-complete supplemented with 10 mM FSK, 100 Ilg/ml 
bFGF, 100 Ilg/ml Neuregulin-l (NRG I)] was replaced every 2-3 days until cells were 
approximately 80 % confluent, as observed under phase-contrast microscopy, at which 
point they were either sub-cultured or used for experiments before passage 8. Cells were 
passaged by trypsinisation, as described previously. Cells were recovered by 
centrifugation at 400 x g for 5 minutes and the pellet was re suspended in DMEM-
complete for use in the various systems in this study. 
2.2.5 Human neural progenitor cells (ReNcell ex cell line) 
ReNcell CX (Millipore UK Ltd.) is an immortalized human neural progenitor cellline 
with the ability to readily differentiate into neurons and glial cells (ReNcell CX 
immortalized cell line, Millipore, 2012, SCC007, data sheet). ReNcell CX was 
originally derived from the cortical region of human fetal brain. 
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Undifferentiated CX cells (uCX) were cultured on laminin-coated flasks (20 Ilg/ml 
laminin in DMEMlF12 for at least 4 h at 37°C, 5 % CO2). Cells were cultured in 
ReNcell NSC Maintenance Medium supplemented with 20 ng/ml FGF-2 and 20 ng/ml 
EGF. Nutrient medium was replaced every 2-3 days until cells were approximately 80 
% confluent, as observed under phase-contrast microscopy, whereupon they were either 
sub-cultured or used for experiments. Cells were dissociated with 3-5 ml Accutase™ for 
3-5 minutes at 37 cC, 5 % CO2 and cells were recovered by centrifugation at 300 x g for 
3-5 minutes. 
Differentiation of uCX to a population of mixed glia 
Differentiation was initiated when cells were approximately 50-60 % confluent (to 
prevent overgrowth of the cells by the end of the two-week differentiation protocol), by 
replacing medium with fresh ReNcell NSC Maintenance Medium that did not contain 
FGF-2 and EGF. Medium was replaced every 2-3 days for 2 weeks, with no FGF-2 and 
EGF in the basal medium. Cells were dissociated with 3-5 ml Accutase™ for 3-5 
minutes at 37 QC, 5 % CO2 and were recovered by centrifugation at 300 x g for 3-5 
minutes. 
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2.3 3D hydrogels 
After trypsinisation of cells to be used in culture systems, the number of cells recovered 
was determined using a haemocytometer. The haemocytometer was moistened and a 
coverslip was fixed over the top, creating a chamber between the coverslip and the 
haemocytometer. Cell suspension (7 J.ll) was added to this chamber and then observed 
under the 10X objective on a light microscope. The number of cells in the grid of the 
four corners (16 squares per corner) were counted. The total number of cells was 
divided by four to give an average per corner, and then multiplied by 104 to give the 
number of cells per ml. 3D hydrogels (collagen type I or fibrin) were prepared as 
described below. Details of the cell densities used in the gels are provided for individual 
experiments or protocols. 
2.3.1 Collagen type I 
Type I collagen (2 mg/ml in 0.6 % acetic acid) and 10x MEM were mixed and kept at 
2-4 QC until neutralisation with drop-wise addition of concentrated (10 mM) and dilute 
(1 mM) sodium hydroxide (NaOH). CollagenlMEM solution was mixed by swirling 
after each addition of NaOH and neutralisation was indicated by a colour change of 
phenol red pH indicator in the medium (from yellow to peach/orange). The neutralised 
collagenIMEM solution was then added to the cell suspension containing the 
appropriate number of cells, and swirled to mix, in a final mixture ratio of: 80 % (v/v) 
collagen, 10 % (v/v) 10x MEM and 10 % (v/v) cell suspension. The gel mixture was 
dispensed into appropriate culture vessels or moulds (section 2.4) and left to set for 10-
15 minutes at 37°C before overlaying with appropriate culture medium. 
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2.3.2 Fibrin 
Fibrinogen (5 mg/ml in PBS) was mixed with the appropriate cell suspension (in 
DMEM-complete), and then added to the thrombin (2 V/ml in PBS). These were mixed 
slowly by triturating in a final mixture ratio of: 67 % (v/v) fibrinogen, 16.5 % (v/v) cell 
suspension and 16.5 % (v/v) thrombin. Gels were cast into the tethered moulds (see 
section 2.4.1 for detail) and left to set for 20 minutes at 37°C. Gels were then topped up 
with 7 ml of culture media containing 1 mg/ml of €-Amino Caproic Acid (E-ACA), to 
inhibit enzymatic degradation of the fibrin gel by fibrinolysis. E-ACA prevents the 
binding of plasmin to fibrin and thus blocks fibrinolysis. Fibrin tethered gels were left 
for 18 hours to permit contraction. 
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2.4 Engineered neural tissue protocol 
EngNT is a tissue-like robust hydrogel with highly aligned cells (prepared as described 
in East et al. , 2010). Rat tail and bovine collagen I, and fibrin hydrogels were used for 
preparation of EngNTs for the experiments in this project. The process for making 
EngNT can be divided in two parts: making tethered gels, and then stabilising them 
using the plastic compression process (figure 2.1). 
1. The cellular collagen 
gel i, ca,t into a rectangular 
mould and tethered at 
2. The cell' attach to the 
extracellular matrix 
each end. 
tethering 
~rs 
rectangular 
mould 
petri 
dish 
5. Engineered Neural Tissue (EngNT): 
A tissue-like robust hydrogel wrtIl 
highly Iligned cells 
Figure 2.1 Production of EngNT 
12 hours 
3. The cells contract the gel and 
become elongated. forming chains 
along the longitudInal 
axis of the gel 
..-. 
4. Stabilisation of aligned cellular gel 
by removal of intersbtial ftu id 
This shows the general scheme for the production of EngNT using collagen. However the 
materials and timings were varied in the experiments. 
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2.4.1 Tethered cellular gels 
Cellular hydrogels were prepared as described in section 2.3 and cast in the tethering 
system (Figure 2.2), which was within a petri dish and on a cold block to reduce the rate 
of fibrillogenesis. The cellular collagen solution was integrated with the tethering bars 
using a 200 III Gilson pipette, incubated for 10-15 minutes to allow it to set at 37 DC, 5 
% CO2 and then overlaid with 7 ml of DMEM-complete mediwn before returning it to 
the incubator for 24 hours to pennit gel contraction and cellular self-alignment. 
Figure 2.2 Tethered gel preparation 
Stainless steel mould and tethering bars used for self-aligning tethered gels (A), mould with 
tethering bars in position that will anchor the gel at opposite ends (B), contracted, aligned 
hydrogel (c), and a rolled plastic compressed collagen construct (adapted from East et al., 
2010). 
The cells within this tethering system self-align along the long axis of the gel as a result 
of the tension they generate between the two attachment sites (Eastwood, 1998; Brown 
and Phillips, 2004; Phillips et al. , 2005 ; Alovskaya et al. , 2007). 
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2.4.2 Plastic compression 
Plastic compression (Brown et ai., 2005) is the process used to stabilise the cellular 
alignment in the hydrogel (figure 2.3), once it is removed from the tethering system. 
This process involves loading the gel with a 120 g weight to irreversibly expel most of 
the interstitial fluid held within the mesh of collagen fibrils (the fluid being absorbed by 
filter papers), thereby increasing the matrix and cell density and producing a robust, 
aligned cellular hydrogel (EngNT). 
120g load ---..!>..J 
/ 
glass 
hydrogel-~~~""'~"'.a.:;:-
st ainles s .-.r,.......,tI:-lr::~ __ _ on mesh 
steel mesh L-___ -=:...::.:. __ ---.:~-filter paper x3 
Figure 2.3 Stabilisation of cellular alignment by plastic compression 
The gel is placed between the two nylon meshes, and the weight is applied for I minute (unless 
otherwise stated). 
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Fully-hydrated gels in 24 well-plates were gently removed using a spatula (for initial 
experiments in chapter 3). Tethered gels were cut away from tethering bars (in the 
stabilisation process), so the tethering mould could be gently lifted away from the gel. 
The gel was placed between the two nylon meshes and the 120 g load was applied for I 
minute (unless otherwise stated). For experiments to assess cell survival and alignment 
post-plastic compression, and for co-culture with DRGs, the top layer of nylon mesh 
was slowly peeled away leaving the bottom layer of nylon still in contact with the 
compressed gel. The compressed gel on the nylon mesh was then submerged in a petri 
dish of media, allowing the gel to float away from the nylon. For experiments where the 
tethered cellular gels were compressed and used to generate EngNT rods, the 
compressed gel, with the fluid-leaving surface (FLS) exposed, was gently rolled otT the 
top layer of nylon along the longitudinal axis (the FLS on the inside) forming a rod 
shaped structure (Figure 2.2D). These rods were then placed in a petri dish of DMEM-
complete and, when cut to size, were ready for device assembly. 
2.5 In vitro co-culture of EngNT with neurons 
EngNT was made as described in the previous section. DRG neurons were prepared as 
described in section 2.2.2. These were seeded onto the surface (not the FLS) of EngNT 
sheets in a petri dish with no medium, allowed to settle for 30 minutes, then constructs 
were immersed in culture medium at 37 °C in a humidified incubator with 5 % C0 2/95 
% air. After 3 days the EngNT-neuron co-cultures were washed briefly in phosphate 
buffered saline (PBS) and fixed with 4 % paraformaldehyde (PF A) for 24 hours, then 
immunofluorescence staining was carried out as described in section 2.9.1, to detect 
PIII-tubulin-positive neurons and to label the cells used in the EngNT with a suitable 
antibody against a specific marker. 
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2.6 Tensile testing 
This experiment was conducted by Dr Darren Burke from Bose Limited. Tensile testing 
was used to compare the mechanical behaviour of fresh rat sciatic nerve and acellular 
sheets of plastic compressed collagen. For this experiment, 40 mm lengths of sciatic 
nerve (starting from 5 mm distal to the hip joint) were collected from female 240-300 g 
Sprague-Dawley rats killed by CO2 asphyxiation, and acellular plastic compressed 
sheets of collagen were made. Nerves were maintained at their in situ length on a frame 
made from a piece of card. For each experiment, nerves and sheets of collagen were 
connected to a Bose ElectroForce 3100 system (Bose, UK). Each nerve or construct was 
stretched at a rate of Imm per minute and was tested until point of breakage. WinTest 
Control software was used to produce force/extension curves, from which the resistance 
to deformation of each nerve and sheet of collagen could be assessed. 
2.7 In vivo testing in the rat sciatic nerve model 
2.7.1 Device assembly 
The outer sheath of the device (a silicone tube with a longitudinal slit or NeuraWrapTM) 
was cut to 8 mm for a 5 mm gap and 18 mm for a 15 mm gap to allow a 1.5 mm overlap 
with each nerve stump. EngNT rods or sheets were positioned within the conduits. The 
silicone closed naturally due to its elastic structure, and NeuraWrapTM was closed using 
10-0 sutures along the seam. 
2.7.2 Surgery 
Surgery and animal care were performed in compliance with institutional guidelines, 
under a Home Office Licence. Adult (250-400 g) Sprague-Dawley rats (a transgenic p. 
actin-green fluorescent protein (GFP) reporter line or wild type) were deeply 
anaesthetised by inhalation of isofluorane and oxygen, and maintained under anaesthetic 
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with a gas mask throughout the surgery, which was carried out on a heated table (set to 
40°C). The breathing of the animals was monitored throughout the surgery as an 
indication of depth of anaesthesia, and the anaesthetic dose was adjusted accordingly. 
Lacri-Iube eye ointment was applied to both eyes of the rat to prevent drying during the 
surgery. The skin over the left femur was shaved and a 3 cm lateral skin incision was 
made parallel to and approximately 5 mm dorsal to a straight line between the knee and 
hip joint, to reveal the intennuscular plane, which was then separated using blunt 
dissection to expose the sciatic nerve. Viewed with a Zeiss Sterni DV4 spot 
stereomicroscope, the sciatic nerve was separated from surrounding tissue before a 
transection was made in the nerve mid-way between the hip and the knee, above the 
bifurcation. The repair device or graft was secured to the proximal and distal stumps of 
the transected nerve with 2-3 surgeon's knots per stump, using 10.0 non-absorbable 
nylon sutures. The injury site was closed with separate fascia and skin sutures. 0.1 ml 
Rimadyl analgesic was administered sub-cutaneously to the injury site and Opsite skin 
spray was sprayed over the sutured skin wound to reduce the risk of infection and the 
animal disrupting the wound. Animals that were immunosuppressed received an 
injection (sub-cutaneous) of Cyclosporine A (15 mg/kg) 24 hours prior to the surgery 
and then daily throughout the recovery period. 
During recovery, animals were kept separately in a heated chamber and monitored 
closely until they had regained consciousness before being returned to their previous 
social group. Animals had free access to food and water after recovery from 
anaesthesia. All rats were kept in cages within ventilated Scantainers with room 
temperature maintained at 21 ± 0.5°C and a lighting condition of 12 hour light/dark 
cycle. For each experiment, the weight of the animals was monitored. Animals were 
culled following the recovery period using C02 asphyxiation. 
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2.7.3 Device harvest 
Repaired nerves were excised under a dissecting microscope and harvested devices with 
proximal and distal stumps were maintained at in situ tension using a card frame, which 
keeps the nerve at the same length during fixation. 
2.7.4 Gastrocnemius muscle dissection 
The gastrocnemius muscle is the major calf muscle on the posterior surface of the lower 
hind leg. Both the experimental and contralateral gastrocnemius muscles were exposed 
and then separated from the surrounding tissues before being cut out at the Achilles 
tendon and knee to be weighed. 
2.8 Sectioning 
2.8.1 Vibratome sections 
The vibratome was used to section devices which had a silicone outer tube. Following 
fixation by immersion in 4 % PF A overnight at 4°C, the fixative was aspirated and the 
tissue was washed (3 changes of PBS for five minutes for each wash). The tissue was 
then embedded in warmed (37°C) 20 % gelatin in PBS and left to set for 20-30 minutes 
at 4 °C before adding 4 % PF A at 4 °C overnight. The fixed gelatin block was secured 
to the specimen holder with super glue and 100 Jlm thick sections were cut using the 
Leica vibratome VTl 000. Sections were collected in water using a fine brush and stored 
in PBS prior to immunostaining. 
2.8.2 Cryo-sections 
Frozen sections were cut from the devices which were implanted within the 
NeuraWrapTM outer tube. Following fixation by immersion in 4 % PFA overnight at 4 
QC, the fixative was aspirated and the tissue was washed in PBS. Tissue was placed in a 
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rectangular plastic mould and overlaid with OCT at room temperature. It was oriented 
and frozen quickly in liquid nitrogen. The frozen block containing the tissue was 
removed from the mould and secured to the specimen holder with OCT in the required 
orientation in the -25°C cutting chamber of a Leica CM 1900 Cryostat. 10 Ilm sections 
were cut and collected on poly-L-Iysine (PLL) coated slides and immunostained 
immediately. 
2.9 Staining 
2.9.1 Immunofluorescence labelling protocol 
The following method was used to stain fully hydrated gels, EngNT (with and without 
neurons) and tissue sections from harvested devices and autograft repairs. 
Following fixation of gels by incubation in 4 % PF A overnight at 4 °C, the fixative was 
aspirated and material was washed. Washes for the gels: 3 changes of 2-3 ml PBS for 
five minutes for each wash; washes for tissue sections on slides: immersed in 300 ml 
PBS). Samples were then incubated in 0.1 % Triton-X solution for 30 minutes. After 
another wash in PBS, the material was immersed in a blocking solution containing 5 % 
goat serum in PBS for 40 minutes. Following another wash, material was incubated 
with primary antibody(s) at the appropriate dilution(s) in PBS (see table 2.3) for 18 h at 
4°C. After 18 h, the material was washed and then incubated with secondary 
antibody(s) at the appropriate dilution(s) (see table 2.3) and Hoechst 33258 (l: 1000) in 
PBS for 90 minutes. Finally the material was washed and stored in PBS ready for 
microscopy. 
For staining cells on covers lips the following adaptations were made to the above 
immunofluorescence protocol: primary and secondary antibody incubation was for 90 
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and 45 minutes, respectively, at room temperature. Covers lips were mounted on slides 
using FluorSave TM. 
2.9.2 Flow cytometry 
Following fixation of cells in suspension with 4 % PF A for 10 minutes at 4 °C, cells 
were washed and then stained in suspension. Washes were carried out by the addition of 
5 ml PBS and centrifugation at 400 x g for 5 minutes. After the first wash, the cell pellet 
was resuspended in I ml of 0.1 % Triton-X solution for 1 minute and then washed. 
Cells were then resuspended in 500 III of blocking solution containing 5 % serum in 
PBS and incubated for 30 minutes at 4 °C. Cells were washed and counted, and then 
resuspended into tubes each containing 2 x 105 cells. Following this, 10 J.l1 of primary 
antibody (anti-CD54, I: 10 dilution) was added to each tube and incubated for 1 hour at 
4 0c. Next 1 ml PBS was added and cells were washed by centrifugation, before 
incubation of 100 III of the secondary antibody (dilution 1 :40) for 40 minutes at 4 °C. 
Cells were washed with 500 III PBS and then resuspended in 300 J.l1 PBS before being 
read using the F ACSCalibur. Data was analysed using CellQuestPro software. 
2.9.3 CellTracker™ staining 
Living cellular EngNT was incubated with green CellTracker™ (50 Ilg in 10 III DMSO) 
at 1: 1000 in cell culture media for 45 minutes at 37 °C in a humidified incubator. Gels 
were then washed with media before fixing or using in in vitro experiments. 
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2.10 Electron microscopy 
2.10.1 Scanning electron microscopy 
EngNT sheets were fixed in 4 % parafonnaldehyde in PBS for 24 hours at 4°C. They 
were then prepared from SEM by Francis Colyer. They were post-fixed in I % osmium 
tetroxide in phosphate buffer (PB), dehydrated through a graded series of acetone and 
infiltrated in liquid carbon dioxide in a critical point drying apparatus (Polaron, UK) 
before drying at the critical point of 31°C. The dried samples were mounted on 
aluminium SEM stubs with double-sided carbon sticky tabs (Agar Scientific, UK), 
sputter coated with gold (Polaron sputter coater SC7640, UK) and examined by Gordon 
Imlach in a Zeiss Supra 55 VP field emission guns scanning electron microscope 
(FEGSEM) at 3 k V. 
2.10.2 Transmission electron microscopy 
After excision and dissection of the middle of the repair constructs, samples were fixed 
in 4 % PF A in PBS for 24 h at 4°C. These were then prepared and imaged by Heather 
Davies. Samples were post-fixed in 1 % osmium tetroxide in PB, dehydrated through a 
graded series of acetone, flat-embedded in Epon epoxy resin and polymerised at 60°C 
for 48 h. Semi-thin sections of I J.lm were cut using a glass knife on a UCT 
ultramicrotome (Leica, UK), dried onto poly-L-Iysine coated microscope slides and 
stained with I % toluidine blue with added 5% sodium borate. Ultrathin sections of 70 
nm were cut with a diamond knife (Diatome, UK) and collected on copper slot grids 
with Pioloformlcarbon support films. Sections were counter-stained with aqueous 
uranyl acetate and Reynolds' lead citrate before examination in a JEM 1400 
transmission electron microscopy at 80kV (TEM) (lEOL, UK). 
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2.11 Analyses 
2.1l.1 Cell death quantification 
Cell death analysis was by propidium idodide (PI) exclusion and Hoechst 33258 was 
used as a counterstain to establish total cell numbers. PI is commonly used as a marker 
of cell death because it only enters cells with damaged plasma membranes (i.e. those 
undergoing late apoptotic and necrotic cell death) where it binds to DNA. Cell death 
thus results in cells with condensed, bright red PI-stained nuclei. Cellular gels were 
incubated with PI (20 mg/ml, used at 1: 100) and Hoechst 33258 (1 mg/ml, used at 
I: 1000) in cell culture medium for 30 minutes at 37°C, 5 % CO2 and then washed with 
three changes of cell culture medium for 10 minutes for each wash. 
2.11.2 Assessment of cellular alignment 
Confocal microscopy (Leica SP5) was used in the assessment of cell alignment in 
EngNT. Equivalent fields were analysed per gel using a standardised sampling protocol 
(figure 2.4A). Images were captured using a x40 oil immersion lens; z-stacks were 20 
Ilm with a step size of 1 Ilm. Image analysis was conducted using VolocityTM software 
(Perkin Elmer, Waltham, MA) running automated 3D image analysis protocols to 
measure the angle of cell alignment in each field relative to the long axis of the gel 
(figure 2.4B). 
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A Gel 
= sampled area 
Figure 2.4 Automated 3D analysis of cell alignment in EngNT using VolocityTM 
Sample fi elds of hydrated and compressed gels looking down at the surface on which DRG 
neurons were seeded (A); and the automated analysis using VolocityTM recognises the ce lls, in 
EngNT-Schwann cell in this example, based on colour and intensity. VolocityTM a igns a line 
for the longest length and reports the angle of deviation from the long axis of the gel (B). 
2.11.3 Assessment of neurite growth in vitro 
Con focal microscopy (Leica SP5) was used in the assessment of neurite outgrowth on 
EngNT. The same image acquisition protocol was used as described in section 2. 11 .2. 
Image analysis was conducted using VolocityTM software (Perkin Elmer, Waltham, 
MA) running automated 3D image analysis protocols to measure the length and 
orientation of each neurite for each field. VolocityTM recogn ises th e neurites based on 
colour channel and intensity and traces over th em using the 'skeletal length' tool, which 
gives length (f.lm) and bearing (degrees) read outs relative to the long axis of the gel, to 
enable the amount and direction of neurite growth to be quantified. 
81 
2.11.4 Assessment of neuronal regeneration ill vivo 
Fluorescence microscopy (Olympus BX61) was used to capture images from 
immunostained transverse cryosections. To assess neuronal regeneration, aIJ of the 
neurofilament positive axons present in each transverse section were counted. In some 
cases the localisation of each axon in relation to the EngNT material was asses ed, in 
which case EngNT was visualised using autofluorescence. 
2.11.5 Analysis of myelin ill vivo 
At least 50 myelin profiles were sampled from each of 5 electron micrographs at the 
mid-point of the constructs that were taken from the densest regions of regeneration, 
identified using corresponding semi-thin sections. For each myelinated axon, the axon 
diameter and fibre diameter (axon + myelin sheath) were measured at the widest part of 
the fibre. For the unmyelinated axons, only the axon diameter was measured. 
Measurements were made using Image J software, Figure 2.5 swnmarises this process . 
..... -. . .... 
. ..... , .... " 
Figure 2.5 Example measurements to assess myelination from an electron micrograph 
using Image J. M = myelinated axon. Axon diameter measurements are shown using the red 
arrows and fibre diameter measurement is shown using the orange arrow. 
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3.0 Development and optimisation of Engineered Neural Tissue (EngNT) 
3.1 Introduction 
An important area of research in neural tissue engineering is concerned with how to 
promote and guide neurite extension across a gap in a damaged nerve (Bellamkonda, 
2006, Daly et al., 2012; Bell and Haycock, 2012). Directing regeneration is important 
for an efficient repair and to increase the likelihood of a functional outcome, as guided 
axons will reach their targets faster than those crossing a gap without guidance, 
reducing the time in which a target organ is denervated (Hall, 2005). It is widely agreed 
that the presence of living cells is essential for supplying the signals required for 
optimal neurite extension and for the repair of gaps larger than 3 cm in human nerve/s 
(Duemans et al., 2010). 
Schwann cells tend to be the starting cell type for tissue engineers developing a repair 
device because they are the appropriate resident PNS glial cell type and play an 
important role in the regeneration process (Rodrigues et al., 2012). Previous studies 
have investigated how alignment of Schwann cells can affect neuron regeneration, 
providing topographical and biochemical guidance cues to regenerating neurites 
(Thompson and Buettner, 2005; Weinstein, 1999; Rodrigues et al., 2012). Schwann 
cells secrete factors such as NGF and deposit laminin, which have been shown to 
enhance the effects of Schwann cell topography and orientation. Some approaches focus 
on the development of anisotropic materials that confer alignment to seeded Schwann 
cells (e.g. guidance cues on the material through the influence of surface architecture 
such as, channels, fibres and grooves), which in turn direct neurite outgrowth (Lietz et 
al., 2006). The migratory movement of cells and their interactions with the 
physiochemical properties of their substrata was first described by Weiss as contact-
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guidance, from his experiments on cell and axon orientation (Weiss, 1934; Weiss, 
1945). 
In previous investigations in this area, Schwann cells were cultured on the surfaces of 
three-dimensional scaffolds, owing in large part to the relative ease of fabrication of 
surfaces using many different materials. Ultimately it is the presence of the aligned 
Schwann cells that is important, and efforts to align the material are generally aimed at 
causing alignment of Schwann cells rather than a direct effect on neurites. Some studies 
have used endogenous tension from cell contraction to align cells (Eastwood et al., 
1998, Phillips et al., 2005, East et al., 2010). This approach of enabling the Schwann 
cells to self-align due to tension is employed in this project. 
It is widely agreed that Schwann cell-neurite interactions are very important during 
regeneration, and Schwann cells and neurons are usually found to be in close contact in 
vivo and in experimental models (Terenghi et al., 1999). Additionally, there is a lot of 
evidence to suggest that a cellular element is needed for regeneration across gaps larger 
than 3 or 4 cm in human (Bellamkonda, 2006; Gu et al., 2011; Rodrigues et al., 2012). 
Therefore, it is rational to include a cellular element and focus on aligning this directly, 
instead of developing an aligned material and waiting for the seeded cells to migrate and 
elongate on and along it. 
A wide variety of materials have been evaluated for nerve repair. These can be divided 
into two categories: native materials and synthetic materials. Native tissues such as 
autologous vein (Risitano et al., 2002) and autologous muscle (Battiston et al., 2000) 
have been used as nerve guidance conduits. Although they are able to successfully 
support neuronal regeneration, the disadvantage remains that there is a limited source of 
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these tissues and the lack of Schwann cells is also a disadvantage for longer gaps. As a 
result, materials made from extracellular matrix (ECM) proteins have been explored, 
such as collagen (Yoshii et al., 2001; Dubey et al., 1999; Ceballos et al., 1999),laminin 
(Kuappila et aI., 1993; Toba et al., 2002), fibrin (Kalbermatten et al., 2009) and 
fibronectin (Whitworth et al., 1995; Ahmed et al., 1999). The FDA-approved bovine 
collagen I tube, NeuraGen™, is currently used in the clinic for repairs up to 3 cm in 
length. 
Another alternative for nerve repair is to use synthetic conduits, which are chemically 
pure, easier to make into elaborate structures, better suited to GMP production, cheaper, 
less likely to transmit disease, easier to source and less immunogenic than biological 
materials. The degradation time of bio-degradable synthetic materials such as 
poly(glycolic acid) (PGA) and poly(lactic acid) (PLA) can, for example, be manipulated 
(Evans et ai., 2000; Evans et al., 2002). There are currently FDA-approved synthetic 
conduits available, such as Neurotube (PGA) and Neurolac [poly(DL-lactide-
caprolactone)] (PLC), for short gap repairs up to 3 cm. 
It is important to consider scaffold degradation when developing materials for 
implantation. The initial scaffold for any implanted 3D tissue that is not intended to be a 
permanent prosthesis must eventually be resorbed. Importantly, the timescale for the 
degradation of the implanted scaffold needs to relate to the formation of new, 
replacement tissue from the resident cells. The implanted scaffold must be resorbed to 
avoid compression of the regenerated nerve, which could become restricted as it gets 
thicker. However the implanted scaffold must not degrade before the new nerve tissue 
has formed or it could compromise mechanical integrity. Native protein-based 
materials, where fibrillogenesis and potential for telopeptide cross-linking sites are not 
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impaired (Marenzana et al., 2006) represent a natural part of the cell-matrix 
environment, participating in biological turnover and remodelling. They tend to be 
removed by cell action as new matrix is produced, with no harmful breakdown 
products. Based on this and because of previous expertise, this project used natural 
protein materials, rather than synthetic polymers. 
The matrices explored here for the development of an Engineered Neural Tissue 
(EngNT) are collagen I and fibrin: 
i) Collagen I is the most abundant ECM protein in mammalian tissue and it is the 
predominant structural protein present in peripheral nerve tissue (Ricard-Blum, 
2010; Soderhall et aI., 2007). Collagen fibrils and their networks play a 
dominant role in maintaining the structural integrity of ECM, while being highly 
dynamic and undergoing constant remodelling (Cen et aI., 2008). Collagen is 
one of the most widely used materials for three-dimensional cell culture and 
tissue-engineering applications, partly because of the ability of purified collagen 
I monomers to self-assemble into three-dimensional gels at physiological 
temperature and pH. 
ii) Fibrin was also selected for consideration based on its role in the natural repair 
process that occurs in wound healing. After peripheral nerve injury where 
defects are repaired using an empty conduit, on day 1 the conduit will be filled 
with blood proteins (Belkas et al., 2004). In days 2-6 an hourglass shaped fibrin 
cable forms between the two nerve stumps (for short defects) and in days 7-14 
support cells migrate on to the protein cable and other ECM proteins are 
deposited. Axon elongation (regeneration) begins from day 15 (Belkas et aI., 
2004). Using fibrin to make EngNT to form the core of a repair device may 
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therefore speed up the repair process by removing the delay due to formation of 
the fibrin tissue bridge. 
Several methodologies exist for using collagen and fibrin to guide axonal re growth 
(Ahmed et ai., 2000; Dubey et ai., 2001; Phillips et ai., 2005); the method used in this 
study is a tethering system. The tethering approach results in an aligned cellular 
hydrogel that provides mUltiple stimuli in an effort to mimic the milieu of signals 
normally found in a nerve autograft, i.e. biological, physical and chemical. It facilitates 
cell growth, organisation and differentiation, permitting the cells to self-align and 
remodel the matrix generating a three-dimensional environment for repair and 
regeneration. 
The Open University owns the granted patent for self-alignment of cells in tethered 3D 
hydrogels in Europe, US, Canada and Australia (Brown and Phillips, 2004). It is a 
simple and effective way of aligning cells in a 3D environment and has been used to 
generate tissues with aligned architecture, such as cardiac muscle (Boudou et ai., 2012) 
and nervous system tissue (Phillips et al., 2005; East et al., 2010). Our lab has shown 
that aligned Schwann cells within a tethered collagen gel can promote and guide neuron 
regeneration in vitro and in vivo (Phillips et al., 2005). In that study the cellular collagen 
gel was tethered within the conduit before implantation, generating aligned Schwann 
cells in a 3D collagen environment. This device guided neuronal regeneration across a 5 
mm gap in the rat sciatic nerve model more effectively than an empty tube control. 
However there is limited scope for scale up and translation of that design, which relies 
on a hydrated hydrogel remaining tethered within a conduit, due to the skill required for 
integration and potential for tethering to fail during handling, implantation or post-
implantation. The initial aim of this project therefore was to retain the aligned cellular 
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architecture achieved in these 3D tethered gels but to develop the material to a more 
stable and robust form. 
Plastic compression, a method developed by Brown et al., increases the mechanical 
strength and stability of hydrogels by irreversibly removing most the interstitial fluid 
from the gel, generating a more dense and robust material (Brown et aI., 2005). Plastic 
compression has been used to stabilise collagen hydrogels containing various cell types 
including rat astrocytes (East et aI., 2010), human limbal epithelial cells (Levis et al., 
2010), human bladder smooth muscle cells (Micol et aI., 2011) and human 
osteosarcoma cells (Bitar et al., 2008) with no reported adverse effects on cell viability. 
Plastic compression technology is commercially available (RAFT™ by TAP 
Biosystems) for the fabrication of tissue-like constructs. The Open University and TAP 
Biosystems are currently working in collaboration to develop an advanced RAFT ™ 
process for the production of aligned tissue-like constructs, combining the plastic 
compression and tethering technology. 
In preliminary studies aiming to understand the effect of aligning astrocytes on neuronal 
growth, tethered collagen I gels with aligned astrocytes were successfully compressed to 
generate robust constructs in which astrocyte alignment was maintained (East et al., 
2010). We hypothesized that this method could be developed further in order to stabilise 
tethered hydrogels with PNS glia, retaining the cellular alignment following their 
removal from the tethering system. This could enhance the mechanical properties so the 
material can withstand surgical handling and movement in vivo after implantation. 
This study first tested the hypothesis that combining cellular self-alignment and the 
plastic compression process will produce a robust cellular biomaterial with the potential 
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to support and guide neuronal growth. This was tested by a series of experiments with 
the following aims: 
(i) to investigate Schwann cell survival after plastic compression of collagen 
gels; 
(ii) to assess whether the cellular alignment achieved in tethered rectangular 
collagen gels was retained following plastic compression and whether plastic 
compression was sufficient to stabilise the alignment; 
(iii) to assess whether neurons cultured on the surface of this engineered neural 
tissue (EngNT) with aligned Schwann cells (EngNT-Schwann cell) can 
extend neurites in a directed manner. 
Fibrin was also explored as an alternative hydrogel to collagen, repeating the key 
experiments for the development of the collagen EngNT. 
Despite the evidence that cellular therapies enhance regeneration, the application of 
such therapies in the clinic currently faces a number of biological and regulatory 
hurdles, mainly regarding the source and availability of cells (Bell and Haycock, 2012). 
Approved decellularised nerve guides are currently available, such as A vance ™ from 
AxoGen for nerve defects up to 7 cm. In these, native nerve has been stripped down to 
its extracellular matrix, removing immunogenic cell components and retaining the 
intricate ECM architecture. Such decellularised nerves have been shown to provide a 
3D scaffold to support regeneration in experimental and clinical studies (reviewed by 
Szynkaruk et aI., 2012). In consideration of these fmdings, the potential of aligned 
Schwann cells to precondition the collagen biomaterial, before they are freeze-killed, 
leaving a decellularised guidance matrix was assessed in the present study; in terms of 
the ability of the decellularised material to support and direct neuronal growth. 
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3.2 Results 
3.2.1 Schwann cell characterisation 
The rat Schwann cell line SeL 4.11F7 (Haynes et al., 1994) wa used for the initial 
experiments to develop and optimize the protocols and design of the material. The 
Schwann cell s were plated on coverslips and stained to confiml they were 100 
positive, a marker for Schwann cells (Spreca et aI. , 1989) (figure 3.1 ). 
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Figure 3.1 Schwann cells on coverslips stained to detect S100 
Schwann cells were plated on coverslips and fixed after 24 hrs before staining to detect S I 00. 
The first step was to establish the optimum Schwann cell seed ing density to give 
consistent and reliable contraction of collagen gels within 12 hours. This is important 
because sufficient gel contraction is needed in the tethered ge ls to ensure cellular se lf-
alignment. Contraction profiles were generated using a range of Schwann cell seed ing 
densities within a 2 mg/ml collagen gel (figure 3.2). Subsequent experiments were 
conducted using a cell density of 4 x 106 cells/m!, which gave over 70% contract ion 
(figure 3.2). 
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Figure 3.2 Contraction profile for Schwann cells in collagen gels 
Cells were seeded at a range of seeding densities (1-6 x 106 cells/ml) within 300 ~l collagen gels 
(2 mg/ml) in a 96-well plate. Following a 12 h incubation, gels were photographed and % 
contraction determined [(% contraction = (cross-sectional (cs) area of gel at 0 h - cs area of gel 
at 12 h) / (cs area of gel at 0 h)). Data are means ± SEM from 4 separate gels. 
3.2.2 The effect of plastic compression on Schwann cell death 
To assess the effect of plastic compression on Schwann cell death, collagen gels 
containing Schwann cells in wells of a 96-well plate were subjected to plastic 
compression for 1 or 5 minutes. Cell death was assessed using propidium iodide and 
Hoechst 1 hour after compression or after a further 20 hours in culture and compared 
with uncompressed control gels. Thee fields of view were sampled per gel. Two time 
points were used to determine the relative contribution of immediate or delayed 
mechanisms to any cell death. There was no significant difference in the amount of cell 
death observed following 1 or 5 minute plastic compression at both 1 hour (183 ± 25 
cells were counted per gel) and 20 hours (132 ± 14 cells were counted per gel) 
compared to controls (Figure 3.3, one-way ANOV A, P> 0.05). There was a significant 
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difference in the amount of cell death observed in the control gels that were stained 
either 1 or 20 hours after compression (T-test, P < 0.005). 
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Figure 3.3 The effect of plastic compression on Schwann cell viability 
There was no significant difference in the amount of cell death observed between minute 
compression or 5 minutes compression assayed at 1 and 20 hours post-compression, or in 
uncompressed control gels, P>0.05. However, the amount of cell death differed significantly in 
the uncompressed control gels that were stained I and 20 hours after the gels had set, 
* * P<O.005. n=6 independent gels. 
3.2.3 The effect of plastic compression on Schwann cell alignment 
After confirming that plastic compression did not cause cell death, the next part of this 
investigation was to assess cellular alignment post-plastic compression. It is specu lated 
that if the matrix stiffness is increased so that cytoskeletal contraction force is no longer 
sufficient to deform it in a way that results in cells losing their alignment or overall 
changes in gel size/shape, it could limit further remodeling of the collagen matrix by the 
cells. Therefore it was hypothesized that, by increasing the cell and collagen density, 
plastic compression could stabilize the cellular alignment observed in fu lly hydrated 
tethered collagen gels, producing a robust and mechanically stronger aligned 
biomaterial. 
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To assess cellular alignment, cells within tethered gels were labelled with CellTracker™ 
dye and analysed either before or after plastic compression. Schwann cell alignment 
was determined by comparing the angle of the long axis of each cell to the long axis of 
the gel. Fluorescence micrographs show that cells in fully hydrated and plastic 
compressed gels appeared similar in terms of exhibiting an overall aligned appearance, 
with cells elongated and aligned parallel to the long axis of the gel (figure 3.4). Cell 
alignment was quantified by measuring cell elongation and orientation using 
standardised image capture and analysis protocols (protocol described in methods -
chapter 2, section 2.11.2). Figure 3.5 (i) shows that cells are elongated with a mean 
aspect ratio (width/length) of 0.16 ± 0.00 (± SEM) in hydrated gels and 0.18 ± 0.00 (± 
SEM) in plastic compressed gels (Le. about 6 times longer than their width). This 
difference is not significant, demonstrating that the alignment is stabilised post-plastic 
compression. Figure 3.5 (ii) shows a frequency distribution of the angle of deviation of 
cell orientation from the long axis of the gel. There is a clear trend showing that most of 
the cells were orientated parallel to the long axis of the gel. The quantification revealed 
that 63 ± 15% (± SEM) of the cells within the fully hydrated gel and 51 ± 12% of cells 
within the plastic compressed gel, did not deviate by more than 20° from the long axis 
of the gel. Additionally, only II ± 7% and 16 ± 5% (± SEM) of the cells within, 
respectively, the fully hydrated and plastic compressed gels deviated by more than 50° 
from the long axis of the gel. 
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Figure 3.4 Self-aligned Schwann cells in fully hyd,oated and plastic compressed gels 
(i) Representative confocal micrographs showing Schwann ce ll s (green) labelled with 
CellTracke?M dye in a fully hydrated gel and in a compressed gel; (i i) and within EngNT using 
immunofluorescence, z-distance 20 Ilm, step size I Ilm. Scale bars are 50llm. 
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Figure 3.5 Schwann cell elongation and orientation pre- or post-plastic compression 
(i) The aspect ratio (width/length) of cells was not significantly different in gels pre- or post-
plastic compression. (ii) Frequency distribution of the angle of deviation of cell orientation from 
the long axis of the gel in 10 degree bins. Data are means ± SEM from 3 gels, 6 regions per gel 
were analysed. 
95 
Alignment was a lso seen at the sub-micron scale. Scanning electron micrograph images 
of the surface of plastic compressed collagen with aligned Schwann cells (EngNT-
Schwann cell) show that the Schwann cells and collagen fibril s are a ligned and 
orientated in the same direction, compared to the random orientation of fibrils in the 
acellular plastic compressed collagen (figure 3.6). 
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Figure 3.6 Scanning electron micrographs of plastic compressed collagen with aligned cells 
and without cells 
Scanning electron micrographs of the surface of plastic compressed acellular collagen (A-B) 
and plastic compressed collagen with aligned Schwann cells (EngNT -Schwann cell) (C-D) at 
low (left) and high (right) magnifications. Scale bars are 2 Ilm. 
These initial studies indicated that sheets of robust a ligned ce llular biomaterial could be 
formed using Schwann cells to self-align within a tethered collagen gel that was then 
stab ilized using plastic compression. 
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3.2.4 Neuronal growth on the surface of collagen EngNT -Schwann cell 
The next stage was to investigate neuronal growth on the surface of EngNT -Schwann 
cell and to assess whether the cellular alignment could confer alignment to growing 
neurites. Primary adult rat neurons were cultured on the surface of EngNT-Schwann cell 
for 3 days before fixing overnight and then immunostaining to detect S 100 (a marker 
for Schwann cells), ~III-tubulin (a marker for neurons) and Hoechst to label cell nuclei 
(Figure 3.7). The angle of deviation (between 0-90 degrees) of neurite growth from the 
average direction of Schwann cell alignment on a per field basis was measured. This 
revealed that the angle of neurite growth observed after 3 days corresponded to the local 
Schwann cell alignment within EngNT-Schwann cell. Figure 3.8 shows the distribution 
of neurite deviation from the angle oflocal Schwann cell alignment, with approximately 
80% of neurites not deviating from the orientation of the local Schwann cell population 
by more than 20°, and almost none of them deviating by more than 50°. 
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Figure 3.7 eurona l growth on EngNT-Schwann cell 
Fi emerged con focal micrographs showing the Schwann cells (green) with in the collagen 
EngNT- ch\ ann cell and the neurites (red), stajned for SlOO and ~III-tubulin respective ly. 
uclei (blue) were labelled with Hoech t (A-E). An image containing the red channel o nly is 
also shown for each field (F-J). cale bars are 50~m. 
98 
70 
60 
50 
11) 
.! 40 
't: 
:J 
Cl) 
Z 30 
~ 
20 
10 
0 
10 20 30 40 50 60 70 80 90 
Angle of neurite deviation from cellular alignment 
Figure 3.8 Orientation of neuronal growth on EngNT -Schwann cell 
Frequency distribution showing the angle of neurite deviation from the Schwann cell al ignment 
angle in that field (determined using automated analys is in Volocity, see section 2.11.3) , 332 
neurites were counted in total. Data are means ± SEM from n=3 independent gels, 6 regions per 
gel were analysed. 
The images in figure 3.7 show that the Schwann cells within EngNT fonned parallel 
chains, which were usually continuous within a field of view. The neurites appear to be 
growing along parallel chains of Schwann cells. The neurite length that was in contact 
with a Schwann cell was measured and expressed as a percentage of the total neurite 
length on a per field basis; 91 ± 4% (n = 3) of extended neurites, were found to be in 
close contact with a Schwann cell. 
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3.2.5 Exploring the use of fibrin to engineer EngNT -Schwann cell 
Fibrin plays a role in the natural repair process that occurs in wound healing. Having 
first developed EngNT using collagen, fibrin was investigated to see whether it cou ld be 
used in a similar manner to generate an aligned cellular biomaterial suitable for use 
within a nerve repair device. To explore the use of fibrin for making EngNT with 
Schwann cells, fibrin gel formation was fustly optimised. Initial experiments that 
attempted to construct a contraction profile in 96-well plates failed because the fibrin 
gels could not be freed from the edges of the wells without causing extensive disruption 
to the gels (figure 3.9). As a result, it was not possible to determine the effect of cell 
density on contraction of the fibrin gels (as had been done for the collagen hydrogel). 
Thus the same cell density was used to produce a fibrin based EngNT as was used for 
the production of collagen EngNT-Schwann cell, namely 4 x 106 cells/ml. 
Figure 3.9 Fibrin gel disruption in wells after attempting to free the edges 
Fibrin gels were photographed within the wells containing media after attempting to tree the 
edges from the well using a needle, which caused much disruption. 
Fibrin gel contraction in the stainless steel moulds was simi lar to what was observed 
with the tethered collagen hydrogels. The fibrin could be freed from the straight long 
edges of the mould using a scalpel without disrupting the gel. The first step was to 
assess cell death following plastic compression of fibrin gels containing Schwann cells 
by propidium iodide exclusion with Hoechst. This demonstrated that the plastic 
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compression process, when applied to cellular fibrin gels, did not increase cell death 
compared to uncompressed controls; 2.0 ± 1.5% (mean ± SEM, n=3) cell death was 
observed immediately after plastic compression, compared to 2.0 ± 0.4% (± SEM, n=3) 
in the fully hydrated gels. 
The next step was to investigate Schwann cell self-alignment in fully hydrated and 
plastic compressed fibrin gels. Schwann cells (SIOO, labelled green) appeared elongated 
and weakly aligned in uncompressed or plastic compressed fibrin gels (figure 3.10), 
compared to the Schwann cells in uncompressed or plastic compressed collagen (figure 
3.4). Alignment relative to the long axis of the gel was quantified in the same way as in 
section 3.2.3, and Schwann cells in both fully hydrated and plastic compressed fibrin 
gels were elongated with cell aspect ratios (width/length) of, respectively, 0.15 ± 0.00 
and 0.15 ± 0.00 (figure 3.11) (i.e. about 6 times longer than wide, comparable to the 
Schwann cell elongation seen in collagen gels). Gels were immunostained to detect 
SIOO and cell orientation was quantified by image analysis following confocal 
microscopy. The quantification of cell orientation, in comparison to the long axis of the 
gel, shows that the cells were orientated in different directions with no overall 
alignment in hydrated or plastic compressed fibrin gels. However there were patches of 
alignment in areas. There was a similar distribution of cell orientation angles in 
hydrated and plastic compressed gels (figure 3.11). 
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Figure 3.10 Schwann cells in tethered hydrated or plastic compressed fibrin gels 
Representative confoca1 micrographs of the Schwann cells (green), labelled with S I 00, and 
nuclei (b lue), label led with Hoechst, in full y hydrated (A, B) or plastic compressed (C, D) fibrin 
gels. cale bars are l OOflm . 
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Figure 3.11 Schwann cell elongation and orientation pre- or post-plastic compression of 
fibrin gels 
(i) The aspect ratio of the cells was not significantly different in gels pre- or post-compression. 
(i i) Frequency distribution of the angle of deviation of each cell relative to the long axis of the 
gel. Data are means ± SEM from n=4 independent gels, 6 regions per gel were analysed. 
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Scanning electron micrographs of the surface of fibrin EngNT -Schwann cell and an 
acellular fu lly hydrated fibrin gel showed that there was a flat plaque-like structure 
evident on the surface of all the fibrin materials, which appeared to be most dense and 
obvious in the fibrin EngNT-Schwann cell. This was also evident on the acellular fully 
hydrated fibrin (not plastic compressed), figure 3.12. 
Figure 3.12 Scanlling electron micrographs of fibrin gels in fully hydrated acellular fibrin 
and fibrin EngNT-Schwann cell 
Scanning electron micrographs of the surface of fuIJy hydrated aceIJular fibrin (A) and fibrin 
EngNT-Schwann cell (4 x 106 cells/ml) (B). Scale bars are 2 ~m. Arrow heads point out plaque-
like structures. 
Although there was no clear demonstration of overall Schwann cell alignment in 
tethered fibrin gels, neuronal growth on fibrin EngNT -Schwann cell was still assessed. 
Con focal micrographs show that neurite growth (stained with ~III-tubulin , red) was 
associated with the Schwann cells (stained with S100, green) within fibrin EngNT-
Schwann cell (figure 3.13). The degree of alignment was quantified in the same way as 
in section 3.2.4; i.e. the angle of neurite deviation from the mean direction that the 
Schwann cells are orientated in was determined on a per field basis. These 
measurements supported the observations from the images, which showed the majority 
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of neurite growth was along the Schwann cell s; 70 ± 4% (± SEM ) of neurite growth did 
not deviate by more than 20° from the cell orientation on a per field bas is (figure 3.13). 
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Figure 3.13 Neuronal growth on fibrin EngNT-Schwann cell 
(i) Confocal micrographs showing Schwann cells (green) and neurons (red) stained for SI 00 
and PllI -tubulin, respecti vely, and Hoechst staining of nuclei (blue) (A-C). An image showing 
only the red channel is also shown for each fi eld (D-F). Scale bars are I OO~m. (ii) Frequency 
distribution hO\ ing the angle of neurite deviation from the cellular alignment angle o f that 
field; 570 neurites were counted in total. Data are means ± SEM, n=3 independent gels, 4 
regions sampled b gel. 
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Thus, whilst the collagen EngNT -Schwann cell gave consistent and reliable alignment, 
the fibrin EngNT -Schwann cell showed a more complex pattern of localised orientation, 
and hence in further investigations only the collagen system was employed. 
3.2.6 Exploring the use of decellularised collagen EngNT -Schwann cell 
In view of the overall aim of this project, to develop a nerve repair device for use in the 
clinic, this study went on to investigate the ability of a decellularised material to 
promote and guide neuronal growth. This is based on the hypothesis that the aligned 
Schwann cells could precondition the collagen biomaterial, before being freeze-killed to 
leave a decellularised guidance matrix. Having already shown that cellular constructs 
can support and guide neurite outgrowth, decellularised constructs were investigated 
because they would potentially have a faster route to the clinic than constructs that 
contain living cells. Thus the neuron co-culture experiment was repeated using the 
decellularised material to assess its ability to support and guide neurite outgrowth. 
Collagen EngNT-Schwann cell was made as described previously (figure 2.1) and then 
dipped in liquid nitrogen once to kill the Schwann cells (Hadjipanayi et al.. 2010). Cell 
death in the freeze-killed EngNT-Schwann cell was assessed by propidium iodide 
exclusion with Hoechst and showed that 96 ± 3% (± SEM) of Schwann cells were dead. 
Neurite outgrowth on the freeze-killed material (EngNT-freeze-killed) was compared to 
EngNT-Schwann cell and EngNT-acellular (no Schwann cells, plastic compressed 
collagen only). The images in figure 3.14 shows neurites that had been extended on the 
surface of these materials. Quantification of the neurite growth showed that there was 
47-fold more neurite outgrowth (in terms of the total length extended in the sampled 
fields) on the live EngNT-Schwann cell material than on the EngNT-acellular 
biomaterial, and 26-fold more growth on the live EngNT-Schwann cell material than on 
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the EngNT-freeze-killed material (figure 3.14). These data highlight the importance of 
living Schwann cells for efficient nerve repair, and this will be discussed in some detail 
in section 3.3. 
The direction of neurite outgrowth was assessed for all three materials by measuring the 
deviation of the angle of each neurite compared to the long axis of the gel. Consistent 
with previous fmdings from this study, there was a trend showing guidance of neurites 
parallel with EngNT-Schwann cell (figure 3.14). However there was no evidence of 
guidance by EngNT -acellular and little guidance provided by EngNT -freeze-killed 
(figure 3.14). 
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Figure 3.14 Neuronal growth on EngNT-Schwann cell, EngNT-acellular and EngNT-
freeze-killed 
(i) Confocal micrographs showing neurites (green) stained for PIII-tubulin on EngNT -acellular, 
-freeze-killed and -Schwann celL Scale bars are 50 J..Lm. (ii) The total length of neurite staining 
detected per mm2 was compared in EngNT and freeze-killed and acellular controls; data are 
means ± SEM from 3 independent co-cultures for each condition and 3 fields (total area 0.368 
mm2) were sampled in each ge l. (iii) The angle of neurite growth was compared to the 
longitudinal axis of the construct in each case; data are means ± SEM of the number of neurites 
with angles of deviation from the long a,,, is of the gel within each 10 degree bin. 
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3.3 Discussion 
In this part of the study it has been shown that Schwann cells survive the plastic-
compression process in both collagen and fibrin hydrogels. Schwann cell alignment 
achieved in tethered collagen gels was retained post-plastic compression. Co-culture of 
collagen EngNT-Schwann cells with neurons showed that neurite growth was supported 
and the orientation of neurite outgrowth corresponded to that of the Schwann cells. In 
fibrin gels, there was some evidence of patches of Schwann cell alignment. However 
this was not sufficiently consistent to significantly affect the quantification. In either 
type of substrate material, the results suggested that the presence of a living cellular 
element supports and guides neurite growth. 
An important step in the development of EngNT was to determine whether the plastic 
compression process caused any cell death. Consistent with other fmdings, the 
stabilisation process did not cause cell death in either the collagen (Brown et al., 2005; 
Levis et aI., 2010) or the fibrin (Haugh et aI., 2012) matrices. There was a significant 
decrease in the amount of cell death in the control gel (not compressed) fixed after 20 
hours, compared to that fixed after 1 hour. This may be because the cells that are dead at 
1 hour may no longer be detected after 20 hours; or because of cell proliferation. 
Plastic compression successfully stabilised the collagen gels so that cellular alignment 
was preserved in collagen EngNT-Schwann cell immediately after and 3 days after 
plastic compression. This fmding is consistent with a previous study using plastic 
compression to stabilise astrocyte alignment in collagen gels (East et al., 2010), 
although in that study the persistence of alignment after compression was described but 
not measured. Although the mechanism for the stabilisation of alignment was not 
investigated here, it can be speculated that increased collagen concentration reduces the 
109 
ability of cells to undergo the alterations in shape and alignment associated with 
cytoskeletal contraction in a fully hydrated gel. This is in line with previous findings 
that show hydrogel rigidity and stiffness govern cell-matrix interactions during motility 
(Grinnell, 2003; Tomasek et al., 2002). 
Previous studies have investigated how plastic compression can be used to modulate the 
mechanical properties of cellular collagen I gels (Brown et aI., 2005) and fibrin gels 
(Haugh et aI., 2012), although East et al. were the only previous investigators to use 
plastic compression as a way to stabilise alignment specifically (East et al., 20 I 0). The 
plastic compression technology became commercially available in a multiwell plate 
fonnat (RAFfTM, TAP Biosystems, UK) during the course of this project, and is 
currently being developed in our lab to combine it with the self-alignment technology 
for the production of tissue-like constructs with aligned cells. If successful, that 
commercial development will provide a GMP-compliant production process that could 
be adapted to generate EngNT in a form that would be suitable for future translational 
studies. 
The scanning electron micrographs showed that the Schwann cells and collagen fibrils 
were co-aligned, whereas the collagen fibrils in the plastic compressed acellular 
collagen were randomly oriented. This is in agreement with Eastwood and colleagues 
who imaged a fully hydrated tethered collagen gel with aligned fibroblasts using the 
scanning electron microscope, and showed both the cells and the collagen fibrils were 
aligned in the same direction (Eastwood et aI., 1998). 
Both collagen I and fibrin matrices used to make EngNT created a permissive 
environment for neurites to elongate along Schwann cell columns, which guided and 
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promoted neurite outgrowth in vitro. These results are consistent with fmdings from 
previous co-culture experiments with DRG neurons and Schwann cells, that showed 
neurites were closely associated with columns of aligned Schwann cells (Thomson and 
Buettner, 2006). In this study, the majority of neurite outgrowth was in close contact 
with a Schwann cell, and grew parallel along the Schwann cell chains. This observation 
is in agreement with the current understanding of peripheral nerve repair, where neurite 
regeneration is associated with close contact with Schwann cells and/or their basal 
lamina (Guenard et al., 1992; Dubey et al., 1999; Thomson and Buettner, 2006). 
However, to understand the precise interactions between regenerating neurites and the 
Schwann cells within EngNT it would be interesting to study neurite growth cones 
using time lapse microscopy to see whether neurites seek and follow the aligned 
Schwann cells as one would predict, or whether some alterations to Schwann cell 
position and shape may occur in response to neuronal growth. The fluorescence images 
suggest that there is not a change in Schwann cell morphology because the surrounding 
Schwann cells, which are not in contact with a neurite, are similar in shape to the 
Schwann cells that are already in contact with a neurite. 
In addition to the physical cues from the aligned cells and collagen fibrils, the 
biochemical influence of the live Schwann cells enhanced neurite outgrowth compared 
to acellular and freeze-killed controls. The cellular and freeze-killed EngNT -Schwann 
cell materials both provided guidance, but the presence of living cells resulted in 
considerably greater neuronal growth. This is consistent with reports demonstrating that 
denervated Schwann cells secrete the ECM components laminin 1 and 2 (merosin), 
which have been shown to promote neurite outgrowth in vitro (Anton et al., 1994; Chen 
and Strickland, 2003; Cohen and Johnson, 1991). Denervated Schwann cells also 
secrete neurotrophins which aid regeneration (Rich et al., 1989; Bloch et aI., 2001). 
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This is supported by studies that show the presence of living cells enhances neurite 
outgrowth by cell-neurite contact and through trophic factors (Thomson and Buettner, 
2006; Richardson et al., 2011; Seggio et al., 2010) and is necessary for the repair of 
damaged nerves with a gap larger than 3 cm between the injured stumps in human 
(Nadim and Anderson et al., 1990). 
The overall aim for this part of the study was to develop and test EngNT in vitro. This 
has been done in terms of establishing the density of the cells required to generate 
sheets of EngNT and the time required for compression. In this part of the study it was 
established that the collagen was better than fibrin for the production of aligned EngNT-
Schwann cell. Collagen I was used for subsequent experiments because it gave 
consistent and reliable contraction and alignment. Additionally, collagen I is a well-
defined material, can be obtained in a GMP-compliant form and it is the material used 
in the RAFTTM system; which is also currently being used within the production of 
cornea transplants, for phase I clinical trials which are due to begin in 2013 (Genetic 
Engineering and Biotechnology News, 2012). The next step in this present study was to 
see whether EngNT -Schwann cell could be used as the basis for a repair conduit to 
support nerve regeneration in vivo, which is the subject of the next chapter. 
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4.0 Investigating ways to deliver EngNT within a nerve repair conduit 
4.1 Introduction 
The previous chapter showed that EngNT can support and guide neuronal growth in 
vitro. This material displayed structural characteristics and biological guidance cues 
that are beneficial for nerve repair; therefore it was appropriate to investigate ways in 
which it could be incorporated into a nerve repair conduit in order to bridge peripheral 
nerve lesions in vivo. 
The addition of an 'engineered endoneurium' or core within a repair device would 
potentially be a way to improve current commercial options consisting of hollow nerve 
guidance conduits and decellularised allografts, which do not effectively support 
regeneration across gaps of more than 3 cm in humans (Oeumans et aI., 2010). 
Insufficient levels of regeneration in 'empty' conduits may be attributed to the 
inadequate formation of a tissue bridge across the long gap in the initial stages of 
regeneration. This, in turn, will affect subsequent processes such as migration of host 
Schwann cells into the injury site, such that the guidance structure of the Bands of 
Biingner fails to form or is inadequate (Oaly et al., 2012). An appropriate core or 
intraluminal guidance structure in a conduit, could act as a replacement for, or speed up 
the formation of, the tissue bridge and/or the Bands of Bungner (Bellamkonda, 2006), 
Studies comparing conduits (empty tubes) to repair devices with a core, have found that 
the presence of intraluminal guidance structures enhances nerve regeneration in rat (10-
20 mm gaps) (Yoshii and Oka, 2001; Ngo et al., 2003; Kim et aI., 2008; Koh et aI., 
2010) and in an 80 mm gap in a dog model (Matsumoto et al., 2000). Others have added 
a cell component to the core of devices with intraluminal guidance structure and seen 
further enhancement to the regeneration process, when compared to acellular devices 
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(with guidance structures) or an empty tube in rat and dog models (Chang and Hsu, 
2004; Kalbermatten et ai., 2007; Di Summa et al., 2010; Ladak et ai., 2011). This 
indicates that cells and intraluminal guidance structures are beneficial within a nerve 
repair device. 
The next step in this study was to use EngNT -Schwann cell to form the core of a 
peripheral nerve repair device. Bands of Biingner are known to be important for repair 
because columns of aligned cells provide a guidance structure and also secrete 
neurotrophic factors that promote regeneration (Dahlin and Brandt, 2004; Hall, 2005). 
The EngNT material could be used to create something analogous to this because it is 
an aligned collagen matrix containing aligned Schwann cells and it can potentially be 
arranged in various ways to form an 'engineered endoneurium' for a repair device. 
EngNT could promote the regeneration ofaxons by providing trophic factors, 
intraluminal guidance and Schwann cells. To explore this possibility, various core 
designs were developed using EngNT -Schwann cell and these were tested within an 
outer tube in the rat sciatic nerve model. 
It is important that the outer tube or 'sheath' of the repair device can mimic the 
epineurium, containing the core and providing mechanical support at the repair site. The 
epineurium has been shown to be about 6.5 times stronger than the core in the rat sciatic 
nerve (Georgeu et ai., 2005); and ideally a repair device containing EngNT would have 
an outer tube with similar tensile strength and the ability to support sutures. Under 
normal physiological conditions peripheral nerves in the limbs bend and stretch, being 
exposed to combinations of tensile, shear and compressive stresses. The change in the 
length of a nerve caused by longitudinal tensile stress (for example as a result of joint 
movement) is called strain. Human nerves need to be able to bend and stretch to 
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accommodate up to 11% strain (Topp and Boyd, 2006). Changes to the structural 
components of peripheral nerves during surgery can lead to extraneural fibrosis and 
wound-bed adhesions and may cause increases in intraneural tension, which would 
compromise the clinical outcome (Hall, 2005). Localised increases in tension could also 
result from repair of nerves at joints in which a rigid outer tube is used, which could 
prevent the repaired nerve from bending with normal movement, so using materials that 
give a device appropriate mechanical properties is a critical feature of repair device 
design. For example, outer tube materials for repairing a nerve at a joint would ideally 
have more compliance than that for repairing a nerve at a location that would not need 
to bend (Phillips et al., 2004; Mason and Phillips, 2011). It is potentially possible to 
engineer a more complex tailored outer sheath that could have a compliant section and a 
stiff section to match particular anatomical locations. 
The first experiment in this chapter used a silicone tube as the outer part of the device, 
whereas later experiments used biodegradable conduits. Silicone tubes used to 
investigate peripheral nerve regeneration were described as a useful experimental tool 
for studying biological mechanisms in rat sciatic nerve (Lundborg et al., 1982). It has 
subsequently been demonstrated that silicone tubes are well-tolerated in humans (Gu et 
al., 2011), even five years after implantation (Lundborg et al., 2004). The main 
objection to the use of non-biodegradable nerve guides, such as those made of silicone, 
is that they remain in situ as prostheses after the nerve has regenerated. Whilst this is 
not an issue in short term experimental models, the use of non-biodegradable tubes in 
the clinic can require a second surgery to remove the tube, which has clear 
disadvantages for the patient (Merle et al., 1989). 
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Plastic compressed collagen was also explored for use as the outer sheath of a repair 
device. The potential advantages of this would be that the mechanical properties could 
be tailored, by varying the collagen concentration and amount of compression, to match 
those required at specific anatomical locations. Other conduits that have been used 
experimentally include: polylactic acid, poly caprolactone, silicone, fibrin and collagen 
(Schmidt and Leach, 2003, Angius et al., 2012). Silicone tubes provided an economical 
way to test EngNT in initial experiments, but for later experiments that required a more 
clinically relevant conduit, NeuraWrapTM, a clinically approved conduit was used. 
Various biodegradable conduits which remain in the nerve injury site long enough to aid 
the repairs have been developed and are currently in clinical use. A literature search was 
conducted to identify the different commercially available tubes and materials for 
clinical use. Only 4 biodegradable synthetic conduits (by Integra LifeSciences, 
Polyganics, Synovis Micro Companies Alliance Inc. and Collagen Matrix Inc.), 
involving 3 materials (collagen, polycaprolactone and polyglycolic acid) have obtained 
the US FDA and the CE approval for clinical use (Kehoe et al., 2012). These conduits 
are used to bridge gaps of less than 3 cm in damaged human peripheral nerves. They 
provide a conduit to concentrate factors, overall tissue guidance/containment, and 
reduce fibrosis/adhesion (Kehoe et al., 2012; Schmidt and Leach, 2003). 
After considering the various available conduits, the NeuraWrapTM tube was chosen for 
use in these experiments, partly because it is based on a similar material to EngNT, 
namely collagen type I (NeuraWrapTM is composed of cross-linked bovine collagen, 
whereas the EngNT was made from native rat tail collagen). Also, the NeuraWrapTM 
conduit has a longitudinal slit that allows it to be spread open, permitting insertion of 
the engineered core (figure 4.6 and 4.7), and the resilience of the material allows it to 
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recover and maintain closure when not being held open. The mechanical strength of the 
material is sufficient for it to be able to be sutured and NeuraWrapTM is flexible enough 
to be accommodated in the surgery site. While there was little data available about the 
mechanical properties of the tube, the publicly available summary from the FDA 
approval process states that "NeuraWrapTM Nerve Protectors are able to hold a suture, 
resist repeated compression from surrounding tissues." (FDA approval number 
K041620, 2004 http://www .accessdata. fda. gov / cdrh docs/pdf4lk041620. pdD. 
Having used in vitro approaches for the development of EngNT (chapter 3), initial 
attempts to develop the assembly of an EngNT -based conduit were also made using in 
vitro techniques. Advantages of using in vitro models rather than in vivo testing for 
these initial experiments include: improved ability to control specific variables, greater 
accessibility for monitoring purposes, and more efficiency in terms of cost and time. In 
view of these advantages, and considering the principles of the 3Rs, it was decided to 
see whether a novel in vitro approach might allow testing of the ability of a construct 
made from EngNT to support and guide neuronal growth. However, a new in vitro 
model that attempted to use primary adult sensory neurons in culture to mimic the 
interaction between a nerve stump and a conduit containing EngNT was not successful. 
In these experiments dissociated DRG neuronal cell bodies were applied at one end of 
the EngNT devices so that neuronal growth through the device, from end to end, could 
be investigated, and two different approaches were tested. The first approach was to 
place the device vertically and seed the neurons at the top end. This was unsuccessful 
because the neuronal cell bodies were subsequently discovered to be distributed 
throughout the constructs rather than remaining at the top. The second attempt was to 
seed them within a gel at the top end; however this was also unsuccessful because the 
gel volume was too small to support a sufficient number of neuronal cells near the 
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device core. It was therefore decided that the priority was to move forward with the 
device development using conventional in vivo approaches. 
A review of animal models used to study nerve regeneration from the 1950s to 2010, 
showed that 17 different peripheral nerves had been studied in 8 different species. The 
rat sciatic nerve model was the most commonly used model for the study of synthetic 
scaffolds; it was used for 86% of the studies reviewed (308 studies were reviewed in 
total) (Angius et al., 2012). The gap size used in initial in vivo experiments, to compare 
the extent of directed neuronal growth in repair devices of different arrangements, was 5 
mm at 2 or 4 weeks. While this is not a critical sized defect, so no difference would be 
expected in the amount of regeneration through an empty tube compared to a graft, it is 
a useful model for understanding how materials are likely to behave in a nerve repair 
situation (Angius et al., 2012; Phillips et al., 2005). The most optimal device design, in 
terms of the amount/density of neurite regeneration, was then used to repair a critical 
sized long gap (15 mm) in rat sciatic nerve, where an empty tube fails but a graft is able 
to bridge the gap and regeneration was assessed after 8 weeks. 
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The main objective of this part of the study was to engineer an 'endoneurium' that 
supported the re-growth ofaxons across the gap in injured nerves. In addition to this, 
the use of plastic compressed collagen as an outer sheath of a device was also assessed. 
The following specific objectives/questions were addressed: 
(i) The first hypothesis that was tested, based on results from the previous chapter, 
was that EngNT-Schwann cell could support neuronal growth in a more directed 
manner in vivo than equivalent collagen constructs that were either acellular or 
contained unaligned Schwann cells. 
(ii) The next part was to investigate different arrangements of EngNT-Schwann cell 
to see which was the most optimal in terms of supporting neuronal growth. 
(iii)Following this, an experiment was carried out to investigate whether different 
numbers of cells and amounts of material, and different sizes of EngNT 
structures could affect the amount of neuronal regeneration through the device in 
vivo. 
(iv)Next a proof-of-principle experiment was conducted to assess the feasibility of 
using EngNT in the device core to repair a gap in the rat sciatic nerve that is 
representative of the clinical situation (15 mm). 
(v) Finally, a preliminary experiment compared the mechanical strength and 
stiffuess of plastic compressed collagen to rat nerves and silicone tubes as a 
prelude to the possible future development of this material as the outer sheath 
component of repair devices requiring specific mechanical properties or non-
standard dimensions. 
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4.2 Results 
4.2.1 Investigating the contribution of cells and alignment to neuronal regeneration 
through EngNT rods in vivo 
The first approach used to engineer 'endoneurium' was to roll the EngNT sheets into 
rods, bundle them together and then pack them within an outer tube to fonn the core of 
a repair device (figure 4.1). EngNT -Schwann cell, an equivalent cellular construct 
without alignment, and an acellular collagen construct control, were tested in a 5 mm 
gap in the rat sciatic nerve for 2 weeks. For each experimental group, 2 EngNT rods or 
controls (5 mm in length) were packed within a silicone tube (as shown in figure 4.2). A 
longitudinal slit was made in the silicone for the insertion of the engineered 
' endoneurium ', and three holes were made at each end for the suture material to pass 
through (figure 4.2). Each construct was then sutured at either end to the stumps of the 
rat sciatic nerve following a single transection. The animals used in this surgery showed 
no obvious external signs of inflammation/infection, weight loss or distress ; and they all 
survived the entire period (2 weeks) of recovery post-implantation. 
EngNT 
Figure 4.1 The rod-based device design. 
EngNT 
rods packed 
together within 
NeuraWrapTlol 
A sembly ofEng T-Schwann cell rods to form the core ofa peripheral nerve repair device. 
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Figure 4.2 Assembly of a nerve repair device with an EngNT core within a silicone tube 
A silicone outer tube was held open using a clamp and two EngNT -Schwann cell rods (5 mm in 
length) were positioned inside. Holes for the suture materi al are marked with arrow heads. The 
tube returned to its cylindrical shape when the clamp was removed, and the ends were trimmed 
so there was a length of 1.5 mm between the holes for sutures and the end of the tube. 
The total amount of neuronal growth was not compared between treatment groups 
because inconsistent stump-core contact was observed in some samples after harvesting 
(figure 4.3). 
Figure 4.3 : EngNT - chwann cell within a s ilicone outer tube after 2 weeks in vivo. 
Embedded in 20% gelatin and fixed with 4% PF A. In this case, the ends of the EngNT, 
indicated by the arrov head , did not make sufficient contact with the proximal stump, as was 
observed in some other sample . PS = proximal stump; DS = distal stump. 
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The devices were implanted into GFP-positive animals which allowed the infiltrating 
host cells to be distinguished from implanted Schwann cells. Combined fluorescence for 
Hoechst and GFP identified the host cells, whereas implanted cells were positive for 
Hoechst and negative for GFP. There were GFP-positive host cells present in all 
conditions but little neuronal growth in the acellular grafts (figure 4.4). Con focal 
micrographs in figure 4.4 are from longitudinal sections in the proximal part of the 
device, and show an overall longitudinally-aligned pattern of cell staining in all cases. 
The nature of neuronal growth within the device core was assessed by measuring how 
aligned each neurofilament-positive neurite was in relation to the long axis of the 
device, in longitudinal sections in the proximal part of the device. In all groups most of 
the neurites showed longitudinal alignment, although there was a trend towards more 
alignment in the EngNT condition (especially looking at the 200 deviation category) 
(figure 4.4B). 
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B device 
type: EngNT -Schwann cell Acellular Unaligned 
- I- . 
Angle of % frequency of % frequency of % frequency of 
deviation neurites neurites neurites 
from 
longitudinal 
axis Means±sem Means±sem Means:l:sem 
10 46 tS 46 ±27 47 :1:17 
20 34 :1:6 22 ±22 22 ±7 
30 13 :1:7 6 :1:6 18 ±9 
40 2 :1:2 7 ±7 6 ±2 
50 0 to 13 ±13 3 ± 1 
60 4 :t2 0 ±O 2 ±2 
70 0 :to 0 ±O 1 ±1 
80 0 :to 7 ±7 0 ±O 
90 0 :to 0 ±O 1 ±1 
Figure 4.4 Comparison of neurite alignment between EngNT with aligned Schwann cells, 
unaligned Schwann cells and acellular collagen in vivo 
Neurite angle was measured relative to the long axis within the proximal part of the devices in a 
5mm gap in the rat sciatic nerve after 2 weeks. (A) Confocal images from longitudinal sections 
in the proximal part of the device showing host cells (a-f) (GFP, green), nuclei (Hoechst, blue) 
and axons (g-!) (neurofilament, red); (B) Table showing the angle of neurite deviation from the 
long axis of the devices, highlighting the SEM within the groups. There was a directional trend 
for regenerating axons in all device groups. N=3, data are means ± SEM. 
The location of the regenerated axons was investigated to see whether they were within 
the rods or between the rods and results are shown in figure 4.5 part (A). In the EngNT-
Schwann cell devices, the neurites grew preferentially within the rods. In the EngNT 
condition 95 ± 5% of total neuronal growth within the device was within the rods, 
compared to 54 ± 28% in the equivalent cellular constructs without alignment; and in 
the implanted material which contained no Schwann cells there were no neurites 
detected within the rods. No neurites were observed in the areas surrounding the rods, 
and there was less variation in the EngNT-Schwann cell group for the location of 
regenerating neurites, compared to the constructs without alignment and the acellular 
materials. Figure 4.5 part (B) shows the number of host cells (GFP-positive) within and 
between the rods. In all the device groups, over 90% of total host cells were present 
within rods rather than between the rods and the outer tube. 
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Figure 4.5 The location of regenerating axons in the proximal part of the device 
(A) Neurites within the devices grew preferentially within the rods in the cellular devices and 
between the rods in the acellular devices; and (B) host cells in all device groups were present 
within the rods. N=3, data are means ± SEM. 
An optimal device core element would be expected to support more neuronal 
regeneration than the surrounding areas. In this case, despite the limitations of the 
experiment due to the inconsistent proximal stump interface, the EngNT -Schwann cell 
material demonstrated advantages over the unaligned or acellular controls in terms of 
distribution of regenerating neurons. 
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4.2.2 Optimisation of the device core design using EngNT -Schwann cell 
4.2.2.1 Device core assembly 
The rods used in the previous experiments in this study had -4 layers from central axis 
to surface and a mean diameter of -200llm. This is a modular design that provides a 
simple way to generate devices of different sizes using the adjustable NeuraWrapTM 
tube, for example more rods can be used for the repair of nerves with a larger diameter. 
Additionally, the diameter of the rods can be altered by adjusting the size of the initial 
EngNT sheet, providing further versatility. An alternative to the use of rods is a sheet-
based device in which the NeuraWrapTM tube is lined with two sheets of EngNT-
Schwann cell, maintaining a lumen (figure 4.6). This is also a modular design since the 
number and size of the sheets can be varied in order to accommodate a range of nerve 
diameters. The rod-based device design that was used in the experiments described 
above (figure 4.1) was compared to a sheet-based device design (figure 4.6). 
During implantation of the devices, the stumps were inserted 1.5 mm into the device in 
all cases to ensure experimental consistency and improve stump-core contact (figure 
4.7). Subsequent experiments from here on moved from using silicone to NeuraWrapTM 
as the outer tube material, which is a step towards making a translational device and 
also made the device assembly easier. 
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Figure 4.6 The sheet-based device design 
The EngNT-Schwann cell sheet is placed on the inside surface ofNeuraWrapTM, maintaining a 
lumen. Two sheets were used in this experiment, one on top of the other. 
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Figure 4.7 Implantation of rod- and sheet-based devices within a NeuraWrapTM outer tube 
(A) A schematic of the implanted device, showing EngNT within the outer tube; PS = proximal 
stump, PO = proximal part of the device, DD = distal part of the device and OS = distal stump; 
CB) A euraWrapTM outer tube (held open by forceps to prevent it from returning to its normal 
cylindrical hape), containing an Eng T-Schwann cell rod of 15 mm in length; (C) End-on 
iew ofa closed euraWrapTM tube with two Eng T-Sch'vvann cel\ sheets lining the lumen. 
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4.2.2.2 Investigating the effect of different EngNT arrangements on neuronal 
regeneration in vivo 
The next step was to investigate the effect of two different device designs (both within a 
NeuraWrapTM tube) on the amount of neuronal regeneration. The EngNT arrangements 
tested here were the rod-based and sheet-based designs (figure 4.1 and 4.6), which were 
compared to an empty NeuraWrapTM tube. The devices were assembled using the same 
amount of collagen and the same starting cell density for each design, then implanted 
into a 5 mm gap in the rat sciatic nerve. Devices were harvested after 4 weeks in vivo. 
and frozen transverse sections were taken from the centre of the proximal part of the 
device region (see figure 4.7 part A) and stained to detect neurofilament, a marker for 
axons. 
The number and position of neurofilament-positive axons was assessed in 10 Ilm thick 
cross sections. The auto-fluorescence from the collagen was used to locate the position 
of the implanted EngNT structures. The cross-sectional area was divided into zones: 
zone I - within the EngNT -Schwann cell material, zone 2 - the immediate surrounding 
area (within 25 Ilm) of the surface of EngNT -Schwann cell, and zone 3 - the remaining 
area (more than 25 Ilm away from the surface of the EngNT -Schwann cell) within the 
conduit lumen (figure 4.8). 
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NeuraWrap® 
Zone 3 - the remaining 
surrounding ar8. 
Figure 4.8 The different zones within cross-sections from the rod- and sheet-based devices 
CA) A key ro sho' the different zones within the implanted Eng T-Schwann cell and empty 
eura WrapTM devices after 4 weeks in vivo in a 5 mm gap in rat sciatic nerve (not drawn to 
scale); (B-D) are 10 !lm cross sections, as observed using auto fluorescence on a fluorescence 
microscope for the different device designs: Eng T-Schwann cell rods (B), EngNT -Schwann 
cell sheets (C), and the empty euraWrap tube (D). The red outlines the EngNT-Schwann cell 
materi al and the blue outlines the device core. Scale bar is 200 Ilm. 
There wa no ignificant difference between the three devices when comparing the total 
number of axon in the cross sections using a one-way ANOV A, figure 4.9 A. Although 
the same amount of material was implanted for each design, the cross sectional area of 
zone 1 in the heet-based design, 0.15 ± 0.02 mm2 (mean ± SEM), was about twice the 
s ize of zone 1 in the rod-based des igns, 0.06 ± 0.01 mm2 (mean ± SEM). The numbers 
of axon in the different zones were counted to give an axon density for each zone in 
each device (figure 4.9 B). There was a trend towards more axons in zone 1 of the 
sheet-ba ed de ign (400 ± 100, m ean ± SEM) than zone 1 of the rod-based design (200 
± 40 mean ± EM) although there was considerable variability and the trend was not 
sign ificant (using either !-test to compare the two zone 1 regions, or ANOV A to 
compare all zones). 
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In both groups, the axon density was greater in zones 1 and 2 compared to zone 3 
(figure 4.9 B). The axon density was significantly greater in zone 1 than in zone 3 in 
both the rod-based and sheet-based design (P<0.05, one-way ANOVA with Tukey's 
post-test). The axon density in zone 2 was also significantly greater than in zone 3 for 
the rod-based devices (P<0.05, one-way ANOVA with Tukey's post-test). The axon 
density in zones 1 and 2 in the rod-based design appeared to be slightly greater than that 
in zones 1 and 2 in the sheet-based design, although this was not significant. The axon 
density in the empty tube group was similar to that of the zone 3 in both device designs 
and zone 2 of the sheet-based design. The axon density in the empty tube was lower 
than zone 1 in both devices, although this was not significant. 
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Figure 4.9 The number and location ofaxons within cross sections from the proximal 
parts of rod- and sheet-based EngNT devices. 
(A) There was no significant difference in the three devices when comparing the total number of 
axons per cross section (one-way ANOVA). (B) Axon density was greater in zones 1 and 2 
(within or near EngNT-Schwann cell), compared to zone 3 in both device groups. This was 
significant between zones 1 and 3 for the rod-based and the sheet-based device designs; and 
between zones 2 and 3 for the rod-based devices (one-way ANOVA, *P<O.05. n=4, data are 
means ± SEM). 
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4.2.2.3 Investigating how different amounts of EngNT -Schwann cell affects 
regeneration using the rod-based device design in vivo 
The previous experiment showed that the axon density was greater within (zone 1) and 
near (zone 2) the EngNT-Schwann cell material, than in the other surrounding areas 
(zone 3) (figure 4.9 B). The rod-based design was easier to assemble and more robust, 
so this was selected in preference to the sheet-based design and investigated further in 
an experiment to compare different numbers of rods or rods of different diameters 
(thinner rods give an increased surface area). 
To investigate the influence of multi-rod structures on axonal regeneration, the 
following designs were compared: 
(i) 2 standard rods of EngNT-Schwann cell; 
(ii) 4 thin rods of EngNT-Schwann cell (each one contains half the amount of 
EngNT -Schwann cell material that is used to make one standard rod; cut in half 
longitudinally post-plastic compression); 
(iii) 4 standard rods of EngNT-Schwann cell. 
These devices were tested within NeuraWrapTM in a 5 mm gap in the rat sciatic nerve 
(n=3 animals per group). Devices were harvested after 2 weeks, which was a shorter 
time point than in the previous experiment, to permit examination of any differences in 
the initial amount of regeneration between the groups. The animals used in this 
experiment showed no obvious external signs of inflammation/infection, weight loss or 
distress, and they all survived the period of recovery after surgery. Frozen 10 Ilm thick 
longitudinal sections from the proximal part of the device and cross sections from the 
distal part of the device (figure 4.7 A) were stained to detect neurofilament protein. 
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In the proximal part of the devices the infiltrating axons were orientated longitudinally, 
with 50-75% of them deviating by less than 20° from the longitudinal axis (figure 4. 10). 
There did not appear to be any clear advantage or disadvantage associated with any of 
the device designs in terms of orientation of neuronal growth in the proximal part of the 
device. 
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Figure 4.10 Frequency distribution showing the angle of deviation of axon growth from 
the long axis of the device, in longitudinal sections from the proximal part of each device 
There is a directional trend in all device groups, with a slightly higher proportion of neurites 
(- 75%) in the 4 rods-EngNT devices deviating by less than ± 20° from the long axis, N=3, data 
are means ± SEM. 
Regeneration was assessed in the distal part of all the device groups. Figure 4.11 shows 
the number of neurites counted in cross sections from the distal part of each device (n=3 
per group). There were not any clear differences in the amount of regeneration when 
there was more guidance material and cells (4 rods-EngNT) or increased surface area 
(thin rods-EngNT) compared to 2 rods-EngNT. 
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Figure 4.11 The number of neurites in cross sections from the distal part of the each device 
Devices were implanted in a 5 mm gap in the rat sciatic nerve for 2 weeks in vivo. 10 !lm thick 
cross sections were stained to detect neurofilament. The number of neurofilment-positive axons 
was counted for each cross section. N=3, data are means ± SEM. 
The two rod arrangement was the easiest to assemble. It used fewer cells and materials 
than having four rods, and so the two rod arrangement was taken forward for testing in 
the long gap (15 mm) model. 
4.2.3/n vivo proof-of-principle testing in the rat sciatic nerve 
To test the ability of EngNT to support neuronal regeneration In a clinically more 
challenging model, compared to the short gap model, two EngNT rods were packed 
within NeuraWrapTM to form an implantable device (figure 4.1) and used to repair a 
critical-sized defect of a 15 mm gap in the rat sciatic nerve. The EngNT devices were 
compared to empty NeurawrapTM tubes and to grafts taken from the sciatic nerves of 
littermates to simulate the clinical gold standard autograft. The extent of neuronal 
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regeneration across a 15 mm gap in the rat sciatic nerve was compared in these three 
surgical treatment groups, with assessment after 8 weeks of recovery. 
The diameter of the NeuraWrapTM lumen is approximately 1.2 mm; this was similar to 
the diameter of the graft nerve used (figure 4.12). The diameter of one EngNT rod is 
approximately 200 Jlm. The scanning electron microscope (EM) images of the cross 
sections through the middle of the repair site show dense material in the graft group 
(figure 4.12), compared with the empty tube. In the EngNT group the rods are visible as 
the regions of highest density within the core and look similar to the appearance of a 
nerve fascicle in the graft. Among the fIrst animals from all the groups to undergo 
surgery in this long gap experiment, 50% showed a tendency to autotomy, necessitating 
culling before the 8 weeks. Following veterinary advice, this was controlled in 
subsequent procedures by daily administration of 0.05 ml Carprofen analgesic. At the 
defined end-point, all the devices showed no signs of collapse, but there were some 
showing minor signs of degradation. In one instance, one of the empty tubes had 
degraded at the mid-point leaving only a thin visible tissue bridge; this was excluded 
from further analysis. There were no signs of adhesions and fibrosis in any of the 
repairs. 
There were a number of outputs from this experiment, including EM analysis at the 
mid-point, muscle weight measurements, and histological analysis of various positions 
within the graft and stumps (figure 4.13). The next section (4.2.5.1) describes the results 
from the mid-point of the repair site in each group. 
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Figure 4.12 Sca nning electron microscopy images of the mid-point of the different device 
groups after 8 weeks ill vivo 
CA-C) Low power images of the mid-point of the devices after 8 weeks in vivo. Scale bars are 
200 ~m. CA) graft, (B) Eng T-Schwann cell rods and CC) the empty NeuraWrap tube. (D-F) 
High power images of the core of the devices fo r graft, EngNT -cellular and empty tube, 
respectivel . Scale bars are lOO ~m . Red outline in image E is around the EngNT rods. 
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Figure 4.13 Schematic of harvested device/graft with stumps, s howing the 5 sampling 
positions for analysis 
These are PS (proximal stump), PO (proximal part of the device), mid-point, DD (distal part of 
the de ice) and OS (the distal stump). 
4.2.3.1 Mid-point analysis 
Tran erse sections were taken from the middle of the repair site and prepared for 
transml ion M. Regenerated nerve ti ssue in each group was revealed in semi-thin 
section u ing toluidine blue staining (fi gure 4 .1 4) . Dense neural tissue can be observed 
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throughout the nerve grafts and EngNT-Schwann cell devices, whereas the empty tube 
group had only very few patches of neural tissue present. Closer examination of the 
toluidine blue stained sections revealed the presence of longitudinally orientated nerve 
fibres at the mid-point of all the repairs, identified by the presence of dense myelin 
staining, within the densely stained areas. To maximise the neural material present for 
analysis in all groups, particularly in the empty tubes where the material was sparse, 
EM analysis was carried out in the densest areas of regeneration, as identified using the 
toluidine blue stain. Figure 4.15 shows transmission electron micrographs that reveal 
the detailed ultrastructure of the regenerated nerve tissue at the mid-point of the repair 
site. The axons were measured by image analysis from the electron micrographs, 
sampling 1232 ~m2 from each device in each group to capture at least 50 myelin 
profiles per repair. 
Graft EngNT Empty tube 
" .. 
Figure 4.14 Light micrographs of semi-thin transverse sections from the mid-point of each 
repair after 8 weeks in vivo, stained with toluidine blue 
Representative semi-thin sections stained with toluidine blue show the differences in density of 
neural ti ssue between the three groups at low (top row) and higher (bottom row) magnification 
(scale bars 200 J.lm and 100 J.lm respectively). 
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Figure 4.15 Transmission electron micrographs of transverse sections through 
regenerated nerve at the mid-point of the repair site after 8 weeks in vivo 
Areas with the highest density in each case were sampled for transmission EM (M = Myelinated 
axon, S = Schwann cell nucleus, scale bar 2 Ilm), with 10 fields selected from the densest 
regions of each corresponding semi-thin section (which was stained using toluidine blue). 
Myelinated axons, unmyelinated axons and Schwann cell nuclei were present in all 
groups (figure 4.15). Even after selecting the areas with the highest density of material , 
there was a greater density of regenerated fibres per field in the graft and EngNT-
Schwann cell, than in the empty tube device, by visual inspection (figure 4.15). The 
number ofaxons at the different points of the device was quantified and is shown later 
(figure 4.18). 
For each myelinated fibre the diameter of the axon and the diameter of the fibre (axon 
+ myelin sheath) was measured, allowing the myelin thickness and the G-ratio (axon 
diameter/fibre diameter) to be determined and compared (figure 4.l6) to explore the 
quality and extent of myelination present in each group. Both the axon diameter and the 
fibre diameter were significantly lower in the empty conduit group compared to the 
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nerve graft group when compared using a one-way ANOV A (P<0.05), whereas there 
was no significant difference between the EngNT-Schwann cell group and the nerve 
graft group (figure 4.16). The myelin was thicker in the nerve graft group than both the 
EngNT and empty conduit group, and there was no significant difference in G-ratio 
between the three groups, which was approximately 0.7 across aJl groups. The 
myelinated axons were smallest in the empty tube group, with a mean axon diameter of 
1.93 ± 0 .10 ~m (± SEM), figure 4.16. 
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Figure 4.16 Morphological analyses of regenerated nerve fibres at the mid-point of the 
repair site after 8 weeks in vivo 
The following were assessed from transmission EM ultrathin sections: fibre diameter, axon 
diameter, myelin thickness and G ratio. 1232 ~m2 was sampled from each device in each group, 
to capture at least 50 myelin profiles per repair. Data are means ± SEM, n = 5 individual 
devices/grafts, * P<O.05 , ** P<O.O 1, one-way ANOV A with Tukey ' s post-test. 
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The regeneration of different fibre types can be evaluated in each device group. Fibre 
types were categorised according to axon diameter (classified into 4 groups: <1 ~m, 1-6 
~m, 6-12 ~m and 12-20 ~m) and whether it is myelinated or not (Michael-Titus et al., 
2010). The distribution of diameters for the unmyelinated and myelinated nerve fibres 
shows that the population of neuronal fibre types that EngNT supported was equivalent 
to that present in the nerve graft (figure 4.17). There was no significant difference in the 
proportions of the different types of fibres that were present in the regenerated nerve 
sampled for each repair, when compared using a one-way ANOVA (figure 4.17). Most 
of the myelinated axons were in the 1-6 ~m group, with a smaller proportion in the < 1 
~m group and very few larger diameter fibres present. The unmyelinated fibres were 
mainly <1 ~m in diameter with some 1-6 ~m and no larger diameter fibres. 
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Figure 4.17 Distribution of myelinated and unmyelinated fibres by diameter at the mid-
point of the repair site after 8 weeks in vivo 
The different fi bre types are classified according to (i) whether they are myel inated or not and 
(ii) axon diameter: Band C fi bres are <I f.!m, AS and Ay and B fibres are 1-6 f.!m , A~ fibres are 
6-1 2 !lm and a fibres are 12-20 f.!m. Analysis was done from electron micrographs in a 1232 
f.!m2 sample area in the region where there was the most amount of regeneration in the mid-
point of the device for each group. The proportion of the types ofaxons in the regenerated nerve 
was simi lar for each device group. No significant difference when compared using a one-way 
ANOV A, n=5 individual grafts/devices and data are means ± SEM. 
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4.2.3.2 Neurite regeneration analysis 
In addition to characterising the nature and distribution of neuronal regeneration and 
myelination at the mid-point of the EngNT -Schwann cell conduit, further analyses were 
conducted using transverse sections through the proximal and distal ends of the repair 
site and in the stumps to investigate the effectiveness of EngNT -Schwann cell in 
supporting regeneration across the 15 mm gap during the 8 week experiment (figure 
4.18 and 4.19). The 15 mm gap in the rat sciatic nerve is a critical sized defect, where 
there is little regeneration in an empty conduit compared to a nerve graft. The number of 
axons in the distal stumps of the empty conduit repairs was 105 ± 29, which is 
considerably lower than the number ofaxons in the distal stumps of the graft repairs, 
3776 ± 326 (figure 4.18). There was no significant difference between the number of 
axons that were present in the proximal part of the EngNT -Schwann cell conduit and 
the empty conduit, however there were approximately twice as many axons in the 
proximal part of the nerve grafts (4584 ± 231) than the conduits (2014 ± 501) (figure 
4.18). To assess regeneration across the gap in the two conduit groups, the number of 
axons in the distal end of the conduit and the distal stump was expressed as a percentage 
of the number ofaxons detected in the proximal part of the conduit. There was no 
significant difference between the number of neurites detected in the proximal conduit 
and distal conduit of the EngNT-Schwann cell devices (repeated measures ANOVA), 
although there was a trend towards there being (-30%) fewer neurites in the distal 
device than had entered the proximal part of the device (figure 4.19). In contrast, there 
were significantly (-90%) fewer neurites in the distal part of the empty conduit than 
entered the proximal part of the empty conduit. 
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Figure 4.18 The number of regenerated axons in 10 Ilm thick cross-sections from different 
parts of each device from each experimental group 
The ability of each conduit to support neuronal growth was assessed by comparing the number 
ofaxons detected at the different positions within the repairs. Total numbers of neurofilament-
positi ve axons were counted per cross-section. PS = proximal stump, PO = proximal part of the 
device, OD = distal part of the device, OS = distal stump. Data are means ± SEM, n = 5 for all 
groups except EngNT-dADSC, which is n = 3. *P<O.05, ***P<O.OOI , one way ANOVA with 
Tukey 's post-test for n = 5 repair groups. 
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Figure 4.19 Histological overview ofaxons (neurofilament-positive) in the different parts 
of the device 
Transverse sections were taken at different positions within NeuraWrapTM conduits containing 
EngNT and empty euraWrapTM controls, and in the distal nerve stumps, and neurofilament-
positive regenerated a.,xons were detected using neurofilament immunoreactivity. Scale bars are 
I 00 ~m (A). The ability of each conduit to support neuronal growth was assessed by comparing 
the number ofaxons detected at the proximal end to those detected at the distal end and in the 
distal stump (8 ). Data are means ± SEM showing the number ofaxons at each position as a % 
of those present in the proximal device (proximal device axon counts were 2313 ± 260 for 
EngNT and 2059 ± 446 for empty conduit). There was no significant difference in the number 
of a.,xons present in the distal compared to the proximal EngNT conduit (** P<O.Ol , *** P<O.OOI , 
repeated measures A OVA with Dunnett 's post-test comparing proximal regions to distal 
device in each case). 
The atrophy of the gastrocnemius muscle, innervated by the sciatic nerve, gives an 
indication of the extent of motor neuron degeneration/regeneration. Relative muscle 
weight ratio defmed as the ratio of the gastrocnemius muscle weight from the 
experimental side to that of the contralateral control side (E/C), is therefore an 
additional way to estimate the regeneration of the motor neuron component in sciatic 
nerve (figure 4.20). The relative gastrocnemius muscle weight in the graft group was 
significantly greater than that in the EngNT-Schwann cell and empty tube groups (P = 
0.025, one-way ANOVA and Tukey's test). The EngNT devices and empty NeuraWrap 
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repairs were all similar to each other in tenns of relative gastrocnemius muscle weight, 
with values of between 65 and 70% of that of the graft group. 
* 40 
* 
35 
aI 
U 
en 
:l 30 E 
en 
:l 
E 25 
aI 
c: 
0 
L. 
iii 20 
('3 
L-
Cl 
L-
~ 15 
~ 0 
() 
W 10 
5 
0 
Autograft Empty NeuraWrap EngNT-Schwann cell 
Figure 4.20 Relative gastrocnemius muscle weight ratios after the 8 week recovery period 
for each experimental group 
The gastrocnemius muscles (innervated by the sciatic nerve) from both experimental and contra-
lateral hind legs of the animal were dissected and weighed. This figure shows the percentage 
weight of the experimentallhealthy gastrocnemius muscle. The graft group ratio was 
significantly greater than the EngNT -Schwann cell and empty tube groups, P = 0.025 (one-way 
ANOV A with Tukey's post-test). Data are means ± SEM, n = 5. 
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4.2.4 Preliminary investigation into whether sheets of plastic compressed collagen 
would have the appropriate mechanical properties for use as an outer sheath for a 
nerve repair device 
Rather than rely on current commercially available conduits to form the outer sheath of 
a device, initial studies were conducted to explore the feasibility of using sheets of 
plastic compressed collagen as an alternative to NeuraWrapTM for the delivery of 
EngNT. This experiment tested the strength and stiffness of plastic compressed collagen 
as a potential sheath element for the device and compared it to rat sciatic nerve tissue 
and a silicone tube. Based on previous reports on the tensile strength of acellular plastic 
compressed collagen hydrogel, it was predicted that a 5.3 mm2 cross-sectional area of 
this material would have a similar tensile strength to that of a rat sciatic nerve (Brown et 
a/., 2005). When a nerve is extended there will be a reduction in cross sectional area, 
and so a nerve with a bigger cross-sectional area (and thicker perineurium) could resist 
more stress before deformation and have greater tensile strength than a nerve of a 
smaller cross-sectional area. 
The biomechanical behaviour of nerve, compressed collagen and silicone were tested by 
putting the materials under strain, increasing their length by 1 mm per minute, 
generating a load extension curve (figure 4.21). The x axis of the curve displays the 
extension as a percentage of the starting length and the y axis is the force required to 
stretch the material. The peak of the curve, the force at which the material fails, is 
defined as the tensile strength. If the slope of the curve is steep, as it is for silicone, the 
material is stiffer and less compliant to elongation than tissue giving a shallow curve, 
such as the nerve and compressed collagen samples (figure 4.21). The three rat sciatic 
nerves that were tested showed different tensile strength readings to each other but had a 
consistent characteristic profile in terms of the 'toe-region' (initial elongation with 
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relatively little resistance) followed by a linear extension profile (figure 4.21). They 
failed between 2-3 N load. The tensile strength of the plastic compressed collagen was 
similar to one of the nerves, which was 2 N. In contrast, the silicone curve had no ' toe 
region' , and the stiffuess, under the lower strains, was considerably greater than the 
plastic compressed collagen and nerves. 
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Figure 4.21 Tensile strength testing of nerves and selected sheath elements 
Nerve 
Compressed collagen 
Silicone 
Three different materials were tested, silicone (black), plastic compressed collagen (red) and rat 
sciatic nerve (blue). The maximal load for a material is a measure of its tensile strength (the load 
at which the material fails) and the slope of the linear part of the extension curve provides an 
indication of the stiffness of the material. 
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4.3 Discussion 
In this work EngNT -Schwann cell was used to fonn the basis of a peripheral nerve 
repair device, and the results demonstrated that EngNT -Schwann cell devices can be 
used for the repair of critical sized defects in rat. Different arrangements and amounts of 
guidance material were initially tested within a silicone or NeuraWrapTM tube in a short 
gap (5 mm) model of rat sciatic nerve injury. These experiments, which used relatively 
low numbers of animals, were perfonned to identify features of construct design that 
were particularly favourable or unfavourable, and allowed decisions to be made 
regarding the EngNT arrangement within the core of the device prior to the more 
substantial in vivo experiment described in section 4.2.5. 
A long gap (15 mm), 8 week experiment was used to assess the support that could 
potentially be provided by EngNT-Schwann cell to neurons regenerating within a 
conduit. At the mid-point of the repair there was considerably more tissue present in the 
EngNT group compared to the empty conduits, and electron microscopy revealed that 
the tissue associated with the EngNT contained densely packed nerve fibres associated 
with Schwann cells. Detailed analysis of the fibre types (based on diameter and 
presence of myelin) showed similar populations in all repair groups, with mainly 
smaller diameter fibres being present, in common with previous studies showing a shift 
towards smaller fibres in regenerating nerves compared to undamaged tissue (Ikeda and 
Oka, 2012). 
Neuronal regeneration resembled the pattern observed in vitro (chapter 3), where 
neurites grew preferentially within the material that contained aligned Schwann cells, 
compared to the acellular and unaligned cellular material. Despite this, there was little 
difference in the orientation of neuronal growth between conduits containing aligned 
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and unaligned cells. Longitudinal orientation of neuronal regeneration was detected in 
acellular constructs too. Thus, in this short-gap model after 2 weeks, the presence of 
cells, aligned in EngNT or unaligned, did not significantly improve axonal guidance 
when compared to an acellular material. 
A similar rolled conduit design, but with unaligned cells on the surface of unaligned 
collagen sheets, was reported by Goto et al. in 2009. They seeded primary rat Schwann 
cells on the surface of a collagen gel, above a calcium alginate gel on a porous 
membrane. The calcium alginate layer dissolved and the collagen gel layer with the 
Schwann cells detached and was then rolled to form a cellular device. In their culture 
study, they compared the rolled-rod design (which, like ours, had 3-4 layers of gel from 
central axis to the surface) with cells to a rolled-rod design without cells. They observed 
more neuronal growth between the layers in the rolled-rod design with cells, than in the 
equivalent device design without cells. This is in agreement with our findings, which 
showed more regenerating neurites within EngNT -Schwann cell rods than in acellular 
EngNT rods, and is also in agreement with most of the literature which shows neurites 
grow preferentially in close contact with Schwann cells (Guenard et al., 1992; Fawcett 
and Keynes, 1990; Dubey et al., 1999; Thompson and Buettner, 2006; Wang et al., 
2011). 
EngNT could potentially be arranged in many different ways within a conduit. Two 
possibilities (rods and sheets) were compared and a clearer understanding of the 
distribution of neuronal regeneration associated with the constructs was obtained. The 
experiments demonstrated that the rod-based design supported a greater axon density 
within and adjacent to EngNT -Schwann cell than did the sheet-based design. Despite 
the increased EngNT volume and surface area present in the sheet constructs, there was 
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no associated increase in the axon density after 8 weeks, compared to the rod constructs. 
There was no significant difference in the numbers of neurites detected within the 
EngNT sheets compared to the EngNT rods (zone 1), although there was a trend 
towards the sheets containing a greater number (which may reflect the greater cross 
sectional area present in the sheets). 
The increased cross-sectional area of the sheets compared to the rods (zone 1) may be 
due to the sheets being less compact and therefore more able to expand under 
physiological conditions. Rolling the EngNT into rods means they are likely to remain 
orientated longitudinally in vivo, in contrast to the sheet arrangement, which may twist 
or kink post-implantation. EngNT rolled to form rods will combine cell-level guidance 
provided by the EngNT-Schwann cell material with 'z' direction guidance across the 
cross section of the construct (Bellamkonda, 2006). 
Neurite growth was observed within the layers of the rods, although it was hard to 
establish precisely whether the growth was on the surfaces or within the collagen. 
However when the amount of surface area (zone 2) was increased using sheets there 
was not an increase in the growth. This is in contrast with the study by Goto et af. where 
more growth was observed in the cellular rolled-rod design than in a cellular rod design 
(where there are no layers) (Goto et al., 2009). 
The rod-based devices were easier to handle and therefore could be assembled within 
conduits reproducibly, compared to the sheet-based devices in which it was difficult to 
position the layers of the material. The greater neurite density associated with the rods 
(3350 ± 143 axons/mm2) compared to the sheets (2920 ± 587 axons/mm2), although not 
significant, implies that multiple rods may be more optimal for regeneration within a 
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conduit than the equivalent amount of sheet material; so the rod-based design was taken 
forward for use in the subsequent experiments. 
In the experiment to investigate the various EngNT rod fonnats, to see whether 
increasing the surface area by having thinner rods or increasing the amount of guidance 
material and cells by implanting more EngNT rods. would affect the amount of 
neuronal regeneration; there was a similar amount of regeneration in the distal parts of 
the devices for all device groups. The 5 mm gap model at 2 weeks may not fulIy 
demonstrate the advantages or disadvantages of the different device designs in tenns of 
their ability to support neuronal regeneration. The differences between the devices in 
this respect may be better highlighted by using a 5 mm gap model at a shorter time point 
or a longer gap model at 2 weeks. A previous study by Yao and colleagues compared 
the number ofaxons that had grown through multi-channelled collagen conduits: 1-
channel versus 2-, 4- and 7-channel conduits. No significant difference was observed 
between groups in a 7 mm gap for 6 weeks in the rat sciatic nerve model, showing that 
the difference in surface area did not affect the amount of axon regeneration in this 
model (Yao et ai, 2010). In this experiment, there was no difference in the amount of 
regeneration in the distal parts of the devices, if the rods are thinner, or double the 
number of them. This may be because in short gaps the presence or absence of Schwann 
cells makes little difference; it is only in longer gaps where they become more important 
(Angius et al., 2012). 
It would be interesting to examine other ways to organise EngNT within conduits in 
future experiments using critical-sized gaps, in order to optimise regeneration support 
and ease of assembly. Other tissue engineering approaches for the development of 
repair devices with intraluminal guidance structures are more conventional in their 
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approach (Bell and Haycock, 2012; Daly et al., 2012; Nectow et al., 2012), in which 
porous or fibrillar scaffolds are manufactured with surface modification to support cell 
attachment, followed with a cell seeding step prior to implantation. Similarly to the 
EngNT approach, these approaches can deliver cell-level and longitudinal guidance 
through the repair site and the designs can be adapted for the repair of different sized 
nerves. However they are in contrast to the EngNT approach in tenns of their cell-
scaffold relationship, where in EngNT the cells are more intimately associated with the 
matrix, which resembles natural endoneurium (aligned fibrils of type I collagen) 
(Mason and Phillips, 2011). The cell matrix interactions that shape the anisotropic 
structure in EngNT are similar to those that occur naturally in tissue development and 
remodelling, and the complex spatial and mechanical cues that arise when cells are 
forced to grow on stiff surfaces (such as within pores and channels or on the surfaces of 
fibres) are thus avoided (Grinnell, 2003; Phillips and Brown, 2011). Furthennore, the 
use of plastic compression to stabilise the material avoids the need for chemical cross-
linking agents and retains the protein in a native state suitable for integration with host 
tissue. 
Based on observations from the short gap experiments, EngNT -Schwann cell rolled to 
fonn rods was selected for a more detailed investigation of regeneration support in vivo 
using a longer gap. A 15 mm gap length and 8 week time point were appropriate for this 
investigation because under these conditions a clear difference in regeneration between 
the empty tube and the autograft group was evident, which was not apparent in shorter 
gap experiments (Angius et al., 2012). 
Investigation of nerve regeneration at the mid-point of the repairs, showed there was 
considerably more regenerated neural tissue present in the EngNT -Schwann cell groups 
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compared to the empty conduits, and electron microscopy revealed that the EngNT-
Schwann cell contained densely packed nerve fibres associated with Schwann cells. 
The quality of regeneration in the EngNT -Schwann cell devices, as quantified by 
transmission EM, is similar to that observed in the graft group. There was not much 
difference in the profile of myelin, axon and fibre diameter in the graft and EngNT 
groups. However, the fibre diameters were significantly greater in the graft group than 
the empty tube group (**P < 0.01) and axon diameter was significantly lower in the 
empty tube group than the grafts (* P < 0.05). 
Detailed analysis of the fibre types (based on diameter and presence of myelination) 
showed similar populations in all repair groups, with mainly smaller diameter fibres 
being present, in common with previous studies showing a shift towards smaller fibres 
in regenerating nerves compared to undamaged tissue (lkeda and Oka, 2012). At the 8 
week time point in a 15 mm sized defect, there was no difference in the types of fibres 
that had regenerated. Axons that do not make peripheral connections undergo atrophy 
and eventually disappear, whereas axons that do make peripheral connections mature 
and enlarge in size (Allodi et al., 2011). Perhaps therefore, in repairs where axons 
reinnervate target organs, a later time point than used in this study, fewer and/or larger 
axons would be observed. Also, one regenerating axon may support over 10 axon 
sprouts (Witzel et ai., 2005), which would decrease in time as they do not all make 
peripheral connections, so fewer axons may be observed at a later time point. 
In addition to the transmission EM data obtained from the mid-point of the repair, 
histological analysis of the number of neurites present at 4 positions within the repaired 
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nerve revealed details about the ability of this initial EngNT -based device to support 
neuronal regeneration from proximal to distal stump. 
Approximately half as many neurites entered the EngNT devices compared to the nerve 
graft, possibly because the two EngNT rods only occupied a fraction of the lumen so 
did not form a complete interface with the cross-section of the proximal stump. Future 
work should therefore include optimising the quantity and arrangement of EngNT 
components within a device in order to maximise proximal ingrowth. Of the neurites 
present in the proximal part of the EngNT -Schwann cell repair devices, approximately 
70% successfully reached the distal part of the devices and approximately two thirds of 
these entered the distal stump. This was in contrast to the empty tube, where only 10% 
of the neurites present at the proximal end regenerated through the empty conduit. 
The in vivo experiments demonstrated that there is potential for EngNT to be used 
within a nerve repair conduit in order to promote neuronal regeneration across a critical 
sized defect. The EngNT device was more effective than the empty conduit. Further 
work will be required to optimise the device design and investigate different amounts 
and arrangements of the EngNT within NeuraWrapTM to increase the amount of 
neuronal growth entering the device. 
EngNT mimics neural graft tissue, in which key cellular features are known to 
contribute to the repair process (aligned Schwann cells in an aligned matrix). The 
aligned Schwann cells within EngNT resemble the Bands of Bilngner to provide 
physical guidance cues to the regenerating axons. The in vitro experiments (chapter 3) 
suggest that the cells within EngNT secrete factors to promote regeneration, which is in 
line with previous reports (Hall, 2005; Rodrigues et ai., 2012). However, although 
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EngNT does not initially mimic the basement membrane, laminin structures, perineurial 
cells or vasculature, over time, the cells could modify the environment. By providing 
the essential elements (the Schwann cells, alignment and collagen), theoretically it is 
possible to facilitate modifications post-implantation, such as the laying down of other 
extracellular matrix proteins (e.g. laminin) or vascularisation as a result of blood 
vessels growing through the device. 
There was no significant difference in the gastrocnemius muscle weight ratio for the 
experimental to the contralateral muscle. In a peripheral nerve regeneration study using 
a graft, empty fibrin conduit and a fibrin conduit with Schwann cells after a 16 week 
recovery period, higher muscle weight ratios were observed of 0.51 ± 0.03 for the graft 
group and 0.45 ± 0.02 for the repairs with implanted Schwann cells (di Summa et aI., 
2011), compared to the ratio observed in this study with Schwann cells after 8 weeks 
(23.8 ± 1.9). Thus, suggesting that a longer-term group is needed to assess the effects of 
functional recovery. 
The acellular plastic compressed native rat tail collagen (5.3 mm2 cross sectional area) 
for use as a device sheath is close to rat sciatic nerve in terms of strength and stiffness. 
Therefore for a sheath to encompass a lumen that is 2 mm in diameter, the thickness of 
the sheath would need to be 1.3 mm, which is reasonable. It would be important to 
calculate the stiffness modulus to compare to other materials, including human nerve 
and NeuraWrapTM. For example, if the cross sectional area is measured accurately then 
the stiffness modulus could be calculated. An initial attempt to estimate the stiffness 
modulus, indicated by the gradient of the linear part of the curve, is about 2.43 ± 0.33 
N/mm for plastic compressed collagen and 2.25 ± 0.18 N/mm for rat sciatic nerve. 
These values are higher than those reported in the literature for rat sciatic nerve, which 
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are about 0.37 ± 0.13 N/mm, as calculated from force/extension curves (Hayes et al.. 
2007). This difference may be because the sciatic nerve has a number of branch points 
which may influence the local mechanical environment. Therefore, plastic compressed 
collagen for use as a sheath material shows promise in terms of its mechanical 
properties. There are studies that have shown that collagen guidance tubes enhance 
peripheral nerve regeneration, compared to silicone tubes (Chamberlain et ai, 1998; 
Spilker, 2000). Further to this, a study in 2012 also showed there was significantly less 
extraneural adhesion with collagen membranes than vein grafts, which are also currently 
used in the clinic, when tested in the rat sciatic nerve model after 3 months in vivo 
(Mathieu et aI., 2012). Further work is required to investigate other properties of plastic 
compressed collagen, including suture pull-out thresholds, degradation rate and 
resistance to extraneural adhesions. Since outer sheath development was not the main 
focus of the current project, this was not pursued further, and instead the remaining 
experiments focussed on testing core element constructs within the clinically approved 
NeuraWrapTM outer tube. 
The main goal of this part of the study was to optimise the arrangement of EngNT 
within the core of a device in a short gap model (in terms of axon regeneration density), 
and then use the optimal device design to assess the feasibility of using EngNT in the 
device core to repair a gap in the rat sciatic nerve that is representative of the clinical 
situation ( 15 mm). 
The standard EngNT rod constructs supported high density axon growth and there were 
not any clear advantages to increasing the surface area or quantities of EngNT -Schwann 
cell in terms of regeneration using the short gap and time point models. It has also been 
demonstrated that EngNT -Schwann cell can be used for the repair of critical sized 
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defects in which an empty conduit perfonns poorly compared to a nerve graft. The 
production of this device is simple, rapid and reproducible. The adjustable diameter of 
the NeuraWrapTM outer tube and the modular rod design would be advantageous for the 
production of a range of devices with different diameters. Finally, the three-stage 
process of self-alignment, plastic compression and rolling is potentially appropriate for 
scale-up and automation for use in clinical and commercial settings. 
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5.0 Investigating the feasibility of making an EngNT nerve repair device using 
clinically relevant cells and materials 
5.1 Introduction 
Having demonstrated that an implantable device containing EngNT -Schwann cell could 
support neuronal growth in vivo, this study went on to investigate the feasibility of 
constructing a repair device from EngNT using clinically relevant cells and materials. 
The design of the peripheral nerve repair device can be divided into two parts: the outer 
sheath and the core. A range of clinically relevant outer sheath materials are available 
(discussed in chapter 4) such as the NeuraWrapTM tube manufactured by Integra, which 
was used in these experiments. This part of the study begins to investigate some 
therapeutic cell types and collagen sources that can potentially be used to make EngNT 
to form the device core. 
Schwann cells have been used in previous studies to promote regeneration in nerve 
repair models (Duncan et al., 1981; Bunge, 1994; Ide, 1996; Terenghi, 1999; Wiberg 
and Terenghi, 2003; Angius et al., 2012); however, for clinical use there are limitations 
to the availability of these cells. Autologous human Schwann cells would need to be 
derived from invasive nerve biopsies and sufficient numbers for regeneration would 
only become available after a lengthy expansion time in vitro (Guest et a/., 1997). 
Schwann cell-like cells derived from stem cells are therefore a more attractive source 
(Walsh and Midha, 2009). There are a range of cell types that can potentially be used 
within a nerve repair device, including autologous and allogeneic cells. 
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Autologous cells 
An autologous therapy is where the patient's own cells are used, whereas allogeneic 
cells are derived from another person. Autologous cells are generally considered to be 
more readily accepted by the patient because they do not provoke an immune reaction 
(Mosahebi et aI., 2002; Rodrigues et al., 2012). 
There are drawbacks associated with autologous cell therapies, including variability 
between patients in yield and quality of cells, a more complex clinical route to patients 
than with an off-the-shelf allogeneic therapy, and in particular the time delay that results 
from expanding the cell populations. Such delays can, in turn, delay the repair 
operation, which can negatively impact regeneration. A study by Wu et al., compared 
nerve regeneration in the rat sciatic nerve model when it was repaired (using the 
primary repair method) at 1, 4, 6, 8 and 12 weeks after damage. Their results showed 
that whilst there was no significant difference in regeneration in the repairs carried out 
after 1 and 4 weeks in terms of compound muscle action potential (CMAP) amplitudes, 
repairs after 4 weeks showed reduced amplitudes (Wu et al., 2013). 
Adult stem cells can be obtained from the patient for use in an autologous therapy; 
however, before these cells can be approved for use in clinical applications, there are 
challenges to overcome such as availability of the cells, efficacy, safety and ethical 
issues. Table 1.3 (chapter 1) summarised some of the cell types that have been or are 
being used in research in the field of peripheral nerve repair. Schwann cells are 
embryologically derived from the neural crest (Le Douarin and Dupin, 2003; Woodhoo 
and Sommer, 2008). Some neural crest stem cells (NCSCs) persist in adults in sites of 
gliogenesis such as the sciatic nerve and dorsal root ganglia (DRG), and in the bulge 
area of hair and whisker follicles, where they give rise to melanocytes (Sieber-Blum et 
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aI., 2004; Rodrigues et aI., 2012). A study by Aquino et al. has shown that mouse 
NCSCs can be differentiated into Schwann cell-like cells in the presence of neuregulins 
and implanted in suspension within a silicone tube to promote neuron regeneration in a 
10 mm gap in rat sciatic nerve (Aquino et al., 2006). Dental pulp is also a source of 
NCSCs that is easily accessible (Gronthos et al., 2000). Some NCSCs express neural-
progenitor protein markers, even in basal culture conditions (Janebodin et al., 2011; 
Gronthos et al., 2002). The main disadvantage is that the yield of NCSCs is low in 
comparison to adipose or bone-marrow tissue sources. 
Bone marrow mesenchymal stem cells (BM-MSCs) are another source of adult stem 
cells, which have been extensively studied and characterised for use in cell therapies 
(Walsh and Midha, 2009). BM-MSCs can be differentiated into Schwann cell-like 
phenotypes expressing GFAP, S100 and p75 and have been used to enhance neuron 
regeneration (Dezawa et aI., 2001; Shimizu et al., 2007). Wakao et al. have shown that 
autologous BM-MSCs differentiated in vitro to Schwann cell-like cells within a conduit 
containing a collagen sponge structure that filled the lumen, and promoted regeneration 
of median nerve injuries in monkeys (Wakao et aI., 2010). Interestingly, there have also 
been studies that have used undifferentiated BM-MSCs directly for peripheral nerve 
repair. A study by Hu et al. (2007) demonstrated that allogeneic decellularised nerves 
filled with autologous undifferentiated BM-MSCs also promoted functional recovery 
when placed in ulnar nerve gaps of non-human primates. 
Autologous adipose tissue is another source of mUltipotent MSCs. Stem and progenitor 
cells usually make up less than 5% of the total cell population in adipose tissue (Fraser 
et al., 2006), but this is 2500-fold more than the frequency of such cells in bone marrow 
(D'Ippolito et al.. 1999). The abundance of adipose-derived stem cells (ADSCs) and the 
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ability to collect large amounts of adipose tissue via liposuction potentially eliminates 
the need for cell expansion. A study that compared different sources of MSCs from the 
same rats, reported that ADSCs proliferate significantly faster than BM-MSCs in vitro 
(Yoshimura et al., 2007). Culture studies have shown that ADSCs have protective 
effects on DRGs; and implantation of these cells causes significantly increased 
expression of mRNA of anti-apoptotic Bcl-2 and decreased mRNA of pro-apoptotic 
Bax and caspase-3 in DRGs, therefore promoting a neuro-protective effect (Reid et al., 
2011). Rat ADSCs differentiated into Schwann cell-like cells (dADSCs) express a range 
of Schwann cell proteins such as GFAP, p75 and s100 and can promote neurite 
outgrowth in vitro (Kingham et al., 2007; Tomita et al., 2012). It has also been reported 
that dADSCs can promote nerve regeneration in the rat sciatic nerve injury model (Gu 
et al., 2012; di Summa et al., 2010; Tomita et al., 2012). 
Certain important features of ADSCs mean that, compared with BM-MSCs, these cells 
offer advantages in tenns of therapeutic potential. These features include a less invasive 
harvest procedure, high cell viability, and favourable culture and expansion properties. 
ADSCs have also shown promise in other therapeutic areas and are in clinical trials for 
autologous treatment of acute myocardial infarction (Europe, ClinicalTrials.gov 
Identifier: NCT01216995 and NCT00442806), chronic myocardial ischaemia (Europe, 
ClinicalTrials.gov Identifier: NCT00426868) and in the area of reconstructive surgery 
after lumpectomy in breast cancer (ClinicalTrials.gov Identifier: NCT00616l35). Cytori 
Therapeutics, Inc. have developed a Tissue Processing System (the Celution® 800/CRS 
Device), which is approved for certain uses in Europe and which is used in the above 
clinical trials. This device automates and standardises the extraction, washing, and 
concentration ofa patient's own ADSCs. 
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Allogeneic cells 
Alternative cell types are being used to create cell lines for potential allogeneic cell 
therapies. An allogeneic cell therapy is where the donor cells are not from the patient. 
Allogeneic cells are human in origin and potentially immunogenic and so are likely to 
evoke a reaction unless the patient is immunosuppressed prior to and post-implantation 
(Mosahebi et al., 2002). 
Potential allogeneic cell lines that could be used in EngNT within a repair device were 
identified through a comprehensive literature study (carried out in November 2012) to 
identify the cells currently used in clinical trials for nervous system cell therapies 
(reported in Table 5.1 in the next section). For example, the ReNcell CTX cells (human 
neural progenitors), which are currently in a clinical trial to treat Stroke, by ReNeuron 
(Guildford, UK); and MultiStem cells (human adult mesenchymal stem cells), which are 
currently in clinical trials for the treatment of multiple diseases and conditions, 
including neurological conditions by Athersys (Cleveland, Ohio, US). 
Based on the literature study, the following cells were selected for investigation within 
this project: 
• Adipose-derived stem cells differentiated into Schwann cells (dADSCs) -
potential for high yield; derived from ADSCs which are in Table 5.1; existing 
technology for harvest and purification; literature on nerve repair. 
• ReNcell CX neural progenitors: undifferentiated (uCX) and differentiated (dCX) 
- neural; availability of research grade equivalent cells ('CX' refers to the cell 
line available to buy for research, whereas 'CTX' refers to the cells used in their 
clinical trials); factor-free differentiation. 
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• Neural crest stem cells (NCSC) - potential for minimally invasive autologous 
harvest; demonstrated efficacy in SC!; correct Schwann cell lineage. 
• Mesenchymal stem cells (MSC) -long-established transplantable cells; potential 
for allogeneic or 'off-the-shelf use, for example MultiStem cells. The cells used 
in this study were primary rat bone-marrow mesenchymal stem cells. 
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C(l111P.lIl) CL' II I) pI.' I k\ L'II )111111.'111 Illdil.'al iPIl 
Geron (US) GRNOPCl Phase I Acute spinal cord 
(oligodendrocyte 5 Patients treated. injury. Therapy 
progenitor cells, derived indicated at 7 -14 days 
and differentiated from after injury. 
hESCs) 
ReNeuron ReNcell CTX cells are Phase 1111 Ischaemic stroke. 
(UK) neural progenitors (adult First patient has Therapy indicated at 6 
neural stem cells derived been treated months to 2 years after 
from 12-week-old foetal injury. No 
tissue). Committed, not immunosuppression 
pluripotent. Genetically 
engineered to be 
conditionally immortal. 
Some technology licensed 
from Stem Cells Inc. 
Stem Cells, HuCNS-SC (adult stem Phase 1111 Chronic spinal cord 
Inc. (Europe) cells derived from fetal First patient has injury. Patients are 
tissue). been treated immunosuppressed 
Cytori Autologous adipose- Phase IIII Heart disease and 
Therapeutics, derived regenerative cells First patient has reconstructive surgery. 
Inc. (Europe) (ADRCs, also called been treated. No immunosuppression 
ADSCs) 
Advanced Retinal pigment epithelial Phase 1111. Stagardt's Macular 
Cell (RP£) cells derived from 3 patients have Dystrophy and dry 
Technology human embryonic stem been treated AMD 
(ACT) (US) cells 
Athersys, Multistem® derived from Phase 1111 for all Cardiovascular disease, 
Inc. human bone marrow 3 areas immune system 
investigated. disorders and 
Pre-clinical for neurological disorders 
spinal cord like ischaemic stroke. 
lDJUry. Inflammatory bowel 
disease. 
No immunosuppression 
Table 5.1 Therapeutic cells currently in clinical trials for nervous system 
repair/regeneration 
Literature search was conducted in November 2012. 
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In this chapter, the results of using these three types of autologous cells (NCSCs, BM-
MSCs, and ADSCs) and ReNcell CX (research grade) cells, for a potential allogeneic 
therapy, within EngNT are described. To investigate whether these cell types could be 
used to fonn EngNT and whether the resulting material would support and guide neurite 
outgrowth, they were fIrst tested in the in vitro assay described in section 3.2.4. In cases 
where initial data looked promising, analysis of gel contraction and cellular alignment 
were carried out. The differentiated ADSCs (dADSCs) and the differentiated CXs 
(dCXs) were taken forward for testing in vivo in a pre-clinical model. The EngNTs with 
aligned cells were rolled into rods and tested within a NeuraWrapTM tube (see figure 
4.1). Using the rat sciatic nerve model, repair of a long gap (15 mm) was assessed after 
8 weeks. This was so the study could test the potential of therapeutic ce]]s in a pre-
clinical model, and use the previous long gap experiment (section 4.2.3) as control data. 
In addition to exploring some of the possible options for selecting a clinically relevant 
source of cells for EngNT, this part of the study also explored suitable sources of 
collagen. Bovine collagen is currently being processed according to GMP regulations 
and implanted in various fonns such as, for example, the NeuraWrapTM conduit for 
nerve repair. However the collagen that is generally used for current surgical purposes 
would not be suitable for EngNT since it tends to contain enzymatically prepared 
atelopeptides rather than native acid-solubilised type I collagen. As a step towards 
finding a more suitable alternative to the acid-solubilised rat collagen used in the 
previous chapters, a commercially available source of bovine collagen was tested to see 
ifit could be used to fonn EngNT. 
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The overall aim of this part of the study was to investigate the feasibility of constructing 
a repair device from EngNT using clinically relevant cells and materials. This was 
divided into two objectives: 
(i) To test bovine collagen type I for use in EngNT; 
(ii) To identify and test appropriate cell types, exploring both autologous and 
allogeneic cells in vitro. The cells that were able to promote guided 
neuronal growth in vitro were tested in the rat sciatic nerve model. 
The rat sciatic nerve model was used to compare the nerve graft (current gold standard 
treatment), device containing EngNT-Schwann cell and an empty NeuraWrapTM tube to 
a device containing EngNT -dAOSC rods and a device containing EngNT -dCX rods 
within a NeuraWrapTM tube. The aim of this in vivo experiment was to provide an 
indication of the efficacy of dADSCs and dCXs in a peripheral nerve therapy based on 
EngNT, to support and guide neuronal regeneration across a critical sized defect. 
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5.2 Results 
5.2.1 Investigating the use of bovine collagen for the production of EngNT 
A contraction profile using free-floating gels containing Schwann cells was established 
to give an indication of the ability of the cells to generate tension within bovine collagen 
gels. Figure 5.1 shows the contraction profile for Schwann cells in bovine and rat type I 
collagen (2 mg/m!) at a range of cell densities: 1-6 x 106 cells/ml of gel. The percentage 
of gel contraction increased with cell density and began to plateau at a density of 4 x 106 
cells/ml in the bovine collagen gels. There was more contraction (80%) in the bovine 
collagen gels at this density than in the rat collagen gels, which was around 70%. 
Having established that similar contraction behaviour occurred with Schwann cells in 
bovine collagen as in rat collagen, the same Schwann cell density that was used in 
previous experiments, 4 x 106 cells/m 1, was used for subsequent experiments. 
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Figure 5.1 Contraction profile for Schwann cells in bovine and rat collagen gels 
Schwann cells were seeded at a range of cell densities (1-6 x 106 cells/ml) within 75J.11 collagen 
gels (2 mg/ml bovine or rat collagen) in a 96-well plate. Gels were photographed following 
overnight incubation and % contraction was determined {[(original gel area - contracted gel 
area) / o riginal gel area] * lOO}. Data are means ± SEM from 4 replicate gels within one culture. 
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The next step was to assess the effect of plastic compression on Schwann cell survival 
in bovine collagen gels. Cellular gels were subjected to compression for 1 minute and 
cell death was assessed using propidium iodide and Hoechst immediately after 
compression. Less than 1% cell death was observed post-compression, 0.9 ± 0.7% 
(mean ± SEM; n=4). 
Following this, cellular alignment was assessed in EngNT made using bovine collagen. 
Bovine collagen EngNT sheets with Schwann cells were fixed and stained to detect 
SlOO and alignment was quantified as previously (chapter 3). Figure 5.2 A and B show 
the aligned Schwann cells in EngNT made using bovine collagen (cells were elongated 
and orientated in the same direction). Cell elongation was similar to that of Schwann 
cells in rat collagen, figure 5.2 C. The line of best fit shows that the degree of cell 
elongation is slightly less pronounced in bovine collagen than in rat collagen, but cells 
were still considerably more elongated than the predicted line of best-fit for a randomly 
organised population of cells. 
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Figure 5.2 Schwann cell orientation in EngNT made with bovine collagen 
A-B, Representative confocal micrographs showing Schwann cells (S I 00, green) in EngNT 
made with bovine collagen (z stack is 15 -20~m thick, I ~m step size). C Scatter plot showing 
the aspect ratio for each Schwann cell in the areas sampled, after compression in bovine 
(orange) and rat (red) type I collagen gels. 4x 106 cells/ml cell density was used. Sampled 
640,000 ~m2 per gel, n=3 independent gels. 
These results indicated that Schwann cells can contract the bovine type 1 collagen 
matrix and self-align within the fully hydrated tethered gel. Schwann cell alignment is 
retained in bovine EngNT (post-plastic compression). 
5.2.2 Cell characterisation of the different clinically relevant cell types investigated 
for peripheral nerve repair 
The following cell types were tested experimentally within this study: primary rat hair 
follicle NCSCs, primary rat BM-MSCs, primary rat Schwann cell-like cells from 
ADSCs and undifferentiated and differentiated human neural progenitor cells (uCX and 
dCX, respectively). Initial characterisation of each cell population was followed by 
testing the ability of each cell type to form EngNT, this includes assessing cell survival 
post-plastic compres ion, cell alignment and ability of the material to promote guided 
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neurite outgrowth in vitro, using a cell density of 4 x 106 cells/ml in rat type [ collagen 
(the same coll agen a the previous in vitro and in vivo experiments in chapters 3 and 4). 
Immunofluorescence labelling ofNCSC cultures on coverslips showed positive staining 
fo r ox lOin 100% of the population. This transcription factor is expres ed by C Cs 
and plays a role in the differentiation of peripheral glial cells (Brit ch et al .. 200 I ; 
Bremer et al. . 2011 ) (fi gure 5.3). dADSCs were stained to detect the typical chwann 
cell markers, GFAP p75 and soxlO, and were po itive for all three (figure 5.4). Or Paul 
Kingham of Umea university (the supplier of these cells), previous ly characteri ed th e 
cells by immunofluore cence and western blotting and showed they were pos itive for 
the ame markers (Kingham et al., 2007). 
Figu re 5.3 Identification of Sox lOin neural cre t stem cells 
lmmunofluore cence staining of cu ltured primary rat neural crest stem cells that were seeded 
onto coverslip and maintai ned in culture fo r 24 hour before fixation and immunolabelling to 
detect ox I 0 (green). In the merged images blue is Hoechst and green i ox 10 taining. The 
top ro\\' ho\\'s an area positi e fo r ox 10 and the bottom row show the negative control, no 
primary ant ibody. All C C nuclei were positive for Sox 10. Scale bars are 100 J.lm . 
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Figure 5.4 Cha racterisation of dADSCs on coverslips 
Immunofluorescence staining of dADSCs on coverslips after 24 h in culture, for the typical 
Schwann cell markers: GFAP, p75 and Sox 10. (Scale bars are IOO)lm). In the merged images , 
blue is Hoechst and the green is for the antibody. dADSCs were positive for all of these 
markers. 
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Flow cytometry analysis was perfonned on BM-MSCs to detect anti-CD54, a marker 
for mesenchymal stem cells (Mafi et al., 2011). BM-MSCs were positive for CD54 
(figure 5.5) (isotype IgG 1 antibody was included as a control). Immunofluorescence 
labelling of BM-MS Cs on coverslips revealed that 51 % of the population of BM-MS Cs 
was positive for anti-integrin ~1 (CD29), a marker present in mesenchymal stem cells 
(Mafi et al. , 2011). 
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Figure 5.5 Characterisation of BM-MSCs by flow cytometry 
Histogram showing CD54 expression on BM-MSCs (blue). Two experimental runs were carried 
out, with average median fluorescence for anti-CD54 of 46.8 ± 1.1 (mean ± SEM) and the 
average median fluorescence for the isotype IgGI control was 5.6 ± 0.3 (green peak). A no 
primary antibody control was also used, represented by the dashed pink peak. 
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The research grade ReNcell CX cell s, were characterised previously by 
immunofluorescence staining by Millipore (figure 5.6), so no further characterisation 
was performed on this commercially-sourced cell line. The uCX cells were cultured 
with FGF-2 and EGF to maintain their undifferentiated state. The removal of these 
factors from the media initiates differentiation, which is a two week process. The uCX 
cells were positive for nestin, which is required for the self-renewal of neural stem ce lls 
(park et aI. , 20 I 0), and sox-2, a marker for neural stem cells (Ellis et aI., 2004). The 
dCX cells were positive for neuronal and glial markers (~TII-tubulin and GF AP, 
respectively). 
ReNcell CX eel s (Millipore Cat. No. SCCOO7) are grown as monolayers (A) and express NSC markers. Nestin (8 . red; Cat. 
1'«>. MAB5326) and Sox·2 (B. green; A85603). ReNeell CX ceDs are able to differentiate into neurons express ng ~III· 
tubUlin (C; Cat No. MAB1637) and glial cells expressing GFAP (D; Cat. No. A85804). 
Figu re 5.6 Characterisation of undifferentiated (A, B) and differentiated (C, D) CX 
ReNcells by supplier, MilIipore (Reproduced from data sheet, Millipore, Cat. No. 
SCCOO7). 
integrin 
5100 GFAP p75 sox10 sox2 Nestin CD54 
NCSC - - - ,/ - - -
Rat BM-MSCs - - - - - - ,/ 
uCX - - - - ,/ ,/ -
dCX - ,/ - - - - -
dADSCs ,/ ,/ ,/ ,/ - - -
Table 5.2 Summary table for cell characterisation 
The ,/ indicates the cells are positive for the corresponding antibody; the - indicates where the 
test was not performed. 
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The primary rat neural crest stem cells were not explored further for use within the 
EngNT due to their low cell yield (less than one million cells were obtained after 2 
weeks in culture). Following characterisation of the cell populations, BM-MSCs, 
dADSCs, uCX and dCX cells were selected for further testing. Cell death post-
compression was assessed first using propidium iodide. Tethered gels were compressed 
fo llowing overnight incubation to pennit gel contraction. Samples from compressed 
gels were stained with propidium iodide immediately after compression, and then fIXed 
with 4% PF A and stained with Hoechst. As shown in table 5.3, there was little cell 
death post-compression for all the cell types tested. 
Rat BM-MSC 1.90 ± 0.28 
RatdADSC 0.50 ± 0.14 
Human uCX 0.10 ± 0.03 
Human dCX 0.20 ± 0.06 
Table 5.3 Cell death in compressed gels in rat collagen I gels 
Fully hydrated tethered gels (4 x 106 cells/ml) were incubated overnight to permit contraction 
before plastic compression. A sample from one end of the cellular EngNT was taken for 
live/dead analysi immediately after compression (before the remaining EngNT was used in the 
in vitro assa with neurons). 
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5.2.3 Assessing the capacity of (rat collagen) EngNT containing different cell types 
to support and guide neurite outgrowth in vitro 
5.2.3.1 Primary rat BM-MSCs 
Rat BM-MSCs were tested as an initial way to investigate the feasibility of using the 
equivalent human cells to make EngNT (EngNT-BM-MSC). As previously in chapter 3, 
primary rat DRG neurons were cultured on the surface of this material, EngNT-BM-
MSC, for 3 days before fixing overnight and then stained to detect PIII-tubulin. Rather 
than conduct a detailed analysis of BM-MSC orientation within the EngNT, a more 
rapid assay was conducted to screen for the ability of the final material to support 
neurite growth and provide overall guidance parallel to the long axis of the construct. 
Figure 5.7 A-C show confocal micrographs of neurites that were extended on the 
surface. The direction of neurite outgrowth was measured in the sampled area 
(640,OOOllm2 per EngNT-BM-MSC), and there was no obvious directional trend (figure 
5.7 part D). The total neurite length measured in the sampled area per EngNT -BM-
MSCs was 4233 ± 1590llm (mean ± SEM), which is low in comparison to the EngNT 
material with the other cell types tested (figure 5.13). No further analyses were carried 
out using the BM-MSCs, such as the quantification of BM-MSC alignment, because the 
amount of neurite growth extended on EngNT -BM-MSCs was lower than with the other 
cell types within EngNT (section 5.2.2.5). 
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Figure 5.7 Neurite outgrowth on the surface of EngNT-BM-MSCs after 3 days in culture 
A-C Con focal micrographs of DRG neurons extending neurites (PllI -tubulin, grey) on the 
surface, scale bars are 100 ).lm; D Distribution of angle of neuri te deviation from the long axis 
of the gel. eurite length measured in the sampled area per EngNT -BM-MSCs was 4233 ± 
I 590).lm (mean ± SEM). Data are means ± SEM, n=4. 
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5.2.3.2 Schwann cell-like cells differentiated from rat ADSCs 
Schwann cell-like cells differentiated from ADSCs (dADSCs) were tested as a potential 
source of cells for an autologous therapy. Before repeating the in vitro neuron co-culture 
experiment using EngNT-dADSC, the contractility of the cells was assessed in collagen 
gels at a range of cell densities 1-6 x 106 cells/m\. Similar to prior observations with 
Schwann cells in collagen gels (figure 5.1), the amount of contraction observed for 
these cell types at the 4 x 106 cells/ml density is between 60-80% (figure 5.8). 
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Figure 5.8 Contraction profile for rat tail type I collagen gels with Schwann cells or 
dADSCs 
Cells were seeded within 75/l1 collagen gels (rat tail type I, 2mg/ml) in 96-well plates and 
photographed following overnight incubation to determine % contraction {[(original gel area -
contracted gel area) / original gel area] * lOO} . Data are means ± SEM, from 4 replicate gels 
within one culture. 
dADSC alignment and elongation within EngNT was quantified; EngNT -dADSC sheets 
were fixed after 24 hours and then stained to detect SIOO immunoreactivity. Results are 
shown in figure 5.9 parts A and B. The confocal images show the aligned and elongated 
cells (red) within EngNT. Aspect ratio of cells was quantified and results are shown in 
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figure 5.9 part C; the degree of cell elongation is greater in EngNT-Schwann cell than in 
EngNT-dADSC. Cells were mostly orientated parallel to the long axis of the gel, 54 ± 
8% (mean ± SEM) of the cells did not deviate from this by more than 20°, figure 5.10. 
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Figure 5.9 Cell elongation within EngNT-dADSC 
A and B Confocal micrographs showing the cells (S 1 00, red) within EngNT, scale bars are 100 
Jlm ; C catter plot showing each cell aspect ratio/elongation within Eng T-dAOSC (red) and 
Eng T-Schwann cell (blue). n=3 individual gels. 
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Figure 5.10 dADSC orientation in EngNT-dADSC 
Frequency distribution showing the deviation of the orientation of each cell from the long ax is 
of the gel , on a per field basis. Data are means ± SEM, n=3 individual gels. 
The ability of dADSCs within EngNT to support and direct neuronal growth was 
assessed in the same way as the previous neurite outgrowth in vitro assay experiments. 
Confocal micrographs in figure 5.11 A show neurite outgrowth in grey, stained for ~II1-
tubulin. The ability of the cells to confer alignment to the growing neurites was assessed 
and results are shown in figure 5.11 C. There is a clear directional trend in neurite 
outgrowth, with 52% of extended neurites on EngNT-dADSC within 20° of the long 
axis of the gel, and only 1.0 ± 0.6% (mean ± SEM) were extended perpendicular to the 
long axis of the gel. The confocal micrograph in figure 5.11 part B shows neurites 
(green) growing along, and in very close contact with, dADSCs (red). 
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Figure 5.11 Neurite outgrowth on EngNT-dADSC 
A Con focal micrographs of neurites stained for PIlI-tubulin (grey), scale bar is 1 00 ~m ; B 
confocal micrograph showing dADSC (S I00, red) and neurons (PIII-tubulin, green) and C 
frequency distribution showing the angle of neurite deviation from the long axis of the gel. 
Total length of extended neurites in sampled area was 9447 ± 171 O~m, mean ± SEM. Data are 
means ± SEM, n=3 individual gels. 
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5.2.3.3 Human neural progenitor cells (ReNcell) 
The human neural progenitor cells (ReNcell CX) were tested as a potential source of 
cells for an allogeneic approach to making therapeutic EngNT. They were used in their 
undifferentiated state (uCX) as supplied from Millipore, and in their differentiated state 
(dCX) as a population of mixed glia. The differentiation of the CX cells was initiated 
through the removal of growth factors. The in vitro assay to assess neurite outgrowth 
was repeated using these cells within EngNT, EngNT-uCX and EngNT-dCX, assessing 
their ability to support and guide neuronal growth. The cells were used at 4 x 106 
cells/ml, as with the Schwann cells, BM-MSC and dAOSCs. 
Neurite growth was assessed as described previously, using the neurite outgrowth in 
vitro assay. The images in Figure 5.12 show that the amount of neurite outgrowth on 
EngNT-dCX (18888 ± 1043J.1m, mean ± SEM) (images B) was - 8 fold greater than that 
on EngNT-uCX (2313 ± 521 J.1m) (images A), when equivalent areas were sampled. The 
direction of neurite outgrowth was assessed in the same way as described previously. 
The results are shown in frequency distribution graphs in figure 5.12. Neurite extension 
on EngNT-uCX is quantified in figure 5.12 part C; the quantification supports the 
images showing the neurites were extended in all directions, because there was a similar 
portion of neurite outgrowth in all the angle ranges. There was a clear directional trend 
in neurite outgrowth on the surface of EngNT-dCX shown in figure 5.12 part 0, 46 ± 
6% (mean ± SEM) ofneurites extended on EngNT-dCX do not deviate from the long 
axis of the gel by more than 20°. The amount of neuronal growth on the EngNTs with 
the different cell types tested is compared in figure 5.13. 
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Figure 5.12 euronal growth on th e surface of EngNT-uCX and EngNT-dCX 
A Con focal micrograph showing neuronal growth (PllI-tubulin, grey) on the surface of EngNT-
uCX (23 13 ± 52 1 ~m, mean ± SEM); B confocal micrograph of neuronal growth on Eng T-
dCX ( 18888 ± 1 043 ~m)' and C Frequency distribution of neurite angle that have been extended 
on the urface of Eng T-uCX; and D Frequency distribution of neurites that have been 
extended on the urface ofEng T-dCX. n=4 indi vidual gels, data are means ± SEM, scale bars 
are 100 ~m. 
183 
5.2.3.4 Cell type comparison 
The relative ability of the different candidate cell types to support neurite extension in 
vitro on EngNT with the different cell types was compared by measuring the amount of 
neurite outgrowth per mm2 for each gel. Primary rat neurons from a single culture were 
seeded on the surface of the EngNTs with aligned Schwann cells, dADSCs, uCX and 
dCX. The results from the neuron co-culture on EngNT-BM-MSC were included, 
however this was from a different experiment using a different neuron culture so results 
should be interpreted with caution. The cell types that promoted neurite outgrowth the 
least were the BM-MSCs (6.2 ± 2.2 mm-2) and uCX (4.9 ± 1.5 mm-2) so these were 
excluded from subsequent parts of the study. The differentiated cells promoted neurite 
growth the most; dCX (38.5 ± 3.0 mm-2) and dADSC (12 ± 1.0 mm-2) (figure 5.13). 
These differentiated cells were selected for testing in vivo. 
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Figure 5.13 Neurite outgrowth per mm 2 quantification on aligned cellular EngNT 
The total length of neurite outgrowth measured in the sample region (640,000 11m2) of each 
Eng T, data are means ± SEM, n=3 individual gels. 
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5.2.4 Initial in vivo testing in rat sciatic nerve 
Having established that the dADSCs and the dCX cells could be used to generate 
EngNT which supported directed neuronal growth in vitro, they were taken forward for 
testing in the long gap (15 mm) in vivo model and compared to the groups tested in the 
previous long gap experiment (section 4.2.3): a nerve graft (obtained from litter mates 
to simulate the clinical gold standard autograft) and an empty tube. This was a 
preliminary experiment using small numbers of animals. These groups were compared 
using a 15 mm gap in the rat sciatic nerve with assessment after 8 weeks of recovery. 
5.2.4.1 EngNT -dAD se devices 
To test the ability of EngNT-dADSC to support regeneration in the long gap model, two 
15 mm rods were packed within a NeuraWrapTM outer tube to form the implantable 
device (n=3) (figure 4.1). As before (section 4.2.3), transverse sections were taken from 
the middle of the devices and prepared for transmission EM. Toluidine blue staining in 
the semi-thin sections revealed regenerative tissue throughout the cross section of the 
device (figure 5.14), as was observed in EngNT-Schwann cell and autograft groups and 
in contrast to the empty tube group where material was sparse (figure 4.14). The 
transmission EM images revealed the ultrastructure of the regenerated nerve tissue at 
the mid-point of the devices. The mean axon diameter for myelinated axons in EngNT-
dADSC (2.16 ± 0.06 J.lm) was similar to that observed in the EngNT-Schwann cell 
group (2.33 ± 0.10 J.lm) (figure 4.16). The mean fibre diameter for myelinated axons in 
EngNT-dADSC was 3.12 ± 0.18 J.lm, which is approaching the mean fibre diameter 
measured for the graft group (3.29 ± 0.13 J.lm) and greater than that for the empty tube 
(2.64 ± 0.14 J.lm). Myelin thickness in EngNT-dADSC (0.48 ± 0.08 J.lm) was similar to 
that observed in the graft group (0.44 ± 0.01 J.lm), and greater than the myelin thickness 
in the empty tube and EngNT-Schwann cell groups (0.35 ± 0.03 and 0.34 ± 0.02 J.lm, 
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respectively). Similar to the control gro)Jps, the g ratio m EngNT -dADSC was 
approximately 0.7 (figure 4 .16). The different fibre diameters were evaluated as done 
previously (figure 4.17). The distribution of the different fibre types was s imilar in 
EngNT-dADSC to the graft , EngNT-Schwann cell and empty tube groups. 
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Figure 5.14 Micrographs of transverse sections from the mid-point of the EngNT-dADSC 
devices after 8 weeks in vivo 
Representati e semi-thin sections stained with toluidine blue show the regenerated neural ti ssue 
within the de ice, as observed by light microscopy (A) scale bars are 200 and 100 Ilm for the 
images on the left and right, respectively. (B) Representati ve transmission electron micrographs 
taken from the areas of highest density (as determined from toluidine blue stained sections); S = 
Schwann cell nucleus, M = myelinated axon, scale bars are 2 Ilm. 
Neurite regeneration was analysed using transverse sections through the proximal and 
dista l parts of the device and in the stumps, to investigate if EngNT -dAOSC could 
support regeneration across the 15 mm gap during the 8 week recovery period, as done 
previous ly. Figure 5 .1 5 shows representative images of the neurofil ament positive 
axons in the different parts of the repair site. The axon counts in the three EngNT-
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dAD se devices tested gave a similar mean number ofaxons in the different parts of the 
device as were observed with EngNT -Schwann cell devices. There was a greater 
number ofaxons supported in the DD (distal part of the device) in the EngNT devices 
(EngNT-Schwann cell and EngNT-dADSC), compared to the empty tube group, which 
had 290 ± 112 (mean ± SEM) axons, which is approximately a third of the number 
detected in EngNT-Schwann cell (955 ± 348) and EngNT-dADSC (719 ± 306) (figure 
4.18). 
The relative muscle weight ratio was also calculated to give an indication of the extent 
of motor neuron regeneration/degeneration. EngNT-dADSC devices after 8 weeks in 
vivo to bridge a 15 mm gap, had a relative muscle weight ratio 21.0 ± 0.4 % (n = 3), 
which is similar to that observed in EngNT-Schwann cell, 23.8 ± 1.9 % (n = 5), and 
lower than that observed in the graft group, 34.7 ± 2.5 % (n = 5). 
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Figure 5.15 Fluorescent micrographs of transverse sections through the different part of 
the repair site after repair with E ngNT -dADSC devices after 8 weeks ill vivo 
1 0 ~m thick sections were stained to detect neurofilament, scale bars are I 00 ~m . 
5.2.4.2 E ngNT -dCX devices 
Eng T-dCX devices were tested in the same way, within a NeuraWrapTM tube to bridge 
a 15 mm gap in the rat sciatic nerve (n=5) (figure 4. 1). The dCX ce ll are human ce lls 
and so the animals were immunosuppres ed using cyclosporine A (1 5 mg/kg) 24 hours 
prior to implantation and then daily throughout the recovery period. Two out of the fi ve 
devices were pre-Iabel\ ed with Hoechst to allow the implanted cells to be distinguished 
from the ho t cells in the harvested devices, in addition to u ing the GFP label 
expressed in host cells to distinguish them also. 
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The analyses were carried out as described previously (section 4.2.3). Figure 5.16 
shows images of transverse sections through the mid-point of the devices stained with 
toluidine blue (A) and transmission EM (B). Two out of the five devices (one was pre-
labelled with Hoechst and one was not) had regenerated tissue present within the 
devices, however no regeneration was observed in three of the devices (the images in 
figure 5.16 are representative of the two implanted devices that supported regeneration). 
The regeneration observed in the two devices (figure 5.16) shows myelinated axons at 
the mid-point of the repair, however this was sparse and much less than the amount of 
neural tissue observed in the EngNT -Schwann cell and EngNT -dADSC devices, and 
also less than that observed in the empty tube group. Although these cannot be 
compared directly as only the animals in the EngNT -dCX group received were 
immunosuppressed. 
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Figure 5.16 Micrographs of transverse sections from the mid-point of the EngNT-dCX 
devices after 8 weeks in vivo 
Representative semi-thin sections of two of the devices stained with toluidine blue show the 
neural tissue within the device, as observed by light microscopy (A) scale bars 100 ~m ; 
Representative transmission electron micrographs of the two devices taken from the areas of 
highest density (as determined by toluidine blue stained sections), S = Schwann cell nucleus, M 
= myelinated axon, scale bars are 2 J!m and 500 nm for the images on the left and right, 
respectively. 
Transverse sections were taken from the proximal part of the devices and stained to 
identify neurofilament positive axons. All devices were implanted into GFP+ rats, and 
there was evidence of Hoechst staining that was not associated with GFP+ cells, 
indicating persistence of the dCX cells at the repair site (figure 5.17 image A). The 
neurofilament-positive axons shown in red in image B indicated EngNT-dCX can 
support neuronal growth. 
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Figure 5.1 7 Confocal micrographs of transverse sections from the proximal part of 
EngNT-dCX devices after 8 weeks in vivo 
(A) Hoechst-labelled dCX nuclei were present within the implanted dev ice at 8 week 
(indicated by white arrows), and were distinct from host GFP-Iabelled cells, indicating 
persistence of the dCX cells at the repair site (B) The EngNT -dCX devices supported neuronal 
regeneration (red). 
At the time of device harvest, the relative muscle weight ratio was also calculated to 
give an indication of the extent of motor neuron regeneration/degeneration. This was 
greater than the other EngNT device , at 24.8 ± 1.3 % (n=5), compared to 2 1.0 ± 0.4 % 
for EngNT-dADSC (n=3) devices and 23 .8 ± 1.9 % for EngNT-Schwann cell (n=5) 
device; but wa lower than that observed in the graft group, 34 .7 ± 2.5 % (n = 5). 
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5.3 Discussion 
This part of the study tested whether clinically relevant cells and materials could be 
used to make a peripheral nerve repair device based on EngNT. Importantly, it 
demonstrated that sources of collagen and cells similar to those that have already been 
developed for use in clinical trials can be used to engineer neural tissue, providing 
useful evidence to underpin future translational studies. 
This study showed that bovine collagen, which is more clinically relevant than rat 
collagen, supported Schwann cell self-alignment and could be subjected to plastic 
compression to produce EngNT. Studies have reported other cell types contracting 
bovine type I collagen, such as human gingival fibroblasts and human oral keratinocytes 
(Techatanawat et a/. , 2011). The contraction profile experiment (section 5.2.1, figure 
5.1) showed that the amount of contraction after 24 hours with Schwann cells was 
similar in both rat and bovine collagen. A study comparing contraction rates in type I rat 
and bovine collagen, using fibroblasts, showed that rat collagen had a slower 
contraction rate compared to bovine collagen over a 9 day period (Techatanawat et al., 
2011); though the contraction rates reported in that study were similar after a 24 hour 
period, which is in line with the results shown here. 
The form of bovine collagen currently used in the clinic (e.g. for lip fillers in cosmetic 
surgery) is not suitable for use within this method, to form a hydrogel, because it 
contains telopeptide-free collagen, which cannot form a hydrogel. Collagen has been 
used for a considerable period of time in the clinic, providing evidence of safety and 
biocompatibility, making it desirable for use in more advanced tissue engineering. A 
study by Charriere et a/. in 1989, showed that only a small percentage, 2.3%, of the 
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patients treated with bovine collagen implants had an adverse reaction, from the 656 
patients tested (Charriere et al .. 1989). 
The cells investigated in this study were: primary rat bone-marrow mesenchymal stem 
cells, Schwann cell-like cells from differentiated adipose-derived stem cells, 
undifferentiated and differentiated CX cells. Primary neural crest stem cells were 
considered initially but were not used for experiments. The neurite outgrowth in vitro 
assay was used to screen the cell types and showed the undifferentiated cells (BM-
MSCs and uCX) did not enhance neurite outgrowth as much as the cells that had 
differentiated into glial cell types (dADSC and dCX). 
Interestingly, other studies using rat BM-MSCs to repair rat sciatic nerve have shown 
that transplanting stem cells that are not fully differentiated can be effective due to 
subsequent in vivo differentiation (Zhang et al.. 2004; Chen et al.. 2007). Chen et al. 
showed the BM-MSCs differentiated post-transplantation into S lOO-positive Schwann 
cell-like cells that myelinated the regenerated axons (Chen et al.. 2007). Transplanting 
undifferentiated cells could be useful in the clinical setting because transplanting stem 
cells at the time of injury and permitting their differentiation to a Schwann cell-like 
phenotype in vivo would potentially reduce the delay associated with expanding and 
differentiating autologous cell populations. However, when comparing undifferentiated 
and differentiated BM-MSCs directly, the differentiated cells secrete greater amounts of 
neurotrophic factors, which can enhance regeneration (Dezawa et al.. 2001). 
Additionally, using differentiated/more mature cells may ensure a more precise and 
complete therapeutic effect because the cell population will be more homogeneous than 
the cell population from transplanted undifferentiated cells, where their differentiation 
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to a particular cell type is not controlled or monitored and the long term safety is 
unknown. 
The undifferentiated cell types tested in the in vitro assay, BM-MSCs and uCX, were 
not taken forward because they did not promote neurite outgrowth as well as the 
Schwann cells. The dADSe and dCX cells however were better in promoting neurite 
outgrowth and could be used to make EngNT which supported directed neurite 
outgrowth. The ex cells are equivalent to the clinical grade CTX cells, which are 
already being transplanted into patients, with no immunosuppression, to treat stroke. 
Their differentiation into glial cells is mediated through the removal of factors, which is 
an appealing feature from a regulatory point of view since no additional factors would 
need to be used to manipulate the CTX cells. 
Having established that an EngNT -based device could be assembled using clinically 
relevant cells, the effectiveness of these devices was investigated in a long gap in vivo 
model. EngNT -dADSe or EngNT -dCX devices were implanted into a 15 mm gap in the 
rat sciatic nerve for 8 weeks. Data obtained using the EngNT-Schwann cell devices, 
empty NeuraWrapTM tubes and nerve grafts from littermates reported in chapter 4 were 
used as comparators, and hence were not repeated for the dADSC and dCX in vivo 
experiments. 
The EngNT -dADSe devices showed equivalent regeneration to the EngNT -Schwann 
cell devices, in terms of the amount of neural tissue at the mid-point of the devices and 
the number of regenerated axons that were supported at the distal part of the device, 
although no statistical analysis was done because the number of animals used in the 
EngNT-dADSe group was n=3 only. 
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The regeneration across a 15 mm gap after 8 weeks using the EngNT -dCX devices was 
less clear because there was no regeneration present in three out of the five implanted 
devices, and so no quantification was carried out because of the inconsistency within 
the group. The regeneration observed in the two EngNT -dCX devices that did show 
some regeneration, was less than that observed in the other EngNT devices. This may 
be due to species differences and the immune response to the human cells and indeed 
the animals receiving immunosuppression lost up to 20 % of their weight prior to the 
surgery. 
Interestingly, the relative gastrocnemius muscle weight ratio was similar in the EngNT-
dCX repairs (n = 5), compared to EngNT-Schwann cell (n = 5) and EngNT-dADSC (n 
= 3) groups, even though less regeneration was observed in the mid-point of EngNT-
dCX. This may be because in the EngNT -dCX repairs, the degeneration of the 
gastrocnemius muscle is not as rapid. The effect of cyclosporine A (CsA) on neuron 
regeneration is not clear from the literature. CsA has been known to promote neuro-
protection and neuro-regeneration (Strittmatter et al., 1992; Ibarra et aI., 2007). The 
dose of CsA used in this experiment was 15 mg/kg body weight. A study comparing 
different doses of Cs A (2,4,8 and 16 mglkg), administered daily after primary repair of 
the rat sciatic nerve, concluded that CsA had adverse effects on peripheral nerve 
regeneration (Meirer et al., 2002). In this study by Meirer and colleagues, histology 
revealed significantly reduced numbers of myelinated axons, reduced myelin sheath 
thickness, and reduced diameters in all CsA treatment groups compared with the 
untreated control group, which seemed to be dose related for sensory neuron 
recovery (Meirer et al.. 2002). It would be essential to conduct control experiments 
using the same immunosuppression protocol in conjunction with the control groups 
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before the fmdings can be interpreted. However this was an initial experiment to 
investigate the feasibility of using the dCX cells, and while the data are not promising, 
they are inconclusive (without the controls) and it may be worth exploring these cells 
more in the future because the failure may be due to the technical challenge of testing 
human cells in rats. To avoid this issue, an alternative to immunosuppression would be 
to use nude rats or mice. 
The overall aim for this part of the study was to investigate the feasibility of 
constructing a repair device from EngNT using clinically relevant cells and materials. It 
has shown that bovine collagen, which is currently used in the clinic, can be used to 
produce EngNT. Furthermore, autologous (dADSC) and allogeneic (dCX) cells were 
tested within EngNT and results from the in vitro assay showed that they could promote 
guided neurite outgrowth within EngNT. The EngNT-dADSC devices could support 
neuron regeneration across a long gap in vivo, where regeneration was equivalent to that 
observed using EngNT-Schwann cell devices. There was some regeneration in the 
EngNT -dCX devices, however this was not consistent and requires further 
investigation. In summary, there is evidence of the efficacy of dADSCs and dCXs in a 
peripheral nerve therapy within EngNT devices. 
The findings of the present study suggest that the dADSCs have potential to be used for 
peripheral nerve repair. There are many advantages of using Schwann cell-like cells 
differentiated from a patient's own adipose-derived stem cells, these include: no 
immune reaction as it would be an autologous therapy, large amounts of adipose tissue 
can be collected via liposuction, eliminating the need for cell expansion and dADSCs 
have been reported to promote peripheral nerve regeneration in animal models. 
Peripheral nerve repair using the dCX cells is less clear, but that may be due to the 
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complications of using immunosuppression, so it is worth investigating them further. 
There is a clear advantage in using the dCX cells in that they are allogeneic and can be 
used for an off-the-shelf therapy; however allogeneic cells are potentially immunogenic 
and so are likely to evoke an immune response unless the patient is immunosuppressed. 
In summary, this part of the study demonstrates that EngNT can be constructed using 
clinically relevant cells and materials. Furthermore, the in vivo experiments provide an 
indication of efficacy of dAOSCs and dCXs in a peripheral nerve therapy based on 
EngNT, to support and guide neuronal regeneration. 
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6.0 Discussion 
The overall aim for this thesis was to develop an implantable tissue-engineered device 
for the surgical repair of the peripheral nervous system. The primary goals were to 
develop an aligned cellular biomaterial that could promote guided neuronal growth and 
be used to form the basis of a peripheral nerve repair device, with a proof-of-principle 
study to demonstrate efficacy in vivo in a model representative of the clinical situation. 
The main objectives were outlined in section 1.5: 
1. To develop and optimise a robust biomaterial with highly aligned cells 
[Engineered Neural Tissue (EngNT)) that could potentially form the basis of a 
peripheral nerve repair device. 
2. To engineer an 'endoneurium' using EngNT that supported the re-growth of 
axons across the gap in injured nerves. 
3. To investigate the feasibility of constructing a repair device from EngNT using 
clinically relevant cells and materials. 
As described in chapter 3, the alignment of cells in tethered hydrogels was preserved by 
plastic compression (stabilisation) once the gel was removed from the tethering bars, 
thereby forming EngNT. The studies in this chapter showed that EngNT-Schwann cell 
could support and guide neurite outgrowth in vitro (objective I). The next step was to 
investigate whether this material could be used to form the basis of a repair device. The 
studies described in chapter 4 assessed the different ways in which EngNT could be 
incorporated into a repair device, investigating different arrangements, amounts of 
'surface' and material, and cell density. This allowed decisions to be made regarding the 
EngNT arrangement within a conduit and indicated an arrangement based on ease of 
assembly and amount of regeneration in a short gap model (objective 2). A proof-of-
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principle study using EngNT -Schwann cell in a long gap model, representative of the 
clinical situation where an autograft would be indicated, showed that the EngNT-
Schwann cell devices supported regeneration across the gap (15 mm) at the injury site 
better than the empty conduit group (objective 2). 
The next step was to assess the feasibility of constructing an EngNT device from 
clinically relevant cells and materials (chapter 5). In these studies, a bovine source of 
native collagen was used to construct EngNT-Schwann cell, which was equivalent to 
the rat collagen EngNT -Schwann cell, in tenns of gel contraction and cellular alignment 
(objective 3). A comprehensive literature search was conducted to identify cells that 
might be suitable for this approach. Potential therapeutic cells were tested within 
EngNT; EngNT -dADSC devices showed promising preliminary results in the long gap 
(15 mm) in vivo model, indicating their potential for use in an autologous therapy 
(objective 3). An allogeneic source of cells was also used within EngNT (EngNT -dCX) 
and tested in the same model; results showed evidence of regeneration, however further 
investigation into their use is required (objective 3). 
This thesis began with the hypothesis that combining two techniques (cellular self-
alignment in tethered gels and plastic compression) could produce a robust material 
(EngNT) that could support guided neuronal growth. The combination of these two 
techniques had been attempted before (East et al., 2010); however established protocols 
for the procedure, and a quantitative assessment of the efficacy of this approach, were 
lacking. This project has developed protocols to identify some of the parameters 
required to construct aligned gels (e.g. contraction profiles to establish the required cell 
density), and an in vitro assay to assess the ability of EngNT to support and direct 
neurite outgrowth (i.e. amount and guidance) using 3D image analyses. The 
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combination of alignment and compression is now being developed for commercial use 
by TAP Biosystems (UK) in collaboration with Or James Phillips at The Open 
University, building on existing RAFT~ technology. 
The EngNT material constructed in this present study was used to form a repair device, 
demonstrating regeneration across a repair gap in a relevant model and showing it could 
be used with clinically relevant cells and materials. This study has moved this project 
significantly forward to a point where it is being developed further to construct a 
translational peripheral nerve repair device using therapeutic cells, in collaboration with 
two companies with the relevant expertise. 
There are limitations to the experimental models used in this study. For example, the in 
vitro model used to assay different cell types within EngNT used neurons from 
dissociated dorsal root ganglia, which comprised only the sensory neuronal bodies, 
therefore it does not permit the model to predict the ability of the cells to promote motor 
neuron regeneration. There are differences between motor and sensory neuron 
regeneration (Madorsky et al., 1998). In that study, Madorsky and colleagues showed 
that in the repair of 10 mm gap in rat sciatic nerve using collagen conduits, only 6.2 % 
of motor neurons regenerated and 63 % of sensory neurons regenerated, compared to 
primary (end-to-end) repair where 65 % of motor neurons and 79 % of sensory neurons 
had regenerated (Madorsky et aI., 1998). This could be because of a difference in the 
rate of neuron regeneration. It has been reported that motor neurons regenerate at a 
slower rate (1. 7 mm! day) than sensory neurons (5 mm/day) after primary repair in 
patients following a 2 year follow up (Dolenk and Janko, 1976). 
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The in vivo rat sciatic nerve model also has limitations in that rat nerve microstructure, 
composition, inflammatory response, fibrosis and capacity for nerve regeneration are 
not the same as they are in humans. The rat sciatic nerve used in the in vivo model has 
one fascicle at the level of the hips, whereas human sciatic nerve has multiple fascicles, 
which would potentially make the repair of human sciatic nerve different. Additionally, 
peripheral nerve regeneration is reported to be slower in humans than it is in rats 
(Buchthal and Kuhl, 1979). Furthermore, the proximal stump in humans is less able to 
respond to regenerative cues with time (Fu and Gordon, 1997); and fibrosis occurs after 
PNI in humans, which is inhibitory to the repair process, and so complete recovery is 
less likely to occur after PNI in humans, compared to rat. There is also a key difference 
in the critical sized gap length for rats (15 mm) and humans (30 mm). Despite these 
differences, there are advantages to using the rat sciatic model, these include: rats are 
easy to handle and care for, resistant to surgical infections, economical and can be 
investigated in large groups, which is why it is the most widely used animal model of 
peripheral nerve repair (Angius et al., 2012). 
For the rat sciatic nerve model, it is considered to be important to use a gap size that is 
at least 15 mm in length and to include an autograft control (Bellamkonda, 2006). The 
autograft control data can be used to defme the success criteria of the peripheral nerve 
repair device. Anatomical and histological analyses were used in this study, which are 
adequate to address the experimental questions, to assess the amount of axon 
regeneration at different points along the repair site. A limitation could be the sample 
size of five animals per group was used could be considered too low for reliable 
statistical analysis. However, this is a typical group size for these kinds of experiments 
and represents a compromise between statistical power and the principles of the 3Rs. 
There is currently no consensus on which models should be used to assess nerve 
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regeneration, but it is suggested that a rodent model could be used for initial 
experiments, before progressing to a larger animal for the repair of longer nerve gaps, 
for example in sheep or primate models (Angius et al., 2012). 
Whilst this project has made good progress in addressing the objectives outlined in 
section 1.5, there is scope for considerable additional future work to develop and fully 
characterise EngNT as a nerve repair material. The mechanisms of alignment of cells 
within collagen gels, and longer term effects of stability of EngNT, in terms of cellular 
alignment and guidance were not investigated. The mechanisms of alignment could be 
investigated by looking at how the cells attach to the collagen, by for example, blocking 
integrin attachments and assessing the extent of cell attachment by measuring the 
differences in gel contraction profiles. This could be useful for identifying desirable or 
undesirable cell-matrix interactions, which could identify ways to speed up cellular 
alignment and/or retain cellular alignment. It is important that cellular alignment 
persists in vivo for the duration required to support regeneration, and also alignment 
duration has implications for storage and transport of devices. It would be useful to 
assess whether the cells survive the freeze-thaw process within EngNT and also if the 
alignment is retained after thawing. Future work could investigate these and also some 
features such as cell differentiation or de-differentiation within the material. The 
phenotype and purity of the cells within EngNT should be characterised and monitored 
throughout the process of making EngNT devices, for example, after stabilisation and 
rolling to form rods. The EngNT could be characterised by immunostaining for 
antibodies to detect desirable or undesirable cell markers. 
Further investigation into using fibrin to construct EngNT is required, as there was an 
indication that fibrin could be used to generate EngNT that can promote guided neurite 
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outgrowth, however the cellular alignment in fibrin EngNT was inconsistent. Fibrin was 
not pursued in this study; however future work could investigate, for example, different 
concentrations and proportions of the constituents used to make fibrin EngNT to 
achieve reliable alignment, ability to support regeneration, stability and feasibility. 
The in vivo pilot work to assess the ability of differentiated human neural (CX) cells 
within EngNT to guide neurite regeneration across a 15 mm gap in rat sciatic nerve 
gave inconsistent results. There was some evidence of regeneration and some animals 
with no regeneration. The animals became unresponsive, lost weight and were eating 
much less than usual, as a result of immunosuppression with CsA, which may have also 
had an effect on regeneration. Future work could investigate the dose required for the 
immunosuppression and also the length of time the animal needs to be 
immunosuppressed for. The clinical grade ReNeuron CTX cells (undifferentiated) have 
been used in various species without immunosuppression (personal communication with 
ReNeuron), suggesting that immunosuppression may not be required at all. 
Alternatively, other methods of testing human cells in vivo could be employed such as 
using mutant strains of animal that are immunosuppressed, e.g. nude rats; or other 
immunosuppressive drugs, such as FK506. 
In the future, it would be interesting to understand the mechanisms by which cells in 
EngNT promote regeneration. Two areas to explore would be growth factor release and 
surface proteins. This could be investigated using in vitro models. For example, ELlS As 
to measure factors in the media, co-cultures using transwells to distinguish between 
contact-mediated and diffusible factors. Surface proteins could be identified by 
immunostaining co-cultures of neurons and glia. This would help determine optimal cell 
choice and differentiation state. Beneficial factors could be over-expressed or inhibitory 
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factors could be inhibited. This would also help to optimise the device design; for 
contact-mediated factors the cells would need to be on the surface of the material, or if 
the beneficial factors are diffusible than they could be distributed throughout the 
material. 
The in vivo experiments showed that the EngNT devices could support regeneration 
across the gap; however the growth into the repair device was significantly less than 
that observed in the graft groups. Further work to optimise the rod design is required, 
for example investigating the effect of altering the shape (for example expanded or 
tapered ends) or other physicaVchemical properties (for example using depots of 
immobilised neurotrophic factors) of the EngNT rods at the proximal part of the device 
to promote axonal ingrowth. The incorporation of neurotrophic factors or gradients of 
factors along the length of the device could also enhance regeneration into the device, as 
well as the incorporation of ECM components such as laminin (Dodla and 
Bellamkonda, 2(08). 
Future work could also explore alternative approaches for the construction of EngNT, 
such as using blends of materials, for example collagen and fibrin in order to exploit 
beneficial aspects of each. Combinations of materials could even be used to construct 
different sections within one rod, for example building EngNT rods with one end 
enriched in fibrin and the other enriched in collagen. The fibrin end of the rod could be 
positioned near the proximal stump, providing a fibrin bridge for rapid initial 
regeneration (Liu, 1992), with the potentially more stable collagen elements persisting 
for a longer duration to support sustained repair. Another approach could be to explore 
the potential of composite devices containing collagen rods and fibrin rods in various 
proportions within the repair conduit to promote regeneration. 
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The ultimate aim of this research is to develop a peripheral nerve repair device that can 
be implanted into patients. This will require further studies like the ones mentioned 
above, and also efficacy data for EngNT constructed with clinically relevant cells and 
materials, to obtain regulatory approval to begin clinical trials. An allogeneic device 
would be simpler to produce and administer because the device could be made and 
stored until it is required for use. This is in contrast to an autologous device, which 
would need to be prepared after the patient has sustained an injury, thereby adding a 
time delay to the treatment whilst the patient's cells are expanded and used to construct 
EngNT. A hypothetical scenario would be a patient with a forearm injury that includes 
extensive damage to the median nerve resulting in a gap. An EngNT device would be 
indicated as an alternative to the nerve autograft treatment. The EngNT rods with 
allogeneic cells, for example, dCTX (clinical grade differentiated human neural cells 
from ReNeuron), would be prepared from frozen and the required number of rods 
(corresponding to the size of the injured nerve) placed within an adjustable sheath, and 
then used to bridge the gap at the injury site. 
The field of regenerative medicine is progressing rapidly, particularly in terms of stem 
cell technology (for example iPS cells), and so in a few years there might be a totally 
different environment for tissue engineering technology. The technology reported here 
offers a simple. rapid and effective method for the manufacture of an aligned cellular 
biomaterial and can be made using various therapeutic cells. The most advanced cell 
therapies being used at the moment tend to be injections of cells. This project was 
centred on the next generation of tissue-engineered constructs that go a step further and 
organise the cells into tissues. 
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It is difficult to predict what the future holds in this dynamic field; perhaps off-the-shelf 
cells that require no immunosuppression and can be adapted to over-express 
neurotrophic factors and contract collagen to fonn EngNT in a matter of minutes? Or 
perhaps constructs with a functional neuronal element that can be connected to the 
proximal and distal stumps of the injured nerve to restore patients' function 
immediately? This work may be quite an early step along the road to a useful therapy, 
but it provides an exciting new alternative to the 'seeding cells into scaffolds' paradigm. 
In summary. this project demonstrated that there is potential for EngNT to be used 
within a nerve repair conduit in order to promote neuronal regeneration across a critical 
sized defect in vivo. 
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